SECOND AMENDED & RESTATED INVESTMENT AGREEMENT dated as of August 11, 2010 by and among HAMPTON ROADS BANKSHARES, INC., CARLYLE GLOBAL FINANCIAL SERVICES PARTNERS, L.P. and ACMO-HR, L.L.C.
Exhibit 2
EXECUTION VERSION
SECOND AMENDED & RESTATED INVESTMENT AGREEMENT
dated as of August 11, 2010
by and among
HAMPTON ROADS BANKSHARES, INC.,
CARLYLE GLOBAL FINANCIAL SERVICES PARTNERS, L.P.
and
ACMO-HR, L.L.C.
Table of Contents
Page | ||||
ARTICLE I PURCHASE; CLOSINGS |
5 | |||
1.1. Issuance, Sale and Purchase |
5 | |||
1.2. Closings; Deliverables for Closings; Conditions of Closings |
6 | |||
1.3. Escrow |
12 | |||
ARTICLE II REPRESENTATIONS AND WARRANTIES |
12 | |||
2.1. Certain Terms |
12 | |||
2.2. Representations and Warranties of the Company |
13 | |||
2.3. Representations and Warranties of Anchor Investors |
30 | |||
ARTICLE III COVENANTS |
32 | |||
3.1. Conduct of Business Prior to Second Closing |
32 | |||
3.2. No Shop |
34 | |||
3.3. Access; Reports; Confidentiality |
34 | |||
3.4. Filings; Other Actions |
35 | |||
3.5. Governance Matters |
37 | |||
3.6. Avoidance of Control |
39 | |||
3.7. Notice of Certain Events |
40 | |||
3.8. Commercially Reasonable Efforts |
40 | |||
3.9. Preemptive Rights |
40 | |||
3.10. Most Favored Nation |
42 | |||
3.11. Transfer Taxes |
43 | |||
3.12. Legend |
43 | |||
3.13. Continued Listing Authorization |
44 | |||
3.14. Registration Rights |
44 | |||
3.15. Certain Other Transactions |
57 | |||
3.16. Articles of Amendment |
58 | |||
3.17. Exchange Offers |
58 | |||
3.18. Rights Offering |
58 | |||
ARTICLE IV TERMINATION |
59 | |||
4.1. Termination |
59 | |||
4.2. Effects of Termination |
60 | |||
ARTICLE V INDEMNITY |
60 | |||
5.1. Indemnification by the Company |
60 | |||
5.2. Indemnification by the Anchor Investors |
61 | |||
5.3. Notification of Claims |
62 | |||
5.4. Indemnification Payment |
63 | |||
5.5. Exclusive Remedies |
64 | |||
ARTICLE VI MISCELLANEOUS |
64 | |||
6.1. Survival |
64 | |||
6.2. Expenses |
64 | |||
6.3. Other Definitions |
64 | |||
6.4. Independent Nature of Anchor Investors’ Obligations and Rights |
69 |
i
Page | ||||
6.5. Amendment and Waivers |
70 | |||
6.6. Amendment and Restatement of Original Investment Agreement |
70 | |||
6.7. Counterparts and Facsimile |
70 | |||
6.8. Governing Law |
70 | |||
6.9. Jurisdiction |
70 | |||
6.10. WAIVER OF JURY TRIAL |
70 | |||
6.11. Notices |
71 | |||
6.12. Entire Agreement |
72 | |||
6.13. Successors and Assigns |
72 | |||
6.14. Captions |
72 | |||
6.15. Severability |
72 | |||
6.16. Third Party Beneficiaries |
72 | |||
6.17. Public Announcements |
73 | |||
6.18. Specific Performance |
73 | |||
6.19. No Recourse |
73 | |||
6.20. Consent to Supplemental Waiver |
73 |
ii
LIST OF SCHEDULES AND EXHIBITS
Schedule I — Knowledge
Schedule II — Exchange Offer
Schedule III — Additional Disclosures
Schedule II — Exchange Offer
Schedule III — Additional Disclosures
Exhibit A — Form of Voting Agreement
Exhibit B — Passivity or Anti-Association Commitments
Exhibit C — Legal Opinion
Exhibit D — Acknowledgement and Waiver of Executive Officers
Exhibit E — Acknowledgement and Waiver of Directors
Exhibit F — Preferred Stock Articles of Amendment
Exhibit G — General Articles of Amendment
Exhibit H — Equity Commitment Letter
Exhibit B — Passivity or Anti-Association Commitments
Exhibit C — Legal Opinion
Exhibit D — Acknowledgement and Waiver of Executive Officers
Exhibit E — Acknowledgement and Waiver of Directors
Exhibit F — Preferred Stock Articles of Amendment
Exhibit G — General Articles of Amendment
Exhibit H — Equity Commitment Letter
3
SECOND AMENDED AND RESTATED INVESTMENT AGREEMENT, dated as of August 11, 2010 (this
“Agreement”), by and among Hampton Roads Bankshares, Inc., a Virginia corporation (the
“Company”), Carlyle Global Financial Services Partners, L.P. and ACMO-HR, L.L.C. (each, an
“Anchor Investor”, and collectively, the “Anchor Investors”).
RECITALS:
A. Second Amended and Restated Agreement. In connection with the execution of the
Additional Agreements (as defined in Recital C), the Company and the Anchor Investors desire to
amend and restate, in its entirety, the Investment Agreement, dated as of May 23, 2010 (the
“Original Investment Agreement”), and the Amended and Restated Investment Agreement, dated
as of June 30, 2010 (the “Amended and Restated Investment Agreement”), by among the Company
and the Anchor Investors, with this Agreement.
B. The Investment. The Company intends to issue and sell to the Anchor Investors, and
the Anchor Investors, severally and not jointly, intend to purchase from the Company, the number of
shares of Common Stock of the Company (the “Common Stock” or “Common Shares”) as
will result in (i) the Carlyle Anchor Investor owning a number of Common Shares equal to 23.3% of
the shares of Common Stock outstanding immediately after giving effect to the transactions
contemplated by the Transaction Documents (and assuming the Rights Offering is fully subscribed
without use of the backstop commitments) for an aggregate purchase price of $72,982,786 and (ii)
the Anchorage Anchor Investor owning a number of Common Shares equal to 21.3% of the shares of
Common Stock outstanding immediately after giving effect to the transactions contemplated by the
Transaction Documents (and assuming the Rights Offering is fully subscribed without use of the
backstop commitments) for an aggregate purchase price of $66,708,076 (the “Investment”).
Subject to the satisfaction or waiver of the terms and conditions to be satisfied at or prior to
the First Closing, a portion of the Common Shares to be purchased pursuant to the Investment shall
be purchased at the First Closing and, subject to the satisfaction or waiver of the conditions to
be satisfied at or prior to the Second Closing, the remainder of the Common Shares to be purchased
pursuant to the Investment shall be purchased at the Second Closing.
C. Other Private Placements. The Company intends to effect one or more private
placement transactions of Common Stock to accredited investors (the “Additional Investors”,
and together with the Anchor Investors, the “Investors”) with the closing of such
transactions to occur simultaneously with the First Closing (the “Other Private
Placements”). The Investment and the Other Private Placements are currently anticipated to
generate approximately $255.0 million of gross proceeds to the Company, and the Company, in
connection with the Other Private Placements, shall enter into agreements with the Additional
Investors (including the CapGen Investment Agreement) (the “Additional Agreements”).
D. TARP Exchange. The United States Department of Treasury (the “Treasury”)
holds (i) 80,347 shares of Fixed Rate Cumulative Perpetual Preferred Stock, Series C (the “TARP
Preferred Stock”) and (ii) a warrant, dated December 31, 2008, to purchase 1,325,858 shares of
the Common Stock at an exercise price of $9.09 per share (the “TARP Warrant”). On the terms
and subject to the conditions set forth in a letter dated May 18, 2010 from Treasury to the Company
(the “Treasury Letter”), and an Exchange Agreement to be executed by the Treasury and the
Company incorporating the terms of the Treasury Letter (the “Exchange Agreement”), the
Company intends to exchange the TARP Preferred Stock for a new series of mandatorily convertible
preferred stock (the “Convertible Preferred Stock”), which such shares the Company will
then convert into 52,225,550 shares of Common Stock (subject to adjustment as provided therein),
and to amend the TARP Warrant to, among other things, reduce the exercise price thereof to $0.40
per share (collectively, the “TARP Exchange”).
4
E. Exchange Offers. Prior to the First Closing, the Company intends to conduct
exchange offers (the “Exchange Offers”) pursuant to which the Company will offer to
exchange each share of the Non-Convertible Non-Cumulative Perpetual Preferred Stock, Series A (the
“Series A Preferred Stock”) for Common Shares and each share of the Non-Convertible
Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”) for
Common Shares, in each case on the terms set forth on Schedule II hereto.
F. Charter Amendment and Stockholder Proposals. In connection with the transactions
contemplated hereby and the Exchange Offers, the Company will call a special meeting of
stockholders for the purpose of (i) increasing the authorized number of Common Shares to an amount
necessary to consummate the transactions contemplated by the Transaction Documents and the other
transactions referred to herein and therein, (ii) amending the terms of the Series A Preferred
Stock and the Series B Preferred Stock, (iii) approving the issuance of the Common Shares pursuant
to NASDAQ Marketplace Rules 5635(b) and 5635(d), (iv) approving a reverse stock split of the Common
Shares, if such approval is required by the NASDAQ Marketplace Rules or as the Company otherwise
deems necessary and (v) adopting certain other amendments to the Articles of Incorporation of the
Company.
G. The Rights Offering. Following the First Closing, the Company will commence a
rights offering providing holders of record of the Common Stock on the day prior to the First
Closing Date with the right to invest in Common Stock at the same price per share paid by the
Anchor Investors. The rights will be non-transferable and will provide for the purchase of not less
than $20 million and up to $40 million of Common Stock by such existing stockholders, as determined
by the Company.
H. Voting Agreements. Each of the members of the Board of Directors has entered into
separate voting agreements substantially in the form of Exhibit A hereto whereby such
member of the Board of Directors agrees to vote their shares of Common Stock in favor of the
Stockholder Proposals.
I. Equity Commitment Letter. Concurrently with the execution and delivery of this
Agreement, and as a condition to the willingness of the Company to enter into this Agreement, the
Anchorage Anchor Investor and Anchorage Capital Master Offshore, Ltd. (“ACMO”) have entered
into an equity commitment letter, dated as of the date hereof (the “Equity Commitment
Letter”), which supersedes that certain equity commitment letter dated May 23, 2010, and that
certain equity commitment letter dated June 30, 2010, between ACMO and the Anchorage Anchor
Investor.
NOW, THEREFORE, in consideration of the foregoing mutual covenants contained in this
Agreement, and for other good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the Company and each Anchor Investor, severally and not jointly, hereby agree
as follows:
ARTICLE I
PURCHASE; CLOSINGS
1.1. Issuance, Sale and Purchase.
(a) At the First Closing, subject to the terms and conditions set forth herein, the Company
agrees to issue and sell (i) to the Carlyle Anchor Investor, and the Carlyle Anchor Investor,
severally and not jointly with the Anchorage Anchor Investor, agrees to purchase from the Company,
free and clear of any Liens, the number of Common Shares (excluding any shares of Common Stock
issuable upon exercise in full of the warrant to be issued to an Affiliate of the Carlyle Anchor
Investor pursuant to the Carlyle Investor Letter (the “Carlyle Warrant”)) equal to 24.1% of
the shares of Common Stock
5
outstanding immediately after giving effect to the transactions
contemplated by the Transaction
Documents to occur simultaneously with or prior to the First Closing Date, for an aggregate
purchase price of $65,982,786 payable by the Carlyle Anchor Investor to the Company and (ii) to
the Anchorage Anchor Investor, and the Anchorage Anchor Investor, severally and not jointly with
the Carlyle Anchor Investor, agrees to purchase from the Company, free and clear of any Liens, the
number of Common Shares (excluding any shares of Common Stock issuable upon exercise in full of the
warrants to be issued to an Affiliate of the Anchorage Anchor Investor pursuant to the Anchorage
Investor Letter (the “Anchorage Warrants”, and together with the Carlyle Warrant, the
“Warrants”)) equal to 22.4% of the shares of Common Stock outstanding immediately after
giving effect to the transactions contemplated by the Transaction Documents to occur simultaneously
with or prior to the First Closing Date, for an aggregate purchase price of $61,208,076 payable by
the Anchorage Anchor Investor to the Company (the amounts payable pursuant to clause (i) and (ii)
above, collectively the “First Purchase Price”).
(b) At the Second Closing, subject to the terms and conditions set forth herein, the Company
agrees to issue and sell (i) to the Carlyle Anchor Investor, and the Carlyle Anchor Investor,
severally and not jointly with the Anchorage Anchor Investor, agrees to purchase from the Company,
free and clear of any Liens, the number of Common Shares (excluding any shares of Common Stock
issuable upon exercise in full of the Carlyle Warrant) equal to 23.3% of the shares of Common Stock
outstanding immediately after giving effect to the Rights Offering and the other transactions
contemplated by the Transaction Documents to occur simultaneous with or prior to the Second Closing
(including the backstop purchase to be provided, if required, by CapGen pursuant to the CapGen
Investment Agreement), for an aggregate purchase price of $7,000,000 payable by the Carlyle Anchor
Investor to the Company and (ii) to the Anchorage Anchor Investor, and the Anchorage Anchor
Investor, severally and not jointly with the Carlyle Anchor Investor, agrees to purchase from the
Company, free and clear of any Liens, the number of Common Shares (excluding any shares of Common
Stock issuable upon exercise in full of the Anchorage Warrants) equal to 21.3% of the shares of
Common Stock outstanding immediately after giving effect to the transactions contemplated by the
Transaction Documents to occur simultaneous with or prior to the Second Closing (including the
backstop purchase to be provided, if required, by CapGen pursuant to the CapGen Investment
Agreement), for an aggregate purchase price of $5,500,000 payable by the Anchorage Anchor Investor
to the Company (the “Second Purchase Price”; and together with the First Purchase Price,
the “Purchase Price”).
1.2. Closings; Deliverables for Closings; Conditions of Closings.
(a) First Closing. The closing of the purchase of the Common Shares by the Anchor
Investors pursuant to Section 1.1(a) (the “First Closing”) shall occur on the
second Business Day following the satisfaction or waiver of the conditions to the First Closing set
forth in Section 1.2(d) (other than those conditions that by their nature are to be
satisfied at the First Closing, but subject to the satisfaction or waiver of those conditions)
(provided, that the Company shall provide the Anchor Investors with notice of the First
Closing Date and provided further that the First Closing Date shall be postponed as
necessary to ensure that the First Closing Date occurs no earlier than ten (10) Business Days after
the foregoing notice has been provided by the Company to the Anchor Investors) at the offices of
Xxxxxxx Xxxxxxx & Xxxxxxxx located at 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, XX 00000 or such other date
or location as agreed in writing by the parties. The date of the First Closing is referred to as
the “First Closing Date.”
(b) Second Closing. The closing of the purchase of the Common Shares by the Anchor
Investors pursuant to Section 1.1(b) (the “Second Closing”) shall occur on the date
of the closing of the Rights Offering and the backstop purchase to be provided, if required, by
CapGen pursuant to the CapGen Investment Agreement following the satisfaction of the conditions to
the Second Closing set forth in Section 1.2(f) (other than those conditions that by their
nature are to be satisfied at the Second
6
Closing, but subject to the satisfaction or waiver of
those conditions) (provided, that the Company shall
provide the Anchor Investors with notice of the Second Closing Date and provided further that
the Second Closing Date shall be postponed as necessary to ensure that the Second Closing Date
occurs no earlier than ten (10)F Business Days after the foregoing notice has been provided by the
Company to the Anchor Investors) at the offices of Xxxxxxx Xxxxxxx & Xxxxxxxx located at 000
Xxxxxxxxx Xxxxxx, Xxx Xxxx, XX 00000 or such other date or location as agreed in writing by the
parties. The date of the Second Closing is referred to as the “Second Closing Date.” The
term “Closing” shall apply to the First Closing and/or the Second Closing, as applicable
and the term “Closings” shall refer to the First Closing and the Second Closing,
collectively. The term “Closing Date” shall apply to the First Closing Date and/or the
Second Closing Date, as applicable and the term “Closing Dates” shall refer to the First
Closing Date and the Second Closing Date, collectively.
(c) First Closing Deliverables. At the First Closing the parties shall make the
following deliveries:
(A) The Company shall have delivered to each Anchor Investor a certificate
evidencing the incorporation and good standing of the Company and each of the
Company Subsidiaries as of a date within ten (10) Business Days before the First
Closing Date;
(B) The Company shall have delivered (or shall deliver concurrently with the
First Closing) to each Anchor Investor the number of the Common Shares to be
purchased pursuant to Section1.1(a) registered in the name of such
Anchor Investor;
(C) The Company shall have delivered to such Anchor Investor such other
documents relating to the purchase and sale of the Common Shares contemplated by
this Agreement as such Anchor Investors shall have reasonably requested; and
(D) The Escrow Agent shall deliver concurrently with the First Closing the
Escrow Funds comprising the First Purchase Price by wire transfer of immediately
available funds to the account provided to the Escrow Agent by the Company at least
one (1) Business Day prior to the First Closing Date (the “Company
Account”); provided, however, that any Anchor Investor that is
an investment company registered under the Investment Company Act of 1940, as
amended, shall not be required to deliver the Purchase Price prior to its receipt of
the Common Shares purchased by it hereunder.
(d) First Closing Conditions. (1) The respective obligations of each Anchor Investor,
on the one hand, and the Company, on the other hand, to consummate the First Closing are each
subject to the satisfaction or written waiver by the Company and the Anchor Investors of the
following conditions prior to the First Closing:
(A) No provision of any Law and no judgment, injunction, order or decree shall
prohibit the First Closing or the Second Closing or shall prohibit or restrict the
Anchor Investors or any of their Affiliates from owning or voting any Common Shares
to be purchased pursuant to the Transaction Documents;
(B) All Governmental Consents required to have been obtained at or prior to the
First Closing Date in connection with the execution, delivery or performance of the
Transaction Documents and the consummation of the transactions contemplated hereby
and thereby (including the transactions to be effected at the Second Closing) shall
have been obtained and shall be in full force and effect;
7
(C) The waiting period (and any extension thereof) applicable to the
consummation of the transactions contemplated by the Transaction Documents under the
HSR Act shall have expired or been earlier terminated; and
(D) The General Stockholder Proposals shall have been approved and adopted and
the General Articles of Amendment shall have been duly filed with the Commonwealth
of Virginia State Corporation Commission and shall be in full force and effect.
(2) The obligation of each Anchor Investor to purchase the Common Shares to be
purchased by it at the First Closing is also subject to the satisfaction or written waiver
by such Anchor Investor of the following conditions prior to the First Closing:
(A) The representations and warranties of the Company set forth in this
Agreement shall be true and correct in all respects on and as of May 23, 2010 and on
and as of the First Closing Date as though made on and as of the First Closing Date,
except where the failure to be true and correct (without regard to any materiality
or Material Adverse Effect qualifications contained therein), individually or in the
aggregate, would not be reasonably likely to have a Material Adverse Effect with
respect to the Company (and except that (1) representations and warranties made as
of a specified date shall be true and correct as of such date and (2) the
representations and warranties of the Company set forth in Section 2.2(b)
(but only with respect to the last sentence thereof), Section 2.2(c),
Section 2.2(f) and Section 2.2(q)(4) shall be true and correct in
all respects;
(B) The Company shall have performed and complied with in all material respects
all agreements, covenants and conditions required by the Transaction Documents to be
performed by it on or prior to the First Closing Date (except that with respect to
agreements, covenants and conditions that are qualified by materiality, the Company
shall have performed and complied with such agreements, covenants and conditions, as
so qualified, in all respects);
(C) Each Anchor Investor shall have received a certificate, dated as of the
First Closing Date, signed on behalf of the Company by a senior executive officer
certifying to the effect that the conditions set forth in Section
1.2(d)(2)(A) and Section 1.2(d)(2)(B) have been satisfied on and as of
the First Closing Date;
(D) The Investors, the Company and the Escrow Agent shall have executed and
delivered the Escrow Agreement (as defined below) and the Escrow Agent shall have
received prior to 5:00 pm (EST) on the Business Day immediately preceding the First
Closing Date escrow funds in an amount equal to the anticipated proceeds from the
sale of the Common Shares, in each case at a price per share of $0.40, in an
aggregate amount of not less than $255,000,000;
(E) Each Anchor Investor shall have received written confirmation, satisfactory
in its reasonable good faith judgment, from the Board of Governors of the Federal
Reserve System (the “Federal Reserve”) and the Virginia Bureau of Financial
Institutions (the “BFI”) to the effect that (or, with respect to clause
(iii), each Anchor Investor shall otherwise be reasonably satisfied that) the
purchase of the Common Shares and the consummation of the Closings and the
transactions contemplated by the Transaction Documents will not result in the Anchor
Investor or any of its Affiliates
8
being deemed in control of the Company for purposes of (i) the Bank Holding
Company Act of 1956, as amended (the “BHC Act”), (ii) the Code of Virginia,
or (iii) the cross-guaranty liability provisions of the Federal Deposit Insurance
Act, as amended (the “FDI Act”), or (iv) otherwise being regulated as a bank
holding company within the meaning of the BHC Act;
(F) Each Anchor Investor shall have received from the Federal Reserve a written
non-objection to the notice filed by such Anchor Investor in connection with its
purchase of shares of Common Stock pursuant to the Change of Bank Control Act of
1978, as amended;
(G) There shall not be any action taken, or any Law enacted, entered, enforced
or deemed applicable to the Company or the Company Subsidiaries, the Anchor
Investors or the transactions contemplated by the Transaction Documents, by any
Governmental Entity, whether in connection with the Governmental Consents specified
in Section 1.2(d)(1)(B) or otherwise, which imposes any restriction or
condition (other than such restrictions as are described in the passivity or
anti-association commitments described on Exhibit B hereto) which any Anchor
Investor determines, in its reasonable good faith judgment, is materially and
unreasonably burdensome or would reduce the benefits of the transactions
contemplated hereby to such Anchor Investor to such a degree that such Anchor
Investor would not have entered into the Transaction Documents had such condition or
restriction been known to it on May 23, 2010 (any such condition or restriction, a
“Burdensome Condition”), and, for the avoidance of doubt, any requirements
to disclose the identities of limited partners, shareholders or members of any
Anchor Investor or its Affiliates or its investment advisors, other than Anchorage
Capital Partners, L.P. and Anchorage Capital Partners Offshore, Ltd., shall be
deemed a Burdensome Condition unless otherwise determined by such Anchor Investor in
its sole discretion);
(H) As of the First Closing Date, the Company and the Company Subsidiaries
shall have, on a consolidated basis, (a) at least $200,000,000 in (i) cash and due
from banks, (ii) deposits in other banks, (iii) overnight funds sold and due from
the Federal Reserve Bank and (iv) securities available for sale that have not been
pledged and for which a liquid market and price quotations are immediately available
through a major securities dealer; and (b) at least $2,200,000,000 in non-brokered
deposits (including money market, demand, checking, savings and transactional
accounts and certificates of deposits);
(I) Since May 23, 2010, a Material Adverse Effect shall not have occurred and
no change or other event shall have occurred that, either individually or in the
aggregate, would reasonably be likely to have a Material Adverse Effect;
(J) The Company shall have received (or shall receive concurrently with the
First Closing) proceeds from the sale of Common Shares pursuant to the Investment at
the First Purchase Price set forth herein and from the Other Private Placements, in
each case at a price per share of $0.40, in an aggregate amount of not less than
$235,000,000;
(K) Either (i) not less than 100% of the aggregate liquidation preference of
the outstanding shares of the Series A Preferred Stock and the Series B Preferred
Stock shall have been exchanged for Common Shares pursuant to the Exchange Offers or
(ii) (A) not less than 51% of the aggregate liquidation preference of the
outstanding shares of
9
the Series A Preferred Stock and the Series B Preferred Stock shall have been
exchanged for Common Shares pursuant to the Exchange Offer and (B) the Series A
Stockholder Proposals and the Series B Stockholder Proposals shall have been
approved and adopted and the Preferred Stock Articles of Amendment shall have been
duly filed with the Commonwealth of Virginia State Corporation Commission and shall
be in full force and effect.
(L) (1) All of the Convertible Preferred Stock issued by the Company shall have
been Tier 1 capital at all times while outstanding under applicable Law and Federal
Reserve regulations and guidelines, unless all conditions to
conversion of all shares of Convertible Preferred Stock were satisfied or waived in writing prior to
the issuance of such shares and such Convertible Preferred Stock was issued and
converted into Common Stock on the same day; and (2) contemporaneously with the
First Closing, all of the TARP Preferred Stock shall have been exchanged for or
converted into 52,225,550 shares of Common Stock, directly or through an exchange
into and conversion of the Convertible Preferred Stock into Common Stock immediately
following and on the same day the Convertible Preferred Stock was issued;
(M) The TARP Warrants shall have been amended to reflect the reduced conversion
price of $0.40 per share pursuant to the terms and conditions of the Treasury
Letter;
(N) At any time after May 23, 2010, the Company shall not have agreed to enter
into or entered into (a) any agreement or transaction in order to raise capital or
(b) any transaction that resulted in, or would result in if consummated, a Change in
Control of the Company, in each case, other than in connection with the transactions
contemplated by the Transaction Documents;
(O) The Board of Directors shall have eleven (11) members, including two
Designated Anchor Investor Directors, one designated by the CapGen Investor and the
chief executive officer of the Company;
(P) Each Anchor Investor shall have received a certificate signed on behalf of
the Company by a senior executive of the Company, dated as of the First Closing
Date, certifying (a) the resolutions adopted by the Board of Directors or a duly
authorized committee thereof approving the transactions contemplated by the
Transaction Documents and the issuance of the Common Shares in the Other Private
Placements, (b) the current versions of the Articles of Incorporation, as amended,
and By-Laws, as amended, of the Company and (c) as to the signatures and authority
of the individuals signing this Agreement and related documents on behalf of the
Company.
(Q) At the First Closing, the Company shall have caused each Anchor Investor to
receive, substantially in the forms set forth as Exhibit C hereto, opinions
of Xxxxxxxx Xxxxxx, counsel to the Company.
(R) (i) No later than 30 days after May 23, 2010, the Company shall have caused
each of the executives identified in the Disclosure Schedules relating to
Section 2.2(x)(7)(A), and each member of the Board of Directors, to execute
an acknowledgement and a waiver, in the form attached as Exhibit D or
Exhibit E hereto, as applicable and (ii) prior to the First Closing, the
Company shall amend all Benefit Plans identified in the Disclosure Schedules
relating to Section 2.2(x)(7) to clarify that the
10
transactions contemplated by the Transaction Documents shall not result in or
accelerate any payment or severance benefit becoming due to any current of former
employee, officer or director of the Company or any Company Subsidiary; and
(S) The Common Stock, including the Common Shares issued hereunder, (i) shall
be designated for listing and quotation on the Nasdaq Stock Market and (ii) shall
not have been suspended, as of the First Closing Date, by the SEC or the Nasdaq
Stock Market from trading on the Nasdaq Stock Market.
(3) The obligations of the Company hereunder to issue and sell the Common Shares to
each Anchor Investor at the First Closing is subject to the satisfaction or written waiver
by the Company of the following conditions prior to the First Closing:
(A) The representations and warranties of each Anchor Investor set forth in
this Agreement shall be true and correct in all respects on and as of May 23, 2010
and on and as of the First Closing Date as though made on and as of the First
Closing Date except where the failure to be true and correct (without regard to any
materiality qualifications contained therein) would materially adversely affect the
ability of such Anchor Investor to perform its obligations hereunder;
(B) Each Anchor Investor shall have performed and complied with in all material
respects all agreements, covenants and conditions required by the Transaction
Documents to be performed by it on or prior to the First Closing Date (except that
with respect to agreements, covenants and conditions that are qualified by
materiality, each Anchor Investor shall have performed and complied with such
agreements, covenants and conditions, as so qualified, in all respects).
(C) The Company shall have received a certificate, dated as of the First
Closing Date, from each Anchor Investor signed on behalf of such Anchor Investor by
a senior executive officer of such Anchor Investor certifying to the effect that the
conditions set forth in Section 1.2(d)(3)(A) and Section
1.2(d)(3)(B) have been satisfied on and as of the First Closing Date.
(e) Second Closing Deliverables. At the Second Closing the parties shall make the
following deliveries:
(A) The Company shall have delivered (or shall deliver concurrently with the
Second Closing) to each Anchor Investor the number of the Common Shares to be
purchased pursuant to Section 1.1(b), registered in the name of such Anchor
Investor;
(B) The Company shall have delivered to such Anchor Investor such other
documents relating to the purchase and sale of the Common Shares contemplated by
this Agreement as such Anchor Investors shall have reasonably requested in
connection with the Second Closing; and
(C) The Escrow Agent shall deliver concurrently with the Second Closing the
Escrow Funds comprising the Second Purchase Price by wire transfer of immediately
available funds to the Company Account; provided, however, that any
Anchor Investor that is an investment company registered under the Investment
Company Act of 1940, as amended, shall not be required to deliver the Purchase Price
prior to its receipt of the Common Shares purchased by it hereunder.
11
(f) Second Closing Conditions. The respective obligations of each Anchor Investor, on
the one hand, and the Company, on the other hand, to consummate the Second Closing are each subject
to the satisfaction of the following conditions prior to the Second Closing:
(A) The First Closing shall have been consummated in accordance with the terms
of this Agreement;
(B) The Rights Offering shall have been consummated in accordance with the
terms of this Agreement; and
(C) The Company shall have received (or shall receive concurrently with the
Second Closing) proceeds from the sale of the Common Shares pursuant to the
Investment, the Other Private Placements and the Rights Offering, in each case at
the purchase prices set forth herein and at a price per share of $0.40, an
aggregate amount of not less than $275,000,000.
1.3. Escrow.
Prior to the First Closing, each of the Anchor Investors, the Company and Mellon Investors LLC
(the “Escrow Agent”) shall have entered into an escrow agreement substantially in the form
customarily provided by the Escrow Agent, subject to such modifications as may be mutually agreed
to conform such agreement to the transactions contemplated by the Transaction Documents (the
“Escrow Agreement”). The Escrow Agreement will provide that (a) no later than 5:00 pm
(EST) on the Business Day immediately preceding the First Closing, each of the Anchor Investors
shall deposit into escrow by wire transfer of immediately available funds the Purchase Price
payable for its portion of the Investment (the “Escrow Funds”) and (b) the Escrow Funds
shall be disbursed to the Company Account only after (i) with respect to the First Closing, all of
the conditions contained in Section 1.2(d)(2) of this Agreement, and (ii) with respect to
the Second Closing, all of the conditions contained in Section 1.2 (f) of this Agreement,
have been satisfied or waived by each of the Anchor Investors.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
2.1. Certain Terms.
(a) As used in this Agreement, the term “Material Adverse Effect” means any
circumstance, event, change, development or effect that, individually or in the aggregate, would
reasonably be expected to (i) result in a material adverse effect on the assets, liabilities,
business, condition (financial or otherwise) or results of operations of the Company and its
Subsidiaries, taken as a whole, or (ii) materially impair or delay the ability of the Company or
any of the Company Subsidiaries to perform its or their obligations under the Transaction Documents
to consummate either Closing or any of the transactions contemplated hereby or thereby;
provided, however, that in determining whether a Material Adverse Effect has occurred,
there shall be excluded any effect to the extent resulting from (A) actions or omissions of the
Company or any Company Subsidiary expressly required by the terms of the Transaction Documents; (B)
changes, after May 23, 2010, in general economic conditions in the United States, including
financial market volatility or downturn, (C) changes, after May 23, 2010, affecting generally the
industries or markets in which the Company operates, (D) acts of war, sabotage or terrorism,
military actions or the escalation thereof, or outbreak of disease, (E) any changes, after May 23,
2010, in applicable Laws or accounting rules or principles, including changes in GAAP, (F) the
announcement or pendency of the transactions contemplated by the Transaction Documents or (G) any
failure by the
12
Company or any of the Company Subsidiaries to meet any internal projections or
forecasts with regard to
the assets, liabilities, business, condition (financial or otherwise) or results of operations
of the Company and its subsidiaries, taken as a whole (it being understood and agreed that the
facts and circumstances giving rise to such failure that are not otherwise excluded from the
determination of whether a Material Adverse Effect has occurred may be taken into account in
determining whether there has been a Material Adverse Effect); provided further,
however, that any circumstance, event, change, development or effect referred to in clauses
(B), (C), (D) or (E) above shall be taken into account in determining whether a Material Adverse
Effect has occurred or would reasonably be expected to occur to the extent that such circumstance,
event, change, development or effect has a disproportionate effect on the Company compared to other
participants in the industries or markets in which the Company operates; and provided,
further, however, that the parties agree that the facts, events or occurrences
described on Schedule III attached hereto shall not constitute a Material Adverse Effect.
(b) As used in this Agreement, the term “Previously Disclosed” with regard to (1) any
party means information set forth on its Disclosure Schedule corresponding or responsive to the
provision of this Agreement, to which such information relates, provided, however,
that if such information is disclosed in such a way as to make its relevance or applicability to
another provision of this Agreement reasonably apparent on its face, such information shall be
deemed to be responsive to such other provision of this Agreement, (2) the Company includes
information regarding the Company set forth on Schedule III attached hereto and (3) the
Company includes information publicly disclosed by the Company in (A) the Company’s Annual Report
on Form 10-K for the fiscal year ended December 31, 2009, as filed by it with the Securities and
Exchange Commission (the “SEC”), (B) the Company’s Quarterly Report on Form 10-Q for the
quarter ended March 31, 2010, as filed by it with the SEC or (C) any Current Report on Form 8-K
filed or furnished by it with the SEC since January 1, 2010 available prior to May 23, 2010
(excluding any risk factor disclosures contained in such documents under the heading “Risk Factors”
and any disclosure of risks included in any “forward-looking statements” disclaimer or other
statements that are similarly non-specific and are predictive or forward-looking in nature).
Notwithstanding anything in this Agreement to the contrary, the mere inclusion of an item in a
Disclosure Schedule shall not be deemed an admission that such item represents a material exception
or material fact, event or circumstance or that such item has had or would reasonably be expected
to have a Material Adverse Effect on the Company or the Anchor Investors, as applicable.
2.2. Representations and Warranties of the Company.
Except as Previously Disclosed (other than with respect to Sections 2.2(a),
2.2(d)(1), 2.2(d)(3), 2.2(e), 2.2(l), 2.2(o),
2.2(p), 2.2(u), 2.2(v), 2.2(w), 2.2(y), 2.2(bb),
2.2(dd), 2.2(ee), 2.2(hh), 2.2(ii), 2.2(jj),
2.2(kk) and 2.2(ll)), the Company hereby represents and warrants to each of the
Anchor Investors, as of May 23, 2010 and as of the First Closing Date (except for the
representations and warranties that are as of a specific date which shall be made as of that date),
that:
(a) Organization and Authority. Each of the Company and the Company Subsidiaries is a
corporation or limited liability company duly organized and validly existing under the laws of the
jurisdiction of its incorporation or organization, is duly qualified to do business and is in good
standing in all jurisdictions where its ownership or leasing of property or the conduct of its
business requires it to be so qualified and where failure to be so qualified would have,
individually or in the aggregate, a Material Adverse Effect, and has the corporate power and
authority to own its properties and assets and to carry on its business as it is now being
conducted. The Company has furnished to the Anchor Investors true, correct and complete copies of
the articles of incorporation and by-laws (or similar governing documents) as amended through the
date of this Agreement for the Company, The Bank of Hampton Roads (“Hampton Roads”) and
Shore Bank (“Shore”, and together with Hampton Roads, the “Banks”). The Company is
duly registered as a bank holding company under the BHC Act.
13
(b) Company Subsidiaries. The Company has Previously Disclosed a true, complete and
correct list of all of its subsidiaries as of the date of this Agreement (each, a “Company
Subsidiary”, and, collectively, the “Company Subsidiaries”). Except for the Company
Subsidiaries, the Company does not own beneficially, directly or indirectly, more than 5% of any
class of equity securities or similar interests of any corporation, bank, business trust,
association or similar organization, and is not, directly or indirectly, a partner in any
partnership or party to any joint venture. The Company owns, directly or indirectly, all of its
interests in each Company Subsidiary free and clear of any and all Liens. The deposit accounts of
Hampton Roads and Shore are insured by the Federal Deposit Insurance Corporation (“FDIC”)
to the fullest extent permitted by the FDI Act and the rules and regulations of the FDIC
thereunder, and all premiums and assessments required to be paid in connection therewith have been
paid when due. The Company beneficially owns all of the outstanding capital securities and has sole
control of Hampton Roads and Shore.
(c) Capitalization. The authorized Capital Stock of the Company consists of (i)
100,000,000 shares of Common Stock and (ii)1,000,000 shares of preferred stock (including shares of
Series A Preferred Stock, Series B Preferred Stock and TARP Preferred Stock) (the “Company
Preferred Stock”). As of the close of business on May 14, 2010 (the “Capitalization
Date”), there were 22,153,594 shares of Common Stock outstanding and 23,266 shares of Series A
Preferred Stock, 37,550 shares of Series B Preferred Stock and 80,347 shares of TARP Preferred
Stock outstanding. In addition, the TARP Warrant allows for the purchase of 1,325,858 shares of
Common Stock by Treasury at an exercise price of $9.09 per share. Since the Capitalization Date and
through the date of this Agreement, except in connection with the Transaction Documents and the
transactions contemplated hereby and thereby, including the Investment, the Other Private
Placements, the TARP Exchange, the Exchange Offers and the Rights Offering, the Company has not (i)
issued or authorized the issuance of any shares of Common Stock or Company Preferred Stock, or any
securities convertible into or exchangeable or exercisable for shares of Common Stock or Company
Preferred Stock, (ii) reserved for issuance any shares of Common Stock or Company Preferred Stock
or (iii) repurchased or redeemed, or authorized the repurchase or redemption of, any shares of
Common Stock or Company Preferred Stock. As of the close of business on the Capitalization Date,
other than in respect of the Series A Preferred Stock, the Series B Preferred Stock, the TARP
Preferred Stock, the TARP Warrant and awards outstanding under or pursuant to the Benefit Plans in
respect of which an aggregate of 4,447,814 shares of Common Stock have been reserved for issuance
(including 1,799,657 shares reserved with respect to the 2002 Dividend Reinvestment and Optional
Cash Purchase Plan), no shares of Common Stock or Company Preferred Stock were reserved for
issuance. All of the issued and outstanding shares of Common Stock and Company Preferred Stock have
been duly authorized and validly issued and are fully paid, nonassessable and free of preemptive
rights, with no personal liability attaching to the ownership thereof. None of the outstanding
shares of Capital Stock or other securities of the Company or any of the Company Subsidiaries was
issued, sold or offered by the Company or any Company Subsidiary in violation of the Securities Act
or the securities or blue sky laws of any state or jurisdiction, or any applicable securities laws
in the relevant jurisdictions outside of the United States. No bonds, debentures, notes or other
indebtedness having the right to vote on any matters on which the stockholders of the Company may
vote (“Voting Debt”) are issued and outstanding. Section 2.2(c) of the Disclosure
Schedule sets forth the following information with respect to each outstanding option to purchase
shares of Common Stock (a “Company Option”) or right to acquire shares of Common Stock
(“Company Restricted Stock”) under the Hampton Roads Bankshares, Inc. 2006 Stock Incentive
Plan, Bank of Hampton Roads Non-Qualified Limited Stock Option Plan for Directors and Employees,
Gateway Financial Holdings, Inc. 2005 Omnibus Stock Ownership and Long Term Incentive Plan, Gateway
Financial Holdings, Inc. 0000 Xxxxxxxxxxxx Xxxxx Xxxxxx Xxxx, Xxxxxxx Financial Holdings, Inc. 1999
Incentive Stock Option Plan, Gateway Financial Holdings, Inc. 0000 Xxxxxxxxxxxx Xxxxx Xxxxxx Xxxx,
Xxxxxxx Financial Holdings, Inc. 1999 BOR Stock Option Plan, Shore Financial Corporation 2001 Stock
Incentive Plan, and Shore Saving Bank, F.S.B. 1992 Stock Incentive Plan (the “Stock Plans”)
which is true and correct as of May 23, 2010: (A) the name and, to the
14
Knowledge of the Company, the country and state of residence of each holder of Company
Options; (B) the number of shares of Common Stock subject to such Company Option, and as applicable
for each Company Option, the date of grant, exercise price, number of shares vested or not
otherwise subject to repurchase rights, reacquisition rights or other applicable restrictions as of
May 23, 2010, vesting schedule or schedule providing for the lapse of repurchase rights,
reacquisition rights or other applicable restrictions, the type of Company Option and the Stock
Plan or other plan under which such Company Options were granted or purchased; and (C) whether, in
the case of a Company Option, such Company Option is an Incentive Stock Option (within the meaning
of the Code). The Company has made available to the Investors copies of each form of stock option
agreement evidencing outstanding Company Options and has also delivered any other stock option
agreements to the extent there are variations from the form of agreement, specifically identifying
the holder(s) to whom such variant forms apply. An aggregate of 1,674,505 shares of Common Stock
are held for the benefit of participants in the Hampton Roads Bankshares, Inc. 2008 Director
Deferred Compensation Plan, Hampton Roads Bankshares, Inc. Executive Savings Plan, Bank of Hampton
Roads 401(K) Plan, Hampton Roads Bankshares, Inc. Directors’ Deferred Compensation Plan, Director
Emeritus Program Agreements, Hampton Roads Bankshares, Inc. 2002 Dividend Reinvestment and Optional
Cash Purchase Plan, and Gateway Bank & Trust Company 401(K) Plan, all of which are issued and
outstanding as of the Capitalization Date. As of the date of this Agreement, except for (x) the
outstanding Company Options described in this Section 2.2(c) and listed on Section
2.2(c) of the Disclosure Schedule and (y) as set forth elsewhere in this Section
2.2(c), the Company does not have and is not bound by any outstanding subscriptions, options,
warrants, calls, commitments or agreements of any character calling for the purchase or issuance
of, or securities or rights convertible into or exchangeable or exercisable for, any shares of
Common Stock or Company Preferred Stock or any other equity securities of the Company or Voting
Debt or any securities representing the right to purchase or otherwise receive any shares of
Capital Stock of the Company (including any rights plan or agreement). The Company has Previously
Disclosed all shares of Company Capital Stock that have been purchased, redeemed or otherwise
acquired, directly or indirectly, by the Company or any Company Subsidiary since December 31, 2009
and all dividends or other distributions that have been declared, set aside, made or paid to the
stockholders of the Company since that date. Each Company Option under the Stock Plans (i) was
granted in compliance with all applicable Laws and all of the terms and conditions of the Stock
Plans pursuant to which it was issued, (ii) has an exercise price equal to or greater than the fair
market value of a share of Common Stock at the close of business on the date of such grant, (iii)
has a grant date identical to or following the date on which the Company’s Board of Directors or
compensation committee actually awarded such Company Option, (iv) otherwise is exempt from or
complies with Section 409A of the Code so that the recipient of such Company Option is not subject
to the additional taxes and interest pursuant to Section 409A of the Code and (v) except for
disqualifying dispositions, qualifies for the tax and accounting treatment afforded to such Company
Option in the Company’s tax returns and the Company’s financial statements, respectively. There are
no securities or instruments containing anti-dilution or similar provisions that will be triggered
by the issuance of Common Shares pursuant to the transactions contemplated by the Transaction
Documents.
(d) Authorization; Compliance with Other Instruments; Other Contracts.
(1) The Company has the corporate power and authority to execute and deliver
this Agreement and the other Transaction Documents and to perform its obligations
hereunder and thereunder. Except for authorization by stockholder approval of the
Stockholder Proposals as contemplated by this Agreement, the execution, delivery and
performance of the Transaction Documents by the Company and the consummation of the
transactions contemplated hereby and thereby have been authorized by all necessary
corporate action on the part of the Company and no further approval or authorization
is required on the part of the Company or its stockholders (other than the Preferred
Stock Proposals and the General Stockholder Proposals). The Board of
15
Directors has unanimously approved the agreements and the transactions
contemplated by the Transaction Documents, including the Investment, the Other
Private Placements, the TARP Exchange, the Exchange Offers and the Rights Offering.
No other corporate proceedings are necessary for the execution and delivery by the
Company of the Transaction Documents, the performance by it of its obligations
hereunder or thereunder or the consummation by it of the transactions contemplated
hereby or thereby. This Agreement has been and the other Transaction Documents will
have been at the First Closing duly and validly executed and delivered by the
Company and, assuming due authorization, execution and delivery by each of the
Anchor Investors and the other parties thereto, are, or in the case of documents
executed after May 23, 2010, will be, upon execution, the valid and binding
obligations of the Company enforceable against the Company in accordance with their
terms (except as enforcement may be limited by applicable insolvency,
reorganization, moratorium, fraudulent transfer and similar laws of general
applicability relating to or affecting creditors’ rights or by general equity
principles).
(2) Neither the execution and delivery by the Company of the Transaction
Documents, nor the consummation of the transactions contemplated hereby or thereby,
nor compliance by the Company with any of the provisions hereof or thereof, will (A)
violate, conflict with, or result in a breach of any provision of, or constitute a
default (or an event which, with notice or lapse of time or both, would constitute a
default) under, or result in the termination of, or result in the loss of any
benefit or creation of any right on the part of any third party under, or accelerate
the performance required by, or result in a right of termination or acceleration of,
or result in the creation of any liens, charges, adverse rights or claims, pledges,
covenants, title defects, security interests and other encumbrances of any kind
(“Liens”) upon any of the material properties or assets of the Company or
any Company Subsidiary, under any of the terms, conditions or provisions of (i) the
articles of incorporation or by-laws (or similar governing documents) of the Company
and each Company Subsidiary or (ii) any note, bond, mortgage, indenture, deed of
trust, license, lease, agreement or other instrument or obligation to which the
Company or any of the Company Subsidiaries is a party or by which it may be bound,
or to which the Company or any of the Company Subsidiaries, or any of the properties
or assets of the Company or any of the Company Subsidiaries may be subject, or (B)
subject to receipt of the Governmental Consent referred to in Section
2.2(f), violate any Law applicable to the Company or any of the Company
Subsidiaries or any of their respective properties or assets except in the case of
clauses (A)(ii) and (B) for such violations, conflicts and breaches as would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.
(3) The only vote of the stockholders of the Company required to approve
(A) increasing the authorized number of Common Shares to an amount necessary to
consummate the transactions contemplated by the Transaction Documents and the other
transactions referred to herein and therein, (B) amending the terms of the Series A
Preferred Stock and the Series B Preferred Stock, (C) the issuance of the Common
Shares pursuant to NASDAQ Marketplace Rules 5635(b) and 5635(d) and (D) a reverse
stock split of the Common Shares, if such approval is required by the NASDAQ
Marketplace Rules or as the Company otherwise deems necessary, is, with respect to
clauses (A) and (D), the affirmative vote of the holders of not less than a majority
of the
outstanding
Common Shares, with respect to clause (C), the affirmative vote of the holders of not less
than a majority of the total votes cast by holders of Common Stock and with respect to
clause (B), the affirmative vote of the holders of not less than a majority of the
16
outstanding Series A Preferred Stock and the affirmative vote of the holders of
not less than a majority of the outstanding Series B Preferred Stock, as applicable.
(e) Exchange Offers and Proxy Statement.
(1) The issuance of Common Shares in connection with the Exchange Offers will be exempt
from registration pursuant to Section 3(a)(9) promulgated under the Securities Act of 1933,
as amended (the “Securities Act”). The Company has not paid or given, directly or
indirectly, any commission or other remuneration to any Person for soliciting the
acquisition of the Series A Preferred Stock and Series B Preferred Stock or the exchange as
contemplated pursuant to the Exchange Offers. None of the information included or
incorporated by reference in the Schedule TO or any amendment thereto will have, at the time
such Schedule TO or amendment thereto was filed with the SEC and at the time it became
effective under the Securities Act, contained any untrue statement of material fact or
omitted to state any material fact required to be stated therein or necessary to make the
statements therein not misleading.
(2) The Proxy Statement will not have, at the date of mailing to stockholders and at
the time of the meeting of stockholders to be held in connection with the Stockholder
Proposals, contained any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. As of each of the
dates in the foregoing sentence, the Proxy Statement will have complied as to form in all
material respects with the requirements of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”) and the rules and regulations of the SEC thereunder. The Board
of Directors has unanimously recommended (i) that the stockholders entitled to vote thereon
vote in favor of each of the Stockholder Proposals and (ii) that the holders of Series A
Preferred Stock and Series B Preferred Stock tender their shares of Series A Preferred Stock
and Series B Preferred Stock, respectively, in connection with each of the Exchange Offers.
(f) Governmental Consents. No Governmental Consents are necessary for the execution
and delivery of the Transaction Documents or for the consummation by the Company of the
transactions contemplated hereby and thereby.
(g) Litigation and Other Proceedings. Except as would not reasonably be expected to
have a Material Adverse Effect, there is no pending or, to the Knowledge of the Company,
threatened, claim, action, suit, arbitration, complaint, charge or investigation or proceeding
(each an “Action”), against the Company or any Company Subsidiary or any of its assets,
rights or properties, nor is the Company or any Company Subsidiary a party or named as subject to
the provisions of any order, writ, injunction, settlement, judgment or decree of any court,
arbitrator or government agency, or instrumentality. There is no Action by the Company or any
Company Subsidiary pending or which the Company or any Company Subsidiary intends to initiate
(other than collection claims in the ordinary course of business). No director or officer of the
Company is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty as of the date
hereof. There has not been, and to the Company’s Knowledge, there is not pending or contemplated,
any investigation by the SEC involving the Company or any current or former director or officer of
the Company.
(h) Financial Statements. Each of the consolidated balance sheets of the Company and
the Company Subsidiaries and the related consolidated statements of income, operations, changes in
shareholders’ equity and cash flows, together with the notes thereto, included in any Company
Report filed with the SEC prior to the date of this Agreement, and the unaudited consolidated
balance sheets of
17
the Company and the Company Subsidiaries as of March 31, 2010 and the related consolidated
statements of operations, changes in shareholders’ equity and cash flows for the period ending
March 31, 2010, together with the notes thereto, included in the Company’s Form 10-Q filed with the
SEC on May 17, 2010 (the “Interim Financials” and, collectively, the “Company Financial
Statements”), (1) have been prepared from, and are in accordance with, the books and records of
the Company and the Company Subsidiaries, (2) to the extent filed with the SEC, complied, as of
their respective date of such filing, in all material respects with applicable accounting
requirements and with the published rules and regulations of the SEC with respect thereto, (3) have
been prepared in accordance with GAAP applied on a consistent basis and (4) present fairly in all
material respects the consolidated financial position of the Company and the Company Subsidiaries
at the dates and the consolidated results of operations, changes in shareholders’ equity and cash
flows of the Company and the Company Subsidiaries for the periods stated therein (subject to the
absence of notes and normal and recurring year-end audit adjustments not material to the financial
condition of the Company and the Company Subsidiaries in the case of the Interim Financials).
(i) Reports. Since December 31, 2007, the Company and each Company Subsidiary have
filed all material reports, registrations, documents, filings, statements and submissions together
with any required amendments thereto, that it was required to file with any Governmental Entity
(the foregoing, collectively, the “Company Reports”) and have paid all material fees and
assessments due and payable in connection therewith. As of their respective filing dates, the
Company Reports complied in all material respects with all statutes and applicable rules and
regulations of the applicable Governmental Entities, as the case may be. As of the date of this
Agreement, there are no outstanding comments from the SEC or any other Governmental Entity with
respect to any Company Report that were enumerated within such report or otherwise were the subject
of written correspondence with respect thereto. The Company Reports, including the documents
incorporated by reference in each of them, each contained all the information required to be
included in it and, when it was filed and, as of the date of each such Company Report filed with or
furnished to the SEC, or if amended prior to the date of this Agreement, as of the date of such
amendment, did not contain an untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements made in it, in light of the circumstances under which
they were made, not misleading and complied as to form in all material respects with the applicable
requirements of the Securities Act and the Exchange Act. No executive officer of the Company has
failed in any respect to make the certifications required of him or her under Section 302 or 906 of
the Xxxxxxxx-Xxxxx Act of 2002. Copies of all of the Company Reports not otherwise publicly filed
have, to the extent allowed by applicable Law, been made available to the Anchor Investors by the
Company.
(j) Internal Accounting and Disclosure Controls. The records, systems, controls, data
and information of the Company and the Company Subsidiaries are recorded, stored, maintained and
operated under means (including any electronic, mechanical or photographic process, whether
computerized or not) that are under the exclusive ownership and direct control of the Company or
the Company Subsidiaries or accountants (including all means of access thereto and therefrom),
except for any nonexclusive ownership and nondirect control that would not reasonably be expected
to have a Material Adverse Effect on the system of internal accounting controls described below in
this Section 2.2(j). The Company (A) has implemented and maintains disclosure controls and
procedures (as defined in Rule 13a-15(e) of the Exchange Act) to ensure that material information
relating to the Company, including its consolidated Subsidiaries, is made known to the chief
executive officer and the chief financial officer of the Company by others within those entities,
and (B) has disclosed, based on its most recent evaluation prior to the date of this Agreement, to
the Company’s outside auditors and the audit committee of the Board of Directors (x) any
significant deficiencies and material weaknesses in the design or operation of internal control
over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that are reasonably
likely to adversely affect the Company’s ability to record, process, summarize and report financial
information, and (y) any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company’s internal controls over
18
financial reporting. As of the date of this Agreement, the Company has no Knowledge of any
reason that its outside auditors and its chief executive officer and chief financial officer shall
not be able to give the certifications and attestations required pursuant to the rules and
regulations adopted pursuant to Section 404 of the Xxxxxxxx-Xxxxx Act of 2002, without
qualification, when next due. Since December 31, 2007, (i) neither the Company nor any Company
Subsidiary nor, to the Knowledge of the Company, any director, officer, employee, auditor,
accountant or representative of the Company or any Company Subsidiary has received or otherwise had
or obtained knowledge of any material complaint, allegation, assertion or claim, whether written or
oral, regarding the accounting or auditing practices, procedures, methodologies or methods of the
Company or any Company Subsidiary or their respective internal accounting controls, including any
material complaint, allegation, assertion or claim that the Company or any Company Subsidiary has
engaged in questionable accounting or auditing practices, and (ii) no attorney representing the
Company or any Company Subsidiary, whether or not employed by the Company or any Company
Subsidiary, has reported evidence of a material violation of securities laws, breach of fiduciary
duty or similar violation by the Company or any of its officers, directors, employees or agents to
the Board of Directors or any committee thereof or to any director or officer of the Company.
(k) Off Balance Sheet Arrangements. There is no transaction, arrangement, or other
relationship between the Company or any of the Company Subsidiaries and an unconsolidated or other
Affiliated entity that is not reflected on the Company Financial Statements.
(l) Risk Management Instruments. All derivative instruments, including, swaps, caps,
floors and option agreements entered into for the Company’s or any of the Company Subsidiaries’ own
account were entered into (1) only in the ordinary course of business consistent with past
practice, (2) in accordance with prudent practices and in all material respects with all Laws and
(3) with counterparties believed to be financially responsible at the time; and each of them
constitutes the valid and legally binding obligation of the Company or any Company Subsidiary, as
applicable, enforceable in accordance with its terms. Neither the Company, nor, to the Knowledge
of the Company, any other party thereto, is in breach of any of its material obligations under any
such agreement or arrangement.
(m) No Undisclosed Liabilities. There are no liabilities of the Company or any of the
Company Subsidiaries of any kind whatsoever, whether accrued, contingent, absolute, determined,
determinable or otherwise, except for (i) liabilities adequately reflected or reserved against in
accordance with GAAP in the Company’s audited balance sheet for the year ended December 31, 2009,
and (ii) liabilities that have arisen in the ordinary and usual course of business and consistent
with past practice since December 31, 2009, and which have not or could not reasonably be expected
to result in a Material Adverse Effect.
(n) Mortgage Banking Business. The Company and each of the Company Subsidiaries have
complied in all material respects with, and all documentation in connection with the origination,
processing, underwriting and credit approval of any mortgage loan originated, purchased or serviced
by the Company has satisfied in all material respects, (i) all Laws with respect to the
origination, insuring, purchase, sale, pooling, servicing, subservicing, or filing of claims in
connection with mortgage loans, including all Laws relating to real estate settlement procedures,
consumer credit protection, truth in lending laws, usury limitations, fair housing, transfers of
servicing, collection practices, equal credit opportunity and adjustable rate mortgages, (ii) the
responsibilities and obligations relating to mortgage loans set forth in any agreement between the
Company and any Agency, Loan Investor or Insurer, (iii) the applicable rules, regulations,
guidelines, handbooks and other requirements of any Agency, Loan Investor or Insurer and (iv) the
terms and provisions of any mortgage or other collateral documents and other loan documents with
respect to each mortgage loan. No Agency, Loan Investor or Insurer has (i) claimed in writing that
the Company or any of the Company Subsidiaries has violated or has not complied with the applicable
underwriting standards with respect to mortgage loans sold by the Company or any of the
19
Company Subsidiaries to a Loan Investor or Agency, or with respect to any sale of mortgage
servicing rights to a Loan Investor, (ii) imposed in writing material restrictions on the
activities (including commitment authority) of the Company or any of the Company Subsidiaries or
(iii) indicated in writing to the Company or any of the Company Subsidiaries that it has terminated
or intends to terminate its relationship with the Company or any of the Company Subsidiaries for
poor performance, poor loan quality or concern with respect to the Company’s or any of the Company
Subsidiaries’ compliance with Laws.
(o) Bank Secrecy Act, Anti-Money Laundering and OFAC and Customer Information. The
Company is not aware of, has not been advised of, and, to the Company’s Knowledge, has no reason to
believe that any facts or circumstances exist that would cause it or any Company Subsidiary to be
deemed to be (i) not operating in compliance, in all material respects, with the Bank Secrecy Act
of 1970, as amended, the Uniting and Strengthening America by Providing Appropriate Tools Required
to Intercept and Obstruct Terrorism Act of 2001 (also known as the USA PATRIOT Act), any order or
regulation issued by the U.S. Department of the Treasury’s Office of Foreign Assets Control
(“OFAC”), or any other applicable anti-money laundering or anti-terrorist-financing
statute, rule or regulation; or (ii) not operating in compliance in all material respects with the
applicable privacy and customer information requirements contained in any federal and state privacy
Laws and regulations, including, without limitation, in Title V of the Xxxxx-Xxxxx-Xxxxxx Act of
1999 and the regulations promulgated thereunder. The Company is not aware of any facts or
circumstances that would cause it to believe that any non-public customer information has been
disclosed to or accessed by an unauthorized third party in a manner that would cause it to
undertake any material remedial action. The Company and each of the Company Subsidiaries have
adopted and implemented an anti-money laundering program that contains adequate and appropriate
customer identification verification procedures that comply with the USA PATRIOT Act and such
anti-money laundering program meets the requirements in all material respects of Section 352 of the
USA PATRIOT Act and the regulations thereunder, and they have complied in all respects with any
requirements to file reports and other necessary documents as required by the USA PATRIOT Act and
the regulations thereunder. The Company will not knowingly directly or indirectly use the proceeds
of the sale of the Common Shares pursuant to transactions contemplated by the Transaction
Documents, or lend, contribute or otherwise make available such proceeds to any Company Subsidiary,
joint venture partner or other Person, towards any sales or operations in any country sanctioned by
OFAC or for the purpose of financing the activities of any Person currently subject to any U.S.
sanctions administered by OFAC.
(p) Certain Payments. Neither the Company nor any of the Company Subsidiaries, nor
any directors, officers, nor to the Knowledge of the Company, employees or any of their Affiliates
or any other Person who to the Knowledge of the Company is associated with or acting on behalf of
the Company or any of the Company Subsidiaries has directly or indirectly (a) made any
contribution, gift, bribe, rebate, payoff, influence payment, kickback, or other payment to any
Person, private or public, regardless of form, whether in money, property, or services (i) to
obtain favorable treatment in securing business for the Company or any of the Company Subsidiaries,
(ii) to pay for favorable treatment for business secured by the Company or any of the Company
Subsidiaries, (iii) to obtain special concessions or for special concessions already obtained, for
or in respect of the Company or any of the Company Subsidiaries, or (iv) in violation of any Law,
or (b) established or maintained any fund or asset with respect to the Company or any of the
Company Subsidiaries that was required to have been and was not recorded in the books and records
of the Company or any of the Company Subsidiaries.
(q) Absence of Certain Changes. Since December 31, 2009 and except as Previously
Disclosed, (1) the Company and the Company Subsidiaries have
conducted their respective
businesses in all material respects in the ordinary and usual course of business and consistent
with prior practice, (2) none of the Company or any Company Subsidiary has issued any securities or
incurred any liability or
20
obligation, direct or contingent, for borrowed money, except borrowings in the ordinary course
of business, (3) except for publicly disclosed ordinary dividends on the Common Stock and
outstanding preferred stock, the Company has not made or declared any distribution in cash or in
kind to its stockholders or issued or repurchased any shares of its Capital Stock, (4) no fact,
event, change, condition, development, circumstance or effect has occurred that has had or would
reasonably be expected to have a Material Adverse Effect and (5) no material default (or event
which, with notice or lapse of time, or both, would constitute a material default) exists on the
part of the Company or any Company Subsidiary or, to the Knowledge of the Company, on the part of
any other party, in the due performance and observance of any term, covenant or condition of any
agreement to which the Company or any Company Subsidiary is a party and which would reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect.
(r) Compliance with Laws. The Company and each Company Subsidiary have all material
permits, licenses, franchises, authorizations, orders and approvals of, and have made all filings,
applications and registrations with, Governmental Entities that are required in order to permit
them to own or lease their properties and assets and to carry on their business as presently
conducted and that are material to the business of the Company and each Company Subsidiary. The
Company and each Company Subsidiary have complied in all material respects and (i) are not in
default or violation in any respect of, (ii) are not under investigation with respect to, and (iii)
have not been threatened to be charged with or given notice of any material violation of, any
applicable material domestic (federal, state or local) or foreign law, statute, ordinance, license,
rule, regulation, policy or guideline, order, demand, writ, injunction, decree or judgment of any
Governmental Entity (each, a “Law”), other than such noncompliance, defaults or violations
that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect. Except for statutory or regulatory restrictions of general application, no Governmental
Entity has placed any material restriction on the business or properties of the Company or any of
the Company Subsidiaries, and, as of the date hereof, each of Hampton Roads and Shore has a
Community Reinvestment Act rating of “satisfactory” or better.
(s) Agreements with Regulatory Agencies. The Company and the Company Subsidiaries (i)
are not subject to any cease-and-desist or other similar order or enforcement action issued by,
(ii) are not a party to any written agreement, consent agreement or memorandum of understanding
with, (iii) are not a party to any commitment letter or similar undertaking to, (iv) are not
subject to any capital directive by, since December 31, 2007, and (v) each of the Company and the
Company Subsidiaries has not adopted any board resolutions at the request of, any Governmental
Entity that currently restricts in any material respect the conduct of its business or that in any
material manner relates to its capital adequacy, its liquidity and funding policies and practices,
its ability to pay dividends, its credit, risk management or compliance policies, its internal
controls, its management or its operations or business (each item in this sentence, a
“Regulatory Agreement”), nor has the Company nor any of the Company Subsidiaries been
advised since December 31, 2007 by any Governmental Entity that it is considering issuing,
initiating, ordering, or requesting any such Regulatory Agreement, except as set forth in the
Disclosure Schedule (other than the Written Agreement with the Federal Reserve and the BFI
effective as of June 17, 2010). The Company and the Company Subsidiaries are in compliance in all
material respects with each Regulatory Agreement to which they are party or subject, and the
Company and the Company Subsidiaries have not received any notice from any Governmental Entity
indicating that either the Company or any of the Company Subsidiaries is not in compliance in all
material respects with any such Regulatory Agreement.
(t) Contracts. Except as Previously Disclosed, neither the Company nor any Company
Subsidiary is a party to any contracts or agreements:
21
(1) relating to indebtedness for borrowed money, letters of credit, capital
lease obligations, obligations secured by a Lien or interest rate or currency
hedging agreements (including guarantees in respect of any of the foregoing, but in
any event excluding trade payables, securities transactions and brokerage agreements
arising in the ordinary course of business consistent with past practice,
intercompany indebtedness and immaterial leases for telephones, copy machines,
facsimile machines and other office equipment) in excess of $100,000, except for
those issued in the ordinary course of business;
(2) that constitutes a collective bargaining or other arrangement with any
labor union;
(3) that is a “material contract” within the meaning of Item 601(b)(10) of
Regulation S-K;
(4) that is a lease or agreement under which the Company or any of the Company
Subsidiaries is lessee of, or holds or operates, any property owned by any other
Person;
(5) that is a lease or agreement under which the Company or any of the Company
Subsidiaries is lessor of, or permits any Person to hold or operate, any property
owned or controlled by the Company or any of the Company Subsidiaries;
(6) limiting the ability of the Company or any of the Company Subsidiaries to
engage, in any material respect, in any line of business or to compete, whether by
restricting territories, customers or otherwise, or in any other material respect,
with any Person;
(7) that is a settlement, conciliation or similar agreement, the performance of
which will involve payment after the First Closing Date of consideration in excess
of $100,000;
(8) that relates to Intellectual Property Rights (other than a license granted
to the Company for commercially available software licensed on standard terms with a
total replacement cost of less than $100,000);
(9) that concerns the sale or acquisition of any material portion of the
Company’s business;
(10) that concerns a partnership or joint venture;
(11) involving aggregate consideration liability in excess of $100,000 and
which, in each case, cannot be cancelled by the Company without penalty or without
more than 90 days’ notice;
(12) that concerns any material hedge, collar, option, forward purchasing,
swap, derivative or similar agreement, understanding or undertaking; and
(13) any other contract, agreement or understanding material to the Company or
any of the Company Subsidiaries or their respective operations.
22
Each Contract of a type Previously Disclosed above to this Section 2.2(t)
(collectively, the “Material Contracts”), is (i) legal, valid and binding on the Company
and the Company Subsidiaries which are a party to such contract, (ii) is in full force and effect
and enforceable in accordance with its terms and (iii) will continue to be legal, valid, binding,
enforceable, and in full force and effect on identical terms following the consummation of the
transactions contemplated by the Transaction Documents. Neither the Company nor any of the Company
Subsidiaries, nor to the Company’s Knowledge, any other party thereto is in default under any
Material Contract. No benefits under any Material Contract will be increased, and no vesting of
any benefits under any Material Contract will be accelerated, by the occurrence of any of the
transactions contemplated by the Transaction Documents, nor will the value of any of the benefits
under any Material Contract be calculated on the basis of any of the transactions contemplated by
the Transaction Documents. The Company and the Company Subsidiaries, and to the Knowledge of the
Company, each of the other parties thereto, have performed in all material respects all material
obligations required to be performed by them under each Material Contract, and to the Knowledge of
the Company, no event has occurred that with notice or lapse of time would constitute a material
breach or default or permit termination, modification, or acceleration, under the agreement and no
party thereto has repudiated any provision of such contract.
(u) Insurance. The Company and the Company Subsidiaries are, and will remain following
consummation of the transactions contemplated by the Transaction Documents, insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as management
of the Company reasonably believes to be prudent and that are of the type customary in the
businesses and location in which the Company and the Company Subsidiaries are engaged. The Company
and the Company Subsidiaries have not been refused any insurance coverage sought or applied for,
and the Company and the Company Subsidiaries do not have any reason to believe that they will not
be able to renew their existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue their business at a cost
that would not have a Material Adverse Effect.
(v) Title. The Company and the Company Subsidiaries have good and marketable title in
fee simple to all real property owned by them and good and valid title to all personal property
owned by them, in each case free and clear of all Liens, except for Liens which do not materially
affect the value of such property and do not interfere with the use made and proposed to be made of
such property by the Company. Any real property and facilities held under lease by the Company or
the Company Subsidiaries are valid, subsisting and enforceable leases with such exceptions that are
not material and do not interfere with the use made and proposed to be made of such property and
buildings by the Company or the Company Subsidiaries.
(w) Intellectual Property Rights. The Company and the Company Subsidiaries own or
possess adequate rights or licenses to use all trademarks, service marks and all applications and
registrations therefor, trade names, patents, patent rights, copyrights, original works of
authorship, inventions, trade secrets and other intellectual property rights (“Intellectual
Property Rights”) necessary to conduct their business as conducted on the date of this
Agreement. To the Knowledge of the Company, no product or service of the Company or the Company
Subsidiaries infringes the Intellectual Property Rights of others. Except as would not reasonably
be expected to have a Material Adverse Effect, the Company and the Company Subsidiaries have not
received notice of any claim being made or brought, or, to the Knowledge of the Company, being
threatened, against the Company or any of the Company Subsidiaries regarding (i) their Intellectual
Property Rights, or (ii) that the products or services of the Company or the Company Subsidiaries
infringe the Intellectual Property Rights of others. The Company and the Company Subsidiaries are
not aware of any facts or circumstances which might give rise to any of the foregoing claims. The
computers, computer software, firmware, middleware, servers, workstations, routers, hubs, switches,
data communications lines, and all other information technology equipment, and
23
all associated documentation used in the business of the Company and the Company Subsidiaries
(the “IT Assets”) operate and perform in all material respects in accordance with their
documentation and functional specifications and otherwise as required in connection with the
business. To the Company’s Knowledge, no person has gained unauthorized access to the IT Assets.
The Company and the Company Subsidiaries have implemented reasonable backup and disaster recovery
technology consistent with industry practices. The Company and the Company Subsidiaries take
reasonable measures, directly or indirectly, to ensure the confidentiality, privacy and security of
customer, employee and other confidential information. The Company and the Company Subsidiaries
have complied with all internet domain name registration and other requirements of internet domain
registrars concerning internet domain names that are used in the business.
(x) Employee Benefits.
(1) Section 2.2(x) of the Disclosure Schedule sets forth a complete
list of each “employee benefit plan” (within the meaning of Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended (“ERISA”),
including, without limitation, multiemployer plans within the meaning of Section
3(37) of ERISA), and all stock purchase, stock option, severance, employment,
change-in-control, fringe benefit, collective bargaining, bonus, incentive, deferred
compensation, employee loan and all other employee benefit plans, agreements,
programs, policies or other arrangements, whether or not subject to ERISA (including
any funding mechanism therefor now in effect or required in the future as a result
of the transactions contemplated by the Transaction Documents or otherwise), whether
formal or informal, oral or written, legally binding or not, under which (A) any
current or former employee, director or consultant of the Company or any of the
Company Subsidiaries (the “Company Employees”) has any present or future
right to benefits and which are contributed to, sponsored by or maintained by the
Company or any of its Subsidiaries or (B) the Company or any Company Subsidiary has
had or has any present or future liability. All such plans, agreements, programs,
policies and arrangements shall be collectively referred to as the “Benefit
Plans”. Except as Previously Disclosed, there are no Benefit Plans that are
sponsored solely by the Company and the Company Subsidiaries) (excluding Hampton
Roads and Shore) (such Benefit Plans, the “Bankshares Benefits Plans”).
(2) With respect to each Benefit Plan, the Company and each Company Subsidiary
has provided to the Anchor Investors a current, accurate and complete copy (or, to
the extent no such copy exists, an accurate description) thereof and, to the extent
applicable: (A) any related trust agreement or other funding instrument; (B) the
most recent determination letter, if applicable; (C) any summary plan description
and other written communications (or a description of any oral communications) by
the Company and the Company Subsidiaries to the Company Employees or other
beneficiaries concerning the extent of the benefits provided under a Benefit Plan;
(D) a summary of any proposed amendments or changes anticipated to be made to the
Benefit Plans at any time within the twelve months immediately following May 23,
2010, and (E) for the three most recent years (x) the Form 5500 and attached
schedules, (y) audited financial statements and (z) actuarial valuation reports.
(3) (A) Each Benefit Plan has been established and administered in all material
respects in accordance with its terms, and in compliance with the applicable
provisions of ERISA, the Code and other Laws; (B) each Benefit Plan which is
intended to be qualified within the meaning of Section 401(a) of the Code is so
qualified and has received a favorable determination letter as to its qualification,
and nothing has occurred,
24
whether by action or failure to act, that could reasonably be expected to cause
the loss of such qualification; (C) no event has occurred and no condition exists
that would subject the Company and the Company Subsidiaries, either directly or by
reason of their affiliation with any member of their “Controlled Group” (defined as
any organization which is a member of a controlled group of organizations within the
meaning of Sections 414(b), (c), (m) or (o) of the Code), to any tax, fine, lien,
penalty or other liability imposed by ERISA, the Code or other Laws; (D) for each
Benefit Plan with respect to which a Form 5500 has been filed, no material change
has occurred with respect to the matters covered by the most recent Form 5500 since
the end of the period covered by such Form 5500; (E) no “reportable event” (as such
term is defined in Section 4043 of ERISA) that could reasonably be expected to
result in liability, no nonexempt “prohibited transaction” (as such term is defined
in Section 406 of ERISA and Section 4975 of the Code) or “accumulated funding
deficiency” (as such term is defined in Section 302 of ERISA and Section 412 of the
Code (whether or not waived)) has occurred with respect to any Benefit Plan; (F)
except as expressly contemplated by this Agreement, there is no present intention
that any Benefit Plan be materially amended, suspended or terminated, or otherwise
modified to adversely change benefits (or the levels thereof) under any Benefit Plan
at any time within the twelve months immediately following May 23, 2010; and (G) the
Company and the Company Subsidiaries have not incurred any current or projected
liability in respect of post-employment or post-retirement health, medical or life
insurance benefits for current, former or retired employees of the Company or the
Company Subsidiaries, except as required to avoid an excise tax under Section 4980B
of the Code or otherwise except as may be required pursuant to any other Laws.
(4) With respect to each of the Benefit Plans that is not a multiemployer plan
within the meaning of Section 4001(a)(3) of ERISA but is subject to Title IV of
ERISA, as of the First Closing Date, the assets of each such Benefit Plan are at
least equal in value to the present value of the accrued benefits (vested and
unvested) of the participants in such Benefit Plan on a termination and projected
benefit obligation basis, based on the actuarial methods and assumptions indicated
in the most recent applicable actuarial valuation reports.
(5) No Benefit Plan is a “multiemployer plan” (as defined in Section 4001(a)(3)
of ERISA) and neither the Company nor any member of their Controlled Group has at
any time sponsored or contributed to, or has or had any liability or obligation in
respect of, any multiemployer plan.
(6) With respect to any Benefit Plan, (i) no actions, suits or claims (other
than routine claims for benefits in the ordinary course) are pending or threatened,
(ii) no facts or circumstances exist that could give rise to any such actions, suits
or claims, (iii) no written or oral communication has been received from the Pension
Benefit Guaranty Corporation (the “PBGC”) in respect of any Benefit Plan
subject to Title IV of ERISA concerning the funded status of any such plan or any
transfer of assets and liabilities from any such plan in connection with the
transactions contemplated herein and (iv) no administrative investigation, audit or
other administrative proceeding by the Department of Labor, the PBGC, the Internal
Revenue Service or other governmental agencies are pending, threatened or in
progress (including, without limitation, any routine requests for information from
the PBGC).
25
(7) Neither the execution and delivery of the Transaction Documents, nor the
consummation of the transactions contemplated hereby and thereby could (A) result
in any payment (including severance, unemployment compensation or “excess
parachute payment” (within the meaning of Section 280G of the Code), forgiveness of
indebtedness or otherwise)) becoming due to any current or former employee, officer
or director of the Company or any of the Company Subsidiaries from the Company or
any of the Company Subsidiaries under any Benefit Plan or otherwise, (B) increase
any compensation or benefits otherwise payable under any Benefit Plan, (C) result in
any acceleration of the time of payment or vesting of any such benefits, (D) require
the funding or increase in the funding of any such benefits, (E) result in any
limitation on the right of the Company or any of the Company Subsidiaries to amend,
merge, terminate or receive a reversion of assets from any Benefit Plan or related
trust or (F) result in payments under any of the Benefit Plans or otherwise which
would not be deductible under Section 280G of the Code. The Company or any of the
Company Subsidiaries have not taken, or permitted to be taken, any action that
required, and no circumstances exist that will require the funding, or increase in
the funding, of any benefits or resulted, or will result, in any limitation on the
right of the Company or any of the Company Subsidiaries to amend, merge, terminate
or receive a reversion of assets from any Benefit Plan or related trust.
(8) Each Benefit Plan that is in any part a “nonqualified deferred compensation
plan” subject to Section 409A of the Code (i) materially complies and, at all times
after December 31, 2008 has materially complied, both in form and operation, with
the requirements of Section 409A(a)(2), (3) and (4) of the Code and the final
regulations thereunder and (ii) between January 1, 2005 and December 31, 2008 was
operated and maintained in accordance with a good faith reasonable interpretation of
Section 409A of the Code and its purpose, as determined under applicable guidance of
the Department of the Treasury and the Internal Revenue Service. No compensation
payable by the Company or any of the Company Subsidiaries has been reportable as
nonqualified deferred compensation in the gross income of any individual or entity
as a result of the operation of Section 409A of the Code.
(y) Environmental Laws. The Company and the Company Subsidiaries (i) are in
compliance with any and all Environmental Laws, (ii) have received all permits, licenses or other
approvals required of it under applicable Environmental Laws to conduct its business and (iii) are
in compliance with all terms and conditions of any such permit, license or approval except where,
in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply could be reasonably
expected to have, individually or in the aggregate, a Material Adverse Effect.
(z) Taxes.
(1) All material Tax Returns required to be filed by, or on behalf of, Company
or the Company Subsidiaries have been timely filed, or will be timely filed, in
accordance with all Laws, and all such Tax Returns are, or shall be at the time of
filing, complete and correct in all material respects. The Company and the
Company’s Subsidiaries have timely paid all material Taxes due and payable (whether
or not shown on such Tax Returns), or, where payment is not yet due, have made
adequate provisions in accordance with GAAP. There are no Liens with respect to
Taxes upon any of the assets or properties of either the Company or the Company’s
Subsidiaries other than with respect to Taxes not yet due and payable.
26
(2) No deficiencies for any material Taxes have been proposed or assessed in
writing against or with respect to any Taxes due by or Tax Returns of the Company or
the Company’s Subsidiaries, and there is no outstanding audit, assessment, dispute
or
claim concerning any material Tax liability of the Company or the Company’s
Subsidiaries. No written claim has ever been made by any Governmental Entity in a
jurisdiction where neither the Company nor any of the Company’s Subsidiaries files
Tax Returns that are or may be subject to taxation by that jurisdiction.
(3) Neither the Company nor the Company’s Subsidiaries (A) are or have ever
been a member of an affiliated group (other than a group the common parent of which
is the Company) filing a consolidated federal income Tax Return or (B) have any
liability for Taxes of any Person arising from the application of Treasury
Regulation section 1.1502-6 or any analogous provision of state, local or foreign
Law, or as a transferee or successor, by contract, or otherwise.
(4) None of the Company nor the Company’s Subsidiaries are party to, is bound
by or has any obligation under any Tax sharing or Tax indemnity agreement or similar
contract or arrangement.
(5) None of the Company or the Company Subsidiaries have been either a
“distributing corporation” or a “controlled corporation” in a distribution occurring
during the last five years in which the parties to such distribution treated the
distribution as one to which Section 355 of the Code is applicable.
(6) All Taxes required to be withheld, collected or deposited by or with
respect to the Company or the Company’s Subsidiaries have been timely withheld,
collected or deposited as the case may be, and to the extent required, have been
paid to the relevant taxing authority. The Company and the Company’s Subsidiaries
have fully complied with all applicable information reporting requirements.
(7) No closing agreement pursuant to section 7121 of the Code (or any similar
provision of state, local or foreign Law) has been entered into by or with respect
to the Company or the Company’s Subsidiaries. Neither the Company nor the Company’s
Subsidiaries has granted any waiver of any federal, state, local or foreign statute
of limitations with respect to, or any extension of a period for the assessment of,
any Tax. The Disclosure Schedule sets forth the tax year through which the statute
of limitations has run in respect of Tax Liabilities of the Company and the Company
Subsidiaries for US federal, state, local and foreign Taxes.
(8) Neither the Company nor the Company’s Subsidiaries has engaged in any
transaction that could give rise to (i) a registration obligation with respect to
any Person under Section 6111 of the Code or the regulations thereunder, (ii) a list
maintenance obligation with respect to any Person under Section 6112 of the Code or
the regulations thereunder, or (iii) a disclosure obligation as a “listed
transaction” under Section 6011 of the Code and the regulations.
(aa) Labor.
(1) Employees of the Company and the Company Subsidiaries are not represented by any
labor union nor are any collective bargaining agreements otherwise in effect with respect to
such employees. No labor organization or group of employees of the Company or any Company
27
Subsidiary has made a pending demand for recognition or certification, and there are no
representation or certification proceedings or petitions seeking a representation proceeding
presently pending or threatened to be brought or filed with the National Labor Relations
Board or any other labor relations tribunal or authority, nor have there been in the last three
years. There are no organizing activities, strikes, work stoppages, slowdowns, labor
picketing lockouts, material arbitrations or material grievances, or other material labor
disputes pending or threatened against or involving the Company or any Company Subsidiary,
nor have there been for the last three years.
(2) The Company and the Company Subsidiaries, except as would not, individually or in
the aggregate, reasonably be expected to result in a Material Adverse Effect, are in
compliance with all (i) federal and state Laws and requirements respecting employment and
employment practices, terms and conditions of employment, collective bargaining, disability,
immigration, health and safety, wages, hours and benefits, non-discrimination in employment,
workers’ compensation and the collection and payment of withholding and/or payroll taxes and
similar taxes and (ii) obligations of the Company and any Company Subsidiary, as applicable,
under any employment agreement, severance agreement or any similar employment-related
agreement or understanding.
(3) Except as would not reasonably be expected to have a Material Adverse Effect, there
is no charge or complaint pending or threatened before any Governmental Entity alleging
unlawful discrimination in employment practices, unfair labor practices or other unlawful
employment practices by the Company or any Company Subsidiary.
(bb) Knowledge as to Conditions. As of the date of hereof, the Company knows of no
reason why any regulatory approvals and, to the extent necessary, any other approvals,
authorizations, filings, registrations, and notices required or otherwise a condition to the
consummation of the transactions contemplated by the Transaction Documents will not be obtained.
(cc) Brokers and Finders. Except for Sandler X’Xxxxx & Partners, L.P. and Xxxxxxx
Lynch, Pierce, Xxxxxx & Xxxxx Incorporated (collectively, the “Placement Agents”) and the
fees payable thereto (which fees are set forth on the Disclosure Schedule and are to be paid by the
Company), neither the Company nor any of its respective officers, directors, employees or agents
has employed any broker or finder or incurred any liability for any financial advisory fees,
brokerage fees, commissions or finder’s fees, and no broker or finder has acted directly or
indirectly for the Company in connection with the Transaction Documents or the transactions
contemplated thereby.
(dd) Offering of Securities. Neither the Company nor any Person acting on its behalf
has taken any action (including any offering of any securities of the Company under circumstances
which would require the integration of such offering with the offering of any of the securities to
be issued pursuant to the Transaction Documents under the Securities Act and the rules and
regulations of the SEC promulgated thereunder) which might subject the offering, issuance or sale
of any of such securities to the registration requirements of the Securities Act. Neither the
Company nor any person acting on its behalf has engaged or will engage in any form of general
solicitation or general advertising (within the meaning of Regulation D under the Securities Act)
in connection with any offer or sale of the Common Shares pursuant to the transactions contemplated
by the Transaction Documents. Assuming the accuracy of the Anchor Investors’ representations and
warranties set forth in this Agreement, no registration under the Securities Act is required for
the offer and sale of the Common Shares by the Company to the Anchor Investors.
28
(ee) Investment Company Status. The Company is not, and upon consummation of the
transactions contemplated by the Transaction Documents will not be, an “investment company,” a
company controlled by an “investment company” or an “affiliated Person” of, or “promoter” or
“principal
underwriter” of, an “investment company,” as such terms are defined in the Investment Company
Act of 1940, as amended.
(ff) Affiliate Transactions. No officer, director, five percent (5%) stockholder or
other Affiliate of the Company (or any Company Subsidiary), or any individual who, to the Knowledge
of the Company, is related by marriage or adoption to or shares the same home as any such Person,
or any entity in which any such Person owns any beneficial interest (collectively, an
“Insider”), is a party to any contract or transaction with the Company (or any Company
Subsidiary) which pertains to the business of the Company (or any Company Subsidiary) or has any
interest in any property, real or personal or mixed, tangible or intangible, used in or pertaining
to the business of the Company (or any Company Subsidiary). The foregoing representation and
warranty does not cover deposits at the Company (or any Company Subsidiary) or loans of $50,000 or
less made in the ordinary course of business consistent with past practice.
(gg) Additional Investors. To the extent any Additional Agreements and additional
agreements or modification to Transaction Documents have been entered into on or prior to the date
hereof, the Company has provided the Anchor Investors with true and accurate copies of the
Additional Agreements, other additional agreements or modified Transaction Documents into which it
has entered with each of the Additional Investors.
(hh) Anti-takeover Provisions Not Applicable. The Company has not adopted any
stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership of
Common Stock or a change in control of the Company. The Board of Directors has taken all necessary
action to ensure that the transactions contemplated by the Transaction Documents and the
consummation of the transactions contemplated hereby and thereby will be exempt from any
anti-takeover or similar provisions of the Company’s Articles of Incorporation and By-Laws, and any
other provisions of any applicable “moratorium”, “control share”, “fair price”, “interested
stockholder” or other anti-takeover Laws and regulations of any jurisdiction.
(ii) Issuance of the Common Shares and Warrants. The issuance of the Common Shares and
the Warrants in connection with the transactions contemplated by the Transaction Documents
(including, but not limited to, the Common Shares issued to the Anchor Investors on the Second
Closing Date and the Common Shares issuable upon exercise of the Warrants) has been duly authorized
and such Common Shares and Warrants, when issued and paid for in accordance with the terms of the
Transaction Documents, will be duly and validly issued, fully paid and non-assessable and free and
clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents
or imposed by applicable securities laws, and shall not be subject to preemptive or similar rights.
(jj) Price of Common Stock. The Company has not, and to the Company’s Knowledge no
one acting on its behalf has, taken, directly or indirectly, any action designed to cause or to
result in the stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of any of the Common Shares.
(kk) Shell Company Status. The Company is not, and has never been, an issuer
identified in Rule 144(i)(1) of the Securities Act.
(ll) Disclosure. The Company confirms that neither it nor any of its officers or
directors nor any other Person acting on its or their behalf has provided, and it has not
authorized the
29
Placement Agents or any other Representative to provide, any Anchor Investor or its
respective agents or counsel with any information that it believes constitutes or could reasonably
be expected to constitute material, non-public information except insofar as the existence,
provisions and terms of the Transaction
Documents and the proposed transactions hereunder and thereunder may constitute such
information, all of which will be disclosed by the Company by the dates referenced in the
Additional Agreements. The Company understands and confirms that each of the Anchor Investors will
rely on the foregoing representations in effecting transactions in securities of the Company. No
event or circumstance has occurred or information exists with respect to the Company or any of the
Company Subsidiaries or its or their business, properties, operations or financial conditions,
which, under applicable Law, requires public disclosure or announcement by the Company but which
has not been so publicly announced or disclosed, except for the announcement of this Agreement and
related transactions and as may be disclosed pursuant to Section 6.16 hereof.
2.3. Representations and Warranties of Anchor Investors. Except as Previously
Disclosed, each Anchor Investor, severally and not jointly, hereby represents and warrants to the
Company, as of June 30, 2010 and as of the First Closing Date (except for the representations and
warranties that are as of a specific date which shall be made as of that date), for itself and for
no other Anchor Investor, that:
(a) Organization and Authority. Such Anchor Investor is duly organized,
validly existing and in good standing under the laws of the jurisdiction of its
organization, is duly qualified to do business and is in good standing in all jurisdictions
where its ownership or leasing of property or the conduct of its business requires it to be
so qualified and where failure to be so qualified would be reasonably expected to materially
and adversely impair or delay such Anchor Investor’s ability to perform its obligations
under the Transaction Documents or to consummate the transactions contemplated hereby and
thereby.
(b) Authorization; Compliance with Other Instruments.
A. Such Anchor Investor has the necessary power and authority to execute and
deliver the Transaction Documents to which such Anchor Investor is a party and to
perform its respective obligations hereunder and thereunder. The execution, delivery
and performance of the Transaction Documents to which such Anchor Investor is a
party and the consummation of the transactions contemplated hereby and thereby have
been duly authorized by such Anchor Investor’s respective board of directors,
general partner or managing members, investment committee, investment adviser or
other authorized person, as the case may be, and no further approval or
authorization by any of its stockholders, partners or other equity owners, as the
case may be, is required. This Agreement has been and the other Transaction
Documents to which such Anchor Investor is a party will have been at the First
Closing duly and validly executed and delivered by such Anchor Investor and,
assuming due authorization, execution and delivery by the Company and the other
parties thereto, are, or in the case of documents executed after June 30, 2010, will
be, upon execution, the valid and binding obligations of such Anchor Investor
enforceable against such Anchor Investor in accordance with their terms (except as
enforcement may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent transfer and similar laws of general applicability relating
to or affecting creditors’ rights or by general equity principles).
B. Neither the execution, delivery and performance by such Anchor Investor of
the Transaction Documents nor the consummation of the transactions contemplated
hereby or thereby, nor compliance by such Anchor Investor with any of the
30
provisions
hereof or thereof, will (A) violate, conflict with, or result in a breach of any
provision of, or constitute a default (or an event which, with notice or lapse of
time or both, would constitute a default) under, or result in the termination of, or
accelerate the
performance required by, or result in a right of termination or acceleration
of, or result in the creation of any Liens upon any of the properties or assets of
such Anchor Investor under any of the terms, conditions or provisions of (i) such
Anchor Investor’s articles of incorporation or by-laws, its certificate of limited
partnership or partnership agreement or its similar governing documents or (ii) any
note, bond, mortgage, indenture, deed of trust, license, lease, agreement or other
instrument or obligation to which such Anchor Investor is a party or by which such
Anchor Investor may be bound, or to which such Anchor Investor or any of the
properties or assets of such Anchor Investor may be subject, or (B) subject to
compliance with the statutes and regulations referred to in the next paragraph (and
assuming the correctness of the representations and warranties of the Company and
the other parties to the Transaction Documents), violate any Law applicable to such
Anchor Investor or any of its properties or assets except in the case of clauses
(A)(ii) and (B) for such violations, conflicts and breaches as would not reasonably
be expected to materially adversely affect such Anchor Investor’s ability to perform
its obligations under the Transaction Documents or consummate the transactions
contemplated hereby or thereby on a timely basis.
(c) Governmental Consents. Assuming the correctness of the representations and
warranties of the Company and the other parties to this Agreement, no Governmental Consents
are necessary to be obtained by such Anchor Investor for the consummation of the
transactions contemplated by the Transaction Documents to which such Anchor Investor is a
party, other than a statement by the Federal Reserve that it has no objection to the
investments by the Anchor Investors as such investments are described by the Anchor
Investors in notices filed by them under the Change in Bank Control Act of 1978 (the
“CBCA”).
(d) Purchase for Investment. Such Anchor Investor acknowledges that the Common
Shares have not been registered under the Securities Act or under any state securities laws.
Such Anchor Investor (1) is acquiring the Common Shares pursuant to an exemption from
registration under the Securities Act and other applicable securities laws solely for
investment with no present intention to distribute any of the Common Shares to any Person,
(2) will not sell or otherwise dispose of any of the Common Shares, except in compliance
with the registration requirements or exemption provisions of the Securities Act and any
other applicable securities laws, (3) has such knowledge and experience in financial and
business matters and in investments of this type that it is capable of evaluating the merits
and risks of its investment in the Common Shares and of making an informed investment
decision and (4) is an “accredited investor” (as that term is defined by Rule 501 of the
Securities Act).
(e) Brokers and Finders. Neither such Anchor Investor, nor its respective
Affiliates nor any of their respective officers or directors has employed any broker or
finder or incurred any liability for any financial advisory fees, brokerage fees,
commissions or finder’s fees, and no broker or finder has acted directly or indirectly for
such Anchor Investor in connection with this Agreement or the transactions contemplated
hereby.
(f) Investment Decision. Such Anchor Investor has made an independent
investment decision with respect to the transactions contemplated under the Transaction
Documents and, except as Previously Disclosed, there are no agreements or understandings
between such Anchor Investor or any of its Affiliates and (i) any of the Investors
(including the other Anchor Investor) or any of their respective Affiliates, (ii) the
Company or (iii) the Company Subsidiaries.
31
(g) Financial Capability. At each Closing, the Carlyle Anchor Investor
shall have, and in the case of the Anchorage Anchor Investor, subject to the funding of the
financing set forth in the Equity Commitment Letter in accordance with its terms, the
Anchorage Anchor Investor shall have, available funds necessary to consummate such Closing
on the terms and conditions contemplated by this Agreement. Concurrently with the execution
of this Agreement, the Anchorage Anchor Investor has delivered to the Company the duly
executed Equity Commitment Letter by and among the Anchorage Anchor Investor and ACMO in the
form attached as Exhibit H to this Agreement, pursuant to which ACMO has committed
to contribute the amount set forth therein to the Anchorage Anchor Investor subject to the
terms and conditions contained therein. The Equity Commitment Letter is a legal, valid and
binding obligation of ACMO and enforceable against ACMO in accordance with its terms, and as
of the date hereof no event has occurred which, with or without notice, lapse of time or
both, would constitute a default on the part of ACMO under the Equity Commitment Letter.
(h) No Other Representations or Warranties. Except as set forth in this
Agreement, the other Transaction Documents and any other documents delivered in connection
with the First Closing of the transactions contemplated by the Transaction Documents, such
Anchor Investor makes no representation or warranty, expressed or implied, at law or in
equity, in respect of such Anchor Investor or such Anchor Investor’s business or prospects
and any such other representations or warranties are hereby expressly disclaimed.
ARTICLE III
COVENANTS
3.1. Conduct of Business Prior to Second Closing.
(a) Except as otherwise expressly required by the Transaction Documents or applicable Law, by
the performance of any Material Contract that was Previously Disclosed, or with the prior written
consent of each Anchor Investor, between May 23, 2010 and the Second Closing, the Company shall,
and the Company shall cause each Company Subsidiary to:
(1) conduct its business only in the ordinary course;
(2) use commercially reasonable efforts to (A) preserve the present business
operations, organization (including officers and employees) and goodwill of the Company and
any Company Subsidiary and (B) preserve the present relationships with persons having
business dealings with the Company (including strategic partners, customers, suppliers,
consultants and subcontractors);
(3) use commercially reasonable efforts to maintain (A) all of the material assets and
properties of, or used by, the Company or any Company Subsidiary in its current condition,
with the exception of ordinary wear and tear, and (B) insurance upon all of the properties
and assets of the Company and the Company Subsidiaries in such amounts and of such kinds
comparable to that in effect on the date of this Agreement;
(4) not (A) declare, set aside or pay any distributions or dividends on, or make any
other distributions (whether in cash, securities or other property) in respect of, any of
its Capital Stock; (B) split, combine or reclassify any of its Capital Stock or issue or
authorize the issuance of any other securities in respect of, in lieu of or in substitution
for Capital Stock or any of its other securities; or (C) purchase, redeem or otherwise
acquire any Capital Stock or any of its
32
other securities or any rights, warrants or options to acquire any such Capital Stock
or other securities;
(5) not issue, deliver, sell, grant, pledge or otherwise dispose of or encumber any
Capital Stock, any other voting securities or any securities convertible into or
exchangeable for, or any rights, warrants or options to acquire, any such Capital Stock,
voting securities or convertible or exchangeable securities, other than any issuance of
Common Stock on exercise of any compensatory stock options outstanding on the date of this
Agreement;
(6) not terminate, enter into, amend, modify (including by way of interpretation),
renew or grant any waiver or consent under any employment, officer, consulting, severance,
change in control or similar contract, agreement or arrangement with any director, officer,
employee or consultant (other than, with respect to (i) a new chief financial officer and
(ii) employees, in the ordinary course of business consistent with past practices) or make,
grant or promise any bonus or any wage, salary or compensation increase to any director,
officer, employee, sales representative or consultant (except in the case of non-officers
and non-directors, amounts that do not exceed $50,000 per year per employee in the
aggregate) or make, grant or promise any increase in any employee benefit plan or
arrangement, or amend or terminate any existing employee benefit plan or arrangement or
adopt any new employee benefit plan or arrangement;
(7) not terminate, enter into, establish, adopt, amend, modify (including by way of
interpretation), make new grants or awards under, renew or grant any waiver or consent under
any pension, retirement, stock option, stock purchase, savings, profit sharing, deferred
compensation, consulting, bonus, group insurance or other employee benefit, incentive or
welfare contract (other than with respect to group insurance and welfare employee benefits,
in the ordinary course of business consistent with past practices), plan or arrangement, or
any trust agreement (or similar arrangement) related thereto, in respect of any director,
officer, employee or consultant, amend the terms of any outstanding equity-based award, take
any action to accelerate the vesting, exercisability or payment (or fund or secure the
payment) of stock options, restricted stock, other equity awards or other compensation or
benefits payable thereunder or add any new participants to any non-qualified retirement
plans (or, with respect to any of the preceding, communicate any intention to take such
action), other than with respect to the salary of any employee (and, with respect to such
employee, only in the ordinary course of business consistent with past practices);
(8) make any other change in employment terms for any of its directors, officers,
employees and consultants outside the ordinary course of business or enter into any
transaction with an Insider;
(9) notwithstanding any other provision hereof, use all commercially reasonable efforts
not to take, or omit to take, any action that is reasonably likely to result in any of the
conditions precedent to either the First Closing or the Second Closing not being satisfied,
or any action that is reasonably likely to materially impair the Company’s or any of the
Company Subsidiaries’ ability to perform their obligations under the Transaction Documents
or to consummate the transactions contemplated hereby, except as required by Law or the
Transaction Documents;
(10) not enter into any contract with respect to, or otherwise agree or commit to do,
any of the foregoing; and
33
(11) not make or change any material Tax election, change a material annual accounting
period, adopt or change any material accounting method with respect to Taxes, file any
amended material Tax Return, enter into any material closing agreement, settle or compromise
any proceeding with respect to any material Tax claim or assessment relating to the Company
or any of the Company Subsidiaries, surrender any right to claim a refund of material Taxes,
consent to any extension or waiver of the limitation period applicable to any material Tax
claim or assessment relating to the Company or any of its Subsidiaries, or take any other
similar action relating to the filing of any material Tax Return or the payment of any
material Tax.
3.2. No Shop.
(a) From May 23, 2010 until the earlier of the Second Closing Date or the termination of this
Agreement in accordance with its terms, the Company shall not, and the Company shall not permit any
of its Affiliates, directors, officers or employees to, and the Company shall use commercially
reasonable efforts to cause its other representatives or agents (together with directors, officers,
and employees, the “Representatives”) not to, directly or indirectly, (i) discuss,
encourage, negotiate, undertake, initiate, authorize, recommend, propose or enter into, whether as
the proposed surviving, merged, acquiring or acquired corporation or otherwise, any transaction
involving a merger, consolidation, business combination, recapitalization, purchase or disposition
of any material amount of the assets of the Company or any material amount of the Capital Stock or
other ownership interests of the Company (other than in connection with the Investment, Other
Private Placements, the TARP Exchange, the Exchange Offers, the Rights Offering or any other
transaction contemplated hereby) (an “Acquisition Transaction”), (ii) facilitate,
encourage, solicit or initiate discussions, negotiations or submissions of proposals or offers in
respect of an Acquisition Transaction, (iii) furnish or cause to be furnished, to any Person, any
information concerning the business, operations, properties or assets of the Company in connection
with an Acquisition Transaction, or (iv) otherwise cooperate in any way with, or assist or
participate in, facilitate or encourage, any effort or attempt by any other Person to do or seek
any of the foregoing. The Company shall notify each Anchor Investor orally and in writing
promptly (but in no event later than one (1) Business Day) after receipt by the Company or any of
the Representatives thereof of any proposal or offer from any Person other than the Anchor
Investors to effect an Acquisition Transaction or any request for non-public information relating
to the Company or for access to the properties, books or records of the Company by any Person other
than the Anchor Investors in connection with an Acquisition Transaction.
3.3. Access; Reports; Confidentiality.
(a) From May 23, 2010 until the date following the First Closing Date on which the Common
Stock purchased pursuant to the Transaction Documents and held by the Anchor Investors represent
less than 5% of the outstanding Common Stock (as adjusted from time to time for any reorganization,
recapitalization, stock dividend, stock split, reverse stock split, or other like changes in the
Company’s capitalization), the Company and the Company Subsidiaries will permit the Anchor
Investors and, at an Anchor Investor’s request, each Affiliate thereof that directly or indirectly
has an interest in the Anchor Investor or the Company, whether or not such Person qualifies, or is
intended to qualify, as a “venture capital operating company” as defined in the regulations (the
“Plan Asset Regulations”) issued by the Department of Labor at Section 2510.3 101 of Part
2510 of Chapter XXV, Title 29 of the Code of Federal Regulations, as the same may be amended from
time to time (a “VCOC”, and each such Person a “VCOC Rights Investor”), to have
customary and appropriate VCOC rights (including consultation rights, inspection and access rights,
and rights to receive materials for all meetings of the Board of Directors, and the right to
audited and unaudited financial statements, annual budget and other financial and operations information, including advance notification of and consultation with respect to
significant corporate actions) relating to inspection, information and consultation with respect to the Company or the
34
Banks; provided that this section shall not entitle the Anchor Investor
to designate any members of the Board of Directors or of the board of directors of the Banks. In
addition to the rights described in the preceding sentence, the Company and the Company
Subsidiaries will permit each VCOC Rights Investor to have access and inspection rights to any
information required by it to comply with Section 3.4(a). The Company shall, and shall
cause the Banks to, consider in good faith the recommendations of any VCOC Rights Investor or its
designated representative in connection with the matters on which it is consulted as described
above, recognizing that the ultimate discretion with respect to all such matters shall be retained
by the Company or the Banks, as applicable. Any consultation or inspection pursuant to this
Section 3.3 shall be conducted during normal business hours and in such a manner as not to
interfere unreasonably with the conduct of the business of the Company or the Company Subsidiaries,
and nothing herein shall require the Company or the Company Subsidiaries to disclose any
information to the extent (1) prohibited by Law or (2) that the Company or the Company Subsidiaries
reasonably believe such information to be competitively sensitive proprietary information (except
to the extent such Anchor Investor provides assurances reasonably acceptable to Company or such
Company Subsidiary, as applicable, that such information shall not be used by such Anchor Investor
or its Affiliates to compete with the Company or such Company Subsidiary, as applicable);
provided that the Company and the Company Subsidiaries shall use commercially reasonable
efforts to make appropriate substitute disclosure arrangements under circumstances where the
restrictions in clauses (1) and (2) of this Section 3.3(a) apply).
(b) The Carlyle Anchor Investor acknowledges that the information being provided to it in
connection with the consummation of the transactions contemplated hereby is subject to the terms of
the Confidentiality Agreement, dated as of February 3, 2010, between Carlyle Investment Management
L.L.C. and the Company (the “Carlyle Confidentiality Agreement”), the terms of which are
incorporated herein by reference.
(c) The Anchorage Anchor Investor acknowledges that the information being provided to it in
connection with the consummation of the transactions contemplated hereby is subject to the terms of
the Confidentiality Agreement, dated as of December 9, 2009, between the Anchorage Anchor Investor
and the Company (the “Anchorage Confidentiality Agreement”, and together with the Carlyle
Confidentiality Agreement, the “Confidentiality Agreements”), the terms of which are
incorporated herein by reference.
3.4. Filings; Other Actions.
(a) Each Anchor Investor, on the one hand, and the Company, on the other hand, will cooperate
and consult with the others and use commercially reasonable efforts to prepare and file all
necessary documentation, to effect all necessary applications, notices, petitions, filings and
other documents, and to obtain all necessary permits, consents, orders, approvals and
authorizations of, or any exemption by, all third parties and Governmental Entities, necessary or
advisable to consummate the transactions contemplated by the Transaction Documents, and to perform
the covenants contemplated by the Transaction Documents, in each case required by it. Each of the
parties hereto shall execute and deliver both before and after each Closing such further
certificates, agreements and other documents and take such other actions as the other parties may
reasonably request to consummate or implement such transactions or to evidence such events or
matters. The Anchor Investors and the Company will each use their commercially reasonable efforts
to promptly obtain or submit, and the Company and each of the Anchor Investors will cooperate as
may reasonably be requested by the Anchor Investors or the Company, as the case may be, to help the
Anchor Investors and the Company promptly obtain or submit, as the case may be, as promptly as
practicable, the approvals and authorizations of, any additional filings and registrations with,
and any additional notifications to, all notices to and, to the extent required by
Law, consents, approvals or exemptions from bank regulatory authorities, for the transactions
contemplated by the Transaction Documents (in each case to the extent it has not done so prior to the date
35
of this Agreement), subject to the following sentence. Notwithstanding the foregoing, in
no event shall an Anchor Investor be required to become a bank holding company, accept any
Burdensome Condition with respect to any regulatory filing or approval, including without
limitation any condition which could jeopardize or potentially have the effect of jeopardizing any
investment opportunities (now or hereafter existing) of such Anchor Investor or any of its
Affiliates, or be required to agree to provide capital to the Company or any Company Subsidiary
thereof other than the Purchase Price to be paid for the Common Shares to be purchased by it
pursuant to the terms of the Transaction Documents. To the extent that any Anchor Investor files a
notice of change in control under the CBCA, such Anchor Investor shall use, and cause its
Affiliates to use, commercially reasonable efforts to obtain regulatory non-objection to the change
in control notice as promptly as possible, including without limitation responding fully to all
requests for additional information from the Federal Reserve, entering into one or more passivity
requirements or rebuttal of control agreements and providing such other non-control and related
commitments as the Federal Reserve may require (in each case, in form and substance reasonably
satisfactory to the Federal Reserve) as a condition to approving and accepting such rebuttal of
control submission (in each case to the extent it has not done so prior to the date of this
Agreement). The Anchor Investors and the Company will have the right to review in advance, and to
the extent practicable each will consult with the other, in each case subject to Laws relating to
the exchange of information and confidential information related to the Anchor Investors, all the
information (other than confidential information) relating to such other parties, and any of their
respective Affiliates, which appears in any filing made with, or written materials submitted to,
any third party or any Governmental Entity in connection with the transactions to which it will be
party contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto
agrees to act reasonably and as promptly as practicable. Each of the parties hereto agrees to keep
the other parties apprised of the status of matters referred to in this Section 3.4. Each
of the Anchor Investors and the Company shall promptly furnish the other with copies of written
communications received by it or its Affiliates from, or delivered by any of the foregoing to, any
Governmental Entity in respect of the transactions contemplated by the Transaction Documents;
provided, that the party delivering any such document may redact any confidential
information contained therein.
(b) The Company shall call a meeting of its stockholders, to be held as promptly as practical
after May 23, 2010, and in no event later than October 28, 2010, to vote on (1) proposals to amend
the Series A Preferred Stock and the Series B Preferred Stock (the “Preferred Stock
Proposals”) pursuant to the Articles of Amendment attached hereto as Exhibit F (the
“Preferred Stock Articles of Amendment”) and (2) proposals to amend the Articles of
Incorporation (A) to increase the number of authorized shares of Common Stock to at least
1,000,000,000 shares or such larger number as the Board of Directors determines in its reasonable
judgment is necessary to effectuate the transactions contemplated by the Transaction Documents and
(B) to effectuate a reverse stock split of shares of the Common Stock to comply with NASDAQ listing
requirements and (3) proposals to approve the issuance of the Common Shares pursuant to the
Transaction Documents, the Investment, the Other Private Placements, the TARP Exchange, the
Exchange Offers and the Rights Offering (including the backstop commitments), pursuant to the
applicable NASDAQ Marketplace Rules (the stockholder proposals described in clauses (2) and (3),
the “General Stockholder Proposals”). The Board of Directors shall unanimously recommend to
the Company’s stockholders that such stockholders approve the General Stockholder Proposals and, if
applicable, the Preferred Stock Proposals and shall take all other actions necessary to adopt such
proposals if approved by the stockholders of the Company. In connection with each of the meetings
at which such proposals will be voted on, the Company shall promptly prepare (and the Anchor
Investors shall reasonably cooperate with the Company to prepare) and file with the SEC a
preliminary proxy statement, shall use its reasonable best efforts to solicit proxies for such
stockholder approval and shall use its reasonable best efforts to respond to any comments of the
SEC or its staff and to cause a definitive proxy statement related to such stockholders’ meeting to be mailed to
the Company’s stockholders as promptly as practicable after clearance thereof by the SEC. The
Company shall notify the
36
Anchor Investors promptly of the receipt of any comments from the SEC or
its staff with respect to the proxy statement and of any request by the SEC or its staff for
amendments or supplements to such proxy statement or for additional information and shall supply
the Anchor Investors with copies of all correspondence between the Company or any of its
representatives, on the one hand, and the SEC or its staff, on the other hand, with respect to such
proxy statement. If at any time prior to such stockholders’ meeting there shall occur any event
that is required to be set forth in an amendment or supplement to the proxy statement, the Company
shall as promptly as practicable prepare and mail or otherwise disseminate to its stockholders such
an amendment or supplement. Each of the Anchor Investors and the Company agree promptly to correct
any information provided by it or on its behalf for use in the proxy statement if and to the extent
that such information shall have become false or misleading in any material respect, and the
Company shall as promptly as practicable prepare and mail or otherwise disseminate to its
stockholders an amendment or supplement to correct such information to the extent required by
applicable Laws. The Company shall consult with the Anchor Investors prior to mailing any proxy
statement, or any amendment or supplement thereto, and provide the Anchor Investors with reasonable
opportunity to comment thereon. The recommendation made by the Board of Directors described in this
Section 3.4(b) shall be included in the proxy statement filed in connection with obtaining
such stockholder approval. Upon approval and adoption of any of the General Stockholder Proposals
and Preferred Stock Proposals, if applicable, the Company shall promptly file the General Articles
of Amendment and the Preferred Stock Articles of Amendment, as applicable, with the Commonwealth of
Virginia State Corporation Commission.
(c) In the event that the approval of any of the Stockholder Proposals described in this
Section 3.4 is not obtained at such stockholders meeting, the Company shall include a
proposal to approve (and the Board of Directors shall unanimously recommend approval of) each such
proposal at a meeting of its stockholders no less than once in each subsequent sixty-day period
beginning on the day following such initial stockholders meeting until all such approvals are
obtained or made
(d) The Company shall amend the Articles of Incorporation to reduce the par value per share of
Common Stock to a nominal amount, which shall be less than the Purchase Price divided by the number
of Common Shares to be purchased by the Anchor Investors hereunder, and the Company shall file
Articles of Amendment reflecting such new par value per share of Common Stock.
3.5. Governance Matters.
(a) Prior to the First Closing, the Company shall take all requisite corporate action to
decrease the size of the Board of Directors to eleven (11) members, including two Designated Anchor
Investor Directors and the chief executive officer of the Company. The Company shall request any
existing member of the Board of Directors who will not be among the eleven (11) members of the
Board of Directors immediately following the First Closing to tender his conditional resignation
from the Board of Directors to the Company to be effective upon the First Closing. Not less than
ten (10) Business Days prior to the First Closing, (i) the Carlyle Anchor Investor shall provide to
the Company the name of the Carlyle Designated Director to the Board of the Directors of the
Company as well as the boards of directors of Hampton Roads and Shore (the “Bank Boards”)
and the committees to which such designee is to be appointed and (ii) the Anchorage Anchor Investor
shall provide to the Company the name of the Anchorage Designated Director to the Board and the
Bank Boards and the committees to which such designee is to be appointed. The Company shall cause
the Carlyle Designated Director to be elected or appointed, subject to satisfaction of all legal
and governance requirements regarding service as a member of the Board and the Bank Boards on the
First Closing Date and thereafter as long as the Carlyle Anchor Investor owns in aggregate with its
Affiliates 20% or more of the number of shares of Common Stock purchased by the Anchorage Anchor Investor pursuant to this Agreement (as adjusted from time
to time for any reorganization, recapitalization, stock dividend, stock split, reverse stock split,
or other like
37
changes in the Company’s capitalization) (the “ Carlyle Qualifying Ownership
Interest”). The Company shall cause the Anchorage Designated Director (collectively with the
Carlyle Designated Director, the “Designated Anchor Investor Directors”) to be elected or
appointed, subject to satisfaction of all legal and governance requirements regarding service as a
director of the Company, to the Board and the Bank Boards on the First Closing Date and thereafter
as long as the Anchorage Anchor Investor owns in aggregate with its Affiliates 20% or more of the
number of shares of Common Stock purchased by the Anchorage Anchor Investor pursuant to this
Agreement (as adjusted from time to time for any reorganization, recapitalization, stock dividend,
stock split, reverse stock split, or other like changes in the Company’s capitalization) (the
“Anchorage Qualifying Ownership Interest”). The Company shall be required to recommend to
its stockholders the election of the Designated Anchor Investor Directors to the Board of Directors
at the Company’s annual meeting, subject to satisfaction of all legal and governance requirements
regarding service as a director of the Company. If the Carlyle Anchor Investor no longer has the
Carlyle Qualifying Ownership Interest or the Anchorage Anchor Investor no longer has the Anchorage
Qualifying Ownership Interest, the applicable Anchor Investor that no longer has such ownership
interest shall have no further rights under Sections 3.5(a), 3.5(b) and
3.5(c) and, in each case, at the written request of the Board of Directors, such Anchor
Investor shall use all reasonable best efforts to cause the Designated Anchor Investor Director
appointed by such Anchor Investor to resign from the Board of Directors as promptly as possible
thereafter. The Board of Directors and the Bank Boards shall cause each Designated Anchor Investor
Director to be appointed to the committees of the Board of Directors and the Bank Boards, as
applicable, identified by the applicable Anchor Investor, so long as such Designated Anchor
Investor Director qualifies to serve on such committees subject to satisfaction of all legal and
governance requirements regarding service as a committee member.
(b) The Designated Anchor Investor Directors shall, subject to applicable Law, be the nominees
of the Company and the Nominating Committee of the Board of Directors (the “Nominating
Committee”) to serve on the Board of Directors and on each of the Bank Boards. The Company
shall use its reasonable best efforts to have the Designated Anchor Investor Directors elected as
directors of the Company by the stockholders of the Company and the Company shall solicit proxies
for the Designated Anchor Investor Directors to the same extent as it does for any of its other
nominees to the Board of Directors.
(c) Subject to Section 3.5(a), upon the death, disability, resignation, retirement,
disqualification or removal from office of a Designated Anchor Investor Director, the Anchor
Investor who designated such director shall have the right to designate the replacement for the
Designated Anchor Investor Director, which replacement shall satisfy all legal and governance
requirements regarding service as a member of the Board of Directors and the Bank Boards, as
applicable. The Board of Directors of the Company shall use its reasonable best efforts to take all
action required to fill the vacancy resulting therefrom with such person (including such person,
subject to applicable Law, being the Company’s and the Nominating Committee’s nominee to serve on
the Board of Directors, calling a special meeting of stockholders to vote on such person, using all
reasonable best efforts to have such person elected as director of the Company by the stockholders
of the Company and the Company soliciting proxies for such person to the same extent as it does for
any of its other nominees to the Board of Directors).
(d) The Company hereby agrees that, from and after the First Closing Date, for so long as an
Anchor Investor owns in aggregate with its Affiliates 20% or more of the number of shares of Common
Stock purchased by the Anchorage Anchor Investor pursuant to this Agreement (as adjusted from time
to time for any reorganization, recapitalization, stock dividend, stock split, reverse stock split,
or other like changes in the Company’s capitalization), the Company shall, subject to applicable
Law, invite a person designated by such Anchor Investor and reasonably acceptable to the Board of
Directors (each, an “Observer”) to attend meetings of the Board of Directors (including any
meetings of committees thereof which such Anchor Investor’s Designated Anchor Investor Director is
a member) in a nonvoting
38
observer capacity. If such Anchor Investor no longer Beneficially Owns the
minimum number of shares of Common Stock as specified in the first sentence of this Section
3.5(d), such Anchor Investor shall have no further rights under this Section 3.5(d).
(e) The Designated Anchor Investor Directors shall be entitled to the same compensation,
including fees, and same indemnification in connection with his or her role as a director as the
other members of the Board of Directors or the Bank Boards, as applicable, and the Designated
Anchor Investor Directors shall be entitled to reimbursement for documented, reasonable
out-of-pocket expenses incurred in attending meetings of the Board of Directors or the Bank Boards,
or any committee thereof, to the same extent as the other members of the Board of Directors or the
Bank Boards, as applicable. The Company shall notify the Designated Anchor Investor Directors and
the Observers of all regular meetings and special meetings of the Board of Directors or the Bank
Boards and of all regular and special meetings of any committee of the Board of Directors or the
Bank Boards of which such Designated Anchor Investor Director is a member in accordance with the
applicable bylaws. The Company, Hampton Roads and Shore shall provide the Designated Anchor
Investor Directors and Observers with copies of all notices, minutes, consents and other material
that they provide to all other members of their respective boards of directors concurrently as such
materials are provided to the other members.
(f) The Company acknowledges that certain Designated Anchor Investor Directors (each, an
“Anchor Investor Indemnitee”) may have certain rights to indemnification, advancement of
expenses and/or insurance provided by the Carlyle Anchor Investor or the Anchorage Anchor Investor,
as applicable, and/or certain of its affiliates (collectively, the “Anchor Investor
Indemnitors”). The Company hereby agrees (i) that it is the indemnitor of first resort (i.e.,
its obligations to each Anchor Investor Indemnitee are primary and any obligation of the Anchor
Investor Indemnitors to advance expenses or to provide indemnification for the same expenses or
liabilities incurred by any Anchor Investor Indemnitee are secondary), and (ii) that it shall be
required to advance the full amount of expenses incurred by each Anchor Investor Indemnitee and
shall be liable for the full amount of all expenses and liabilities to the extent legally permitted
and as required by the terms of this Agreement and the Articles of Incorporation and By-Laws of the
Company (and any other agreement regarding indemnification between the Company and any Anchor
Investor Indemnitee), without regard to any rights an Anchor Investor Indemnitee may have against
any Anchor Investor Indemnitor. The Company further agrees that no advancement or payment by any
Anchor Investor Indemnitor on behalf of any Anchor Investor Indemnitee with respect to any claim
for which such Anchor Investor Indemnitee has sought indemnification from the Company shall affect
the foregoing and the Anchor Investor Indemnitors shall have a right of contribution and/or be
subrogated to the extent of such advancement or payment to all of the rights of recovery of such
Anchor Investor Indemnitee against the Company. The Company and each Anchor Investor Indemnitee
agree that the Anchor Investor Indemnitors are express third party beneficiaries of the terms of
this Section 3.5(f).
3.6. Avoidance of Control. Notwithstanding anything to the contrary in the
Transaction Documents, neither the Company nor any Company Subsidiary shall take any action
(including any redemption, repurchase, or recapitalization of Common Stock, or securities or
rights, options or warrants to purchase Common Stock, or securities of any type whatsoever that
are, or may become, convertible into or exchangeable into or exercisable for Common Stock in each
case, where the Anchor Investors are not given the right to participate in such redemption,
repurchase or recapitalization to the extent of the Anchor Investors’ pro rata proportion), that
would cause any Anchor Investor’s or any other Person’s ownership of voting securities of the
Company (together with the ownership by such Anchor Investor’s or other Person’s Affiliates (as
such term is used under the BHC Act) of voting securities of the Company) to increase above 24.9%, without the prior written consent of such
affected Anchor Investor, or to increase to an amount that would constitute “control” under the BHC
Act, or
39
otherwise cause any Anchor Investor to “control” the Company under and for purposes of the
BHC Act. Notwithstanding anything to the contrary in this Agreement or any Transaction Document, no
Anchor Investor or any other Person (together with the Anchor Investors or Affiliates (as such term
is used under the BHC ACT) shall have the ability to exercise any voting rights of any securities
in excess of 24.9% of the total outstanding voting securities of the Company. In the event either
the Company or any Anchor Investor breaches its obligations under this Section 3.6 or
believes that it is reasonably likely to breach such an obligation, it shall promptly notify the
other parties hereto and shall cooperate in good faith with such parties to modify ownership or
make other arrangements or take any other action, in each case, as is necessary to cure or avoid
such breach.
3.7. Notice of Certain Events. Each party hereto shall promptly notify the other
party hereto of (a) any event, condition, fact, circumstance, occurrence, transaction or other item
of which such party becomes aware prior to each Closing that would constitute a violation or
breach of the Transaction Documents (or a breach of any representation or warranty contained herein
or therein) or, if the same were to continue to exist as of the applicable Closing Date, would
constitute the non-satisfaction of any of the conditions set forth in Section 1.2 hereof,
and (b) any event, condition, fact, circumstance, occurrence, transaction or other item of which
such party becomes aware which would have been required to have been disclosed pursuant to the
terms of the Transaction Documents had such event, condition, fact, circumstance, occurrence,
transaction or other item existed as of May 23, 2010. Notwithstanding the foregoing, neither party
shall be required to take any action that would jeopardize such party’s attorney-client privilege.
3.8. Commercially Reasonable Efforts. Subject to the third sentence in Section
3.4(a) of this Agreement, upon the terms and subject to the conditions herein provided, except
as otherwise provided in the Transaction Documents, each of the parties hereto agrees to use its
commercially reasonable efforts to take or cause to be taken all action, to do or cause to be done
and to assist and cooperate with the other parties hereto in doing all things necessary, proper or
advisable under Laws to consummate and make effective the transactions contemplated hereby,
including but not limited to: (i) the satisfaction of the conditions precedent to the obligations
of the parties hereto; (ii) the obtaining of applicable Governmental Consents, and consents,
waivers and approvals of any third parties (including Governmental Entities); (iii) the defending
of any claim, action, suit, investigation or proceeding, whether judicial or administrative,
challenging the Transaction Documents or the performance of the obligations hereunder or
thereunder; and (iv) the execution and delivery of such instruments, and the taking of such other
actions as the other parties hereto may reasonably request in order to carry out the intent of the
Transaction Documents.
3.9. Preemptive Rights.
(a) Sale of New Securities. After the First Closing, for so long as an Anchor
Investor owns securities representing the Carlyle Qualifying Ownership Interest or the Anchorage
Qualifying Ownership Interest, as applicable (before giving effect to any issuances triggering
provisions of this Section 3.9), at any time that the Company proposes to make any public
or nonpublic offering or sale of any equity (including Common Stock, preferred stock or restricted
stock), or any securities, options or debt that is convertible or exchangeable into equity or that
includes an equity component (such as, an “equity” kicker) (including any hybrid security) (any
such security, a “New Security”) (other than the issuance and sale of securities (i) in
connection with the Rights Offering and the Second Closing; (ii) to employees, officers, directors
or consultants of the Company pursuant to employee benefit plans or compensatory arrangements
approved by the Board of Directors (including upon the exercise of employee stock options granted
pursuant to any such plans or arrangements); (iii) as consideration in connection with any bona fide, arm’s-length direct or indirect merger, acquisition or similar
transaction; or (iv) securities issued pursuant to the Troubled Assets Relief Program (“TARP”) or
any similar United States
40
Government program), such Anchor Investor shall first be afforded the
opportunity to acquire from the Company for the same price (net of any underwriting discounts or
sales commissions) and on the same terms (except that, to the extent permitted by Law and the
Articles of Incorporation and By-Laws of the Company, such Anchor Investor may elect to receive
such securities in nonvoting form, convertible into voting securities in a widely dispersed
offering) as such securities are proposed to be offered to others, up to the amount of such New
Securities to be offered in the aggregate required to enable it to maintain its proportionate
Common Stock-equivalent interest in the Company immediately prior to any such issuance of New
Securities. The New Securities that an Anchor Investor shall be entitled to purchase in the
aggregate shall be determined by multiplying (x) the total number or principal amount of such
offered New Securities by (y) a fraction, the numerator of which is the number of shares of Common
Stock held by such Anchor Investor and its Affiliates (assuming full conversion or exercise of any
securities convertible into or exercisable for Common Stock) and the denominator of which is the
number of shares of Common Stock then outstanding. Notwithstanding anything herein to the contrary,
in no event shall an Anchor Investor have the right to purchase securities hereunder to the extent
that such purchase would result in such Anchor Investor exceeding the ownership limitations of the
Anchor Investors set forth in Section 3.6.
(b) Notice. In the event the Company proposes to offer or sell New Securities that are
subject to an Anchor Investor’s rights under Section 3.9(a), it shall give such Anchor
Investor written notice of its intention, specifying the price (or range of prices), anticipated
amount of securities, timing and other terms upon which the Company proposes to offer the same
(including, in the case of a registered public offering and to the extent possible, a copy of the
prospectus included in the registration statement filed with respect to such offering), at least
thirty (30) days prior to the proposed offer, issuance or sale. An Anchor Investor shall have
twenty-five (25) days from the date of receipt of such a notice to notify the Company in writing
that it intends to exercise its rights provided in this Section 3.9 and as to the amount of
New Securities such Anchor Investor desires to purchase, up to the maximum amount calculated
pursuant to Section 3.9(a). Such notice shall constitute a non-binding agreement of such
Anchor Investor to purchase the amount of New Securities so specified at the price and other terms
set forth in the Company’s notice to it. The failure of an Anchor Investor to respond within such
twenty-five (25) day period shall be deemed to be a waiver of such Anchor Investor’s rights under
this Section 3.9 only with respect to the offering described in the applicable notice.
Notwithstanding anything to the contrary herein in this section, the provisions of subclause (b)
hereto shall not be applicable to any New Securities offered or issued at the written direction of
the applicable federal regulator of the Company or its banking subsidiaries.
(c) Purchase Mechanism. If an Anchor Investor exercises its rights provided in this
Section 3.9, the closing of the purchase of the New Securities with respect to which such
right has been exercised shall take place within sixty (60) days after the giving of notice of such
exercise, provided that, if such issuance is subject to regulatory approval, such sixty (60)-day
period shall be extended until the expiration of ten (10) Business Days after all such approvals
have been received, but in no event later than 120 days from the date of the Company’s initial
notice pursuant to Section 3.9(b). Each of the Company and the Anchor Investors agrees to
use its commercially reasonable efforts to secure any regulatory or stockholder approvals or other
consents, and to comply with any Law necessary in connection with the offer, sale and purchase of,
such New Securities.
(d) Failure of Purchase. In the event an Anchor Investor fails to exercise its rights
provided in this Section 3.9 within the 25-day period described in Section 3.9(b)
or, if so exercised, such Anchor Investor is unable to consummate such purchase within the time
period specified in Section 3.9(c) above because of its failure to obtain any required
regulatory or stockholder consent or approval, the Company shall thereafter be entitled during the period of 90 days following the conclusion of
the applicable period to sell or enter into an agreement (pursuant to which the sale of the Common
Stock
41
covered thereby shall be consummated, if at all, within 30 days from the date of such
agreement) to sell the Common Stock not elected to be purchased pursuant to this Section
3.9 or which such Anchor Investor is unable to purchase because of such failure to obtain any
such consent or approval, at a price and upon other terms that, taken in the aggregate, are not
more favorable to the purchasers of such securities than were specified in the Company’s notice to
such Anchor Investor. Notwithstanding the foregoing, if such sale is subject to the receipt of any
regulatory or stockholder approval or consent or the expiration of any waiting period, the time
period during which such sale may be consummated shall be extended until the expiration of five (5)
Business Days after all such approvals or consents have been obtained or waiting periods expired,
but in no event shall such time period exceed 90 days from the date of the applicable agreement
with respect to such sale. In the event the Company has not sold the Common Stock or entered into
an agreement to sell the Common Stock within such 90-day period (or sold and issued Common Stock in
accordance with the foregoing within 30 days from the date of said agreement (as such period may be
extended in the manner described above for a period not to exceed 90 days from the date of such
agreement)), the Company shall not thereafter offer, issue or sell such Common Stock without first
offering such securities to each Anchor Investor in the manner provided above.
(e) Non-Cash Consideration. In the case of the offering of securities for
consideration in whole or in part other than cash, including securities acquired in exchange
therefor (other than securities by their terms so exchangeable), the consideration other than cash
shall be deemed to be the fair value thereof as determined by the Board of Directors; provided,
however, that such fair value as reasonably determined by the Board of Directors shall not exceed
the aggregate market price of the securities being offered as of the date the Board of Directors
authorizes the offering of such securities.
(f) Cooperation. The Company and each Anchor Investor shall cooperate in good faith to
facilitate the exercise of such Anchor Investor’s rights under this Section 3.9, including
securing any required approvals or consents.
3.10. Most Favored Nation. During the period from May 23, 2010 through the Second
Closing, neither the Company nor the Company Subsidiaries shall enter into any additional
agreements, or modify any existing agreements or Transaction Documents, including the CapGen
Investment Agreement or any other agreements with future investors in the Company or any of the
Company Subsidiaries (including any Additional Agreements entered into with the Additional
Investors) that have the effect of establishing rights or otherwise benefiting such investor in a
manner more favorable in any material respect to such investor than the rights and benefits
established in favor of the Anchor Investors by the Transaction Documents, unless, in any such
case, each Anchor Investor will be given a copy of such additional or modified agreement and has
been offered the opportunity to receive such rights and benefits of such additional or modified
agreement within 60 days of the later of the execution of such additional or modified agreement and
May 23, 2010. Such Anchor Investor shall notify the Company in writing, within 30 days after the
date it receives a copy of such additional or modified agreement, of its election to receive the
rights and benefits set forth therein. For the avoidance of doubt, the Anchor Investors will
receive a copy of each additional or modified agreement (including any Additional Agreements
entered into with any Additional Investors) agreed to with one or more other investors. Without
limiting the foregoing, the Company shall not offer any investors in the Other Private Placements,
or any other capital raising transaction occurring at the same time as the transactions
contemplated by the Transaction Documents on terms more favorable, in form or substance, than those
offered in connection with the Investment, unless the Anchor Investors are also provided with such
terms or has consented thereto in writing; provided, however, that for purposes of
this Section 3.10, the Anchor Investors hereby consent to the Company’s entry into (i) the CapGen
Investment Agreement, (ii) the letter agreement dated as of the date hereof between the Company and
an Affiliate of the Carlyle Anchor Investor (and the related agreements attached thereto) (the “Carlyle Investor
Letter”), (iii) the letter agreement dated as of the date hereof between the Company and an
Affiliate of the Anchorage Anchor
42
Investor (and the related agreements attached thereto) (the “Anchorage Investor Letter”), (iv) the letter agreement dated as of the date hereof
between the Company and CapGen (and the related agreements attached thereto), (v) the letter
agreement dated as of the date hereof between the Company and Midtown Acquisitions L.P. (the
“Davidson Investor Letter”), and (vi) the letter agreement dated as of the date hereof
between the Company and Fir Tree Value Master Fund, LP, Fir Tree Capital Opportunity Master Fund,
LP, Fir Tree Mortgage Opportunity Master Fund, LP and Fir Tree REOF II Master Fund, LLC
(collectively, the “Fir Tree Investors”) (the “Fir Tree Investor Letter”) and the
terms and conditions thereof in each case in the form previously delivered by the Company to the
Anchor Investors; provided further, however, that any proposed modification to any
Investor Letter from the form of such Investor Letter provided to the Anchor Investors and any
proposed modification of such Investor Letter executed as of the date hereof after the date hereof
shall be subject to the Anchor Investors’ rights and the Company’s obligations set forth above.
For the purposes of this Agreement, all parties agree that the terms and conditions of those
documents referred to in clauses (i), (ii), (iii), (iv), (v) and (vi) of this paragraph shall be
deemed Previously Disclosed, as that term is used herein, including for the purposes of modifying
the Company’s representations and warranties.
3.11. Transfer Taxes. On each Closing Date, all stock transfer or other taxes (other
than income or similar taxes) which are required to be paid in connection with the sale and
transfer of the Common Shares to be sold to such Anchor Investor hereunder will be, or will have
been, fully paid or provided for by the Company, and all Laws imposing such taxes will be or will
have been complied with.
3.12. Legend.
(a) The Anchor Investors agree that all certificates or other instruments representing the
securities subject to the Transaction Documents shall bear a legend substantially to the following
effect, until such time as they are not required under Section 3.12(b):
“(i) THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE AND
MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION
STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE
SECURITIES LAWS OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH
LAWS.
(ii) THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND
OTHER RESTRICTIONS SET FORTH IN AN INVESTMENT AGREEMENT, DATED AS OF JUNE 30, 2010,
COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.”
(b) Following the earlier of (i) the effective date of a resale registration statement
covering such Common Shares or (ii) Rule 144 becoming available for the resale of the Common
Shares, without the requirement for the Company to be in compliance with the current public
information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to the Common
Shares and without volume or manner-of-sale restrictions, the Company shall instruct the Company’s
transfer agent to remove the legend set forth in Section 3.12(a) from the Common Shares and
shall cause its counsel to issue any legend removal opinion required by the transfer agent. Any
fees (with respect to the transfer agent, Company counsel or otherwise) associated with the
issuance of such opinion or the removal of such legend shall be borne by the Company. If a legend
is no longer required pursuant to the foregoing, the Company will no later than three (3) Business Days following the delivery by an Anchor
Investor to the Company or the transfer agent (with notice to the Company) of a legended
certificate or instrument
43
representing such Common Shares (endorsed or with stock powers attached,
signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer)
and any required representation letter, deliver or cause to be delivered to such Anchor Investor a
certificate or instrument (as the case may be) representing such Common Shares that is free from
all restrictive legends. The Company may not make any notation on its records or give instructions
to its transfer agent that enlarge the restrictions on transfer set forth in this Section
3.12(b). Certificates for Common Shares free from all restrictive legends may be transmitted
by the transfer agent to the Anchor Investors by crediting the account of the Anchor Investor’s
prime broker with the Depository Trust Company as directed by such Anchor Investor. Each Anchor
Investor acknowledges that the securities have not been registered under the Securities Act or
under any state securities laws and agrees that it shall not sell or otherwise dispose of any of
the securities, except in compliance with the registration requirements or exemption provisions of
the Securities Act and any other applicable securities laws.
3.13. Continued Listing Authorization. The Company shall take all steps necessary to
prevent the Common Shares from being delisted from NASDAQ, including, without limitation, effecting
a reverse stock split of the Common Stock, if necessary, to comply with NASDAQ Listing Rule
5450(a)(1).
3.14. Registration Rights.
(a) Registration.
(1) Subject to the terms and conditions of the Transaction Documents, the
Company covenants and agrees that as promptly as practicable, and in any event no
later than the date that is 15 days, after the First Closing (the “Filing
Deadline”), the Company shall have prepared and filed with the SEC one or more
Shelf Registration Statements covering the resale of all of the Registrable
Securities (or, if permitted by the rules of the SEC, otherwise designated an
existing Shelf Registration Statement filed with the SEC to cover such Registrable
Securities), and, to the extent the Shelf Registration Statement has not theretofore
been declared effective or is not automatically effective upon such filing, the
Company shall use reasonable best efforts to cause such Shelf Registration Statement
to be declared or become effective as soon as practicable (and in any event no later
than the Effectiveness Deadline) and to keep such Shelf Registration Statement
continuously effective and in compliance with the Securities Act and usable for
resale of such Registrable Securities for a period from the date of its initial
effectiveness until the time as there are no such Registrable Securities remaining
(including by refiling such Shelf Registration Statement (or a new Shelf
Registration Statement) if the initial Shelf Registration Statement expires).
Notwithstanding the registration obligations set forth in this Section
3.14(a)(1), in the event the SEC informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for
resale as a secondary offering on a single registration statement, the Company
agrees to promptly (i) inform each of the Holders thereof and use its commercially
reasonable efforts to file amendments to the initial Shelf Registration Statement as
required by the SEC and/or (ii) withdraw the initial Shelf Registration Statement
and file a new Shelf Registration Statement, in either case covering the maximum
number of Registrable Securities permitted to be registered by the SEC, on such form
available to the Company to register for resale the Registrable Securities as a
secondary offering; provided, however, that prior to filing such amendment or new
Shelf Registration Statement, the Company shall be obligated to use its reasonable
best efforts to advocate with the SEC for the registration of all of the Registrable Securities in accordance with
the SEC Guidance, including without limitation, Compliance and Disclosure
Interpretation
44
612.09. Notwithstanding any other provision of this Agreement, if
any SEC Guidance sets forth a limitation of the number of Registrable Securities or
other shares of Common Stock permitted to be registered on a particular Shelf
Registration Statement as a secondary offering (and notwithstanding that the Company
used diligent efforts to advocate with the SEC for the registration of all or a
greater number of Registrable Securities), the number of Registrable Securities or
other shares of Common Stock to be registered on such Shelf Registration Statement
will be reduced as follows: first, the Company shall reduce or eliminate the shares
of Common Stock to be included by any Person other than a Holder; second, the
Company shall reduce or eliminate any shares of Common Stock to be included by any
Affiliate (which shall not include either Anchor Investor or their Affiliates) of
the Company; and third, the Company shall reduce the number of Registrable
Securities to be included by all Holders on a pro rata basis based on the total
number of unregistered Registrable Securities held by such Holders, subject to a
determination by the SEC that certain Holders must be reduced before other Holders
based on the number of Registrable Securities held by such Holders. In the event
the Company amends the initial Shelf Registration Statement or files a new Shelf
Registration Statement, as the case may be, under clauses (i) or (ii) above, the
Company will use its commercially reasonable efforts to file with the SEC, as
promptly as allowed by the SEC or SEC Guidance provided to the Company or to
registrants of securities in general, one or more registration statements on such
form available to the Company to register for resale those Registrable Securities
that were not registered for resale on the initial Shelf Registration Statement, as
amended, or the new Shelf Registration Statement. No Holder shall be named as an
“underwriter” in any Registration Statement without such Holder’s prior written
consent.
(2) Demand Registration.
A. Each of the Anchor Investors shall have the right, by written notice
(the “Demand Notice”) given to the Company, to request, at any time
and from time to time during such periods when a Shelf Registration
Statement or Shelf Registration Statements covering all of the Anchor
Investors’ Registrable Securities is or are not existing and effective, that
the Company register under and in accordance with the provisions of the
Securities Act all or any portion of the Registrable Securities designated
by such Anchor Investor. Upon receipt of a Demand Notice pursuant to the
corresponding provisions of the CapGen Investment Agreement or from an
Anchor Investor pursuant to this Section 3.14, the Company shall
promptly (and in any event within ten (10) Business Days from the date of
receipt of such Demand Notice), notify the other Anchor Investor (or each
Anchor Investor, in the case of a Demand Notice from CapGen) of the receipt
of such Demand Notice and allow such other Anchor Investor (or each Anchor
Investor, in the case of a Demand Notice from CapGen) the opportunity to
include Registrable Securities held by such Anchor Investor in the proposed
registration by submitting its own Demand Notice. The Company, within 45
days of the date on which the Company receives such earlier Demand Notice,
shall file with the SEC, and the Company shall thereafter use its best
efforts to cause to be declared effective as promptly as practicable, a
registration statement on the appropriate form for the registration and sale
as shall be selected by the Company and as shall be reasonably acceptable to
the Anchor Investors registering Registrable Securities and CapGen (if
CapGen is registering Registrable Securities), in accordance with the intended method or
methods of distribution (which may be by an underwritten offering), of the
total number of
45
Registrable Securities specified by the Holders in such Demand Notice (a “Demand Registration Statement”). If the Anchor
Investors registering Registrable Securities intend to distribute any
Registrable Securities by means of an underwritten offering, they shall
promptly so advise the Company and the Company shall take all reasonable
steps to facilitate such distribution, including the actions required
pursuant to Section 3.14(c). The managing underwriters in any such
distribution shall be mutually acceptable to each Anchor Investor
registering Registrable Securities and shall be mutually acceptable to each
of the Anchor Investors and CapGen if CapGen is also registering Registrable
Securities in such underwritten offering. Any Demand Registration Statement
may, at the request of the Holders submitting the Demand Notice, be a
“shelf” registration pursuant to Rule 415, if available.
B. The Company shall use reasonable best efforts to keep each Demand
Registration Statement filed pursuant to this Section 3.14(a)(2)
continuously effective and usable for the resale of the Registrable
Securities covered thereby for a period of one hundred eighty (180) days
from the date on which the SEC declares such Demand Registration Statement
effective, as such period may be extended pursuant to this Section
3.14(a)(2)(B). The time period for which the Company is required to
maintain the effectiveness of any Demand Registration Statement shall be
extended by the aggregate number of days of all suspension periods pursuant
to Section 3.14(d) occurring with respect to such Demand
Registration Statement.
C. The Company shall be entitled to suspend the use of any effective
Registration Statement under this Section 3.14(a)(2) under the
circumstances set forth in Section 3.14(d).
D. For the avoidance of doubt, the rights provided pursuant to
Section 3.14(a)(2) shall not be exercisable until the Effectiveness
Deadline.
(3) Except as provided in Section 3.14(a)(7), any registration (except
for any registration made pursuant to Section 3.14(a)(2)) pursuant to this
Section 3.14(a) shall be effected by means of a shelf registration under the
Securities Act (a “Shelf Registration Statement”) in accordance with the
methods and distribution set forth in the Shelf Registration Statement and Rule 415.
If the Anchor Investors or any other holder of Registrable Securities to whom the
registration rights conferred by the Transaction Documents have been transferred in
compliance with the Transaction Documents intends to distribute any Registrable
Securities by means of an underwritten offering it shall promptly so advise the
Company and the Company shall take all reasonable steps to facilitate such
distribution, including the actions required pursuant to Section 3.14(c).
The lead underwriters in any such distribution shall be selected by the holders of a
majority of the Registrable Securities to be distributed.
(4) If the Company proposes to register any of its securities, whether or not
for its own account (including, without limitation, pursuant to the exercise of any
demand registration rights pursuant to Section 3.14(a)(2)), other than a
registration pursuant to Section 3.14(a)(1), Section 3.14(a)(7) or a
Special Registration, and the registration form to be filed may be used for the
registration or qualification for distribution of Registrable Securities, the Company shall give prompt written notice to each Anchor
Investor and all other Holders of its intention to effect such a registration (but
in no event less than ten
46
(10) Business Days prior to the anticipated filing date)
and shall include in such registration all Registrable Securities with respect to
which the Company has received written requests for inclusion therein within ten
(10) Business Days after the date of the Company’s notice (a “Piggyback
Registration”). Any such person that has made such a written request may
withdraw its Registrable Securities from such Piggyback Registration by giving
written notice to the Company and the managing underwriter, if any, on or before the
fifth Business Day prior to the planned effective date of such Piggyback
Registration. The Company may terminate or withdraw any registration under this
Section 3.14(a)(4) prior to the effectiveness of such registration, whether
or not the Anchor Investors or any other Holders have elected to include Registrable
Securities in such registration.
(5) If the registration referred to in Section 3.14(a)(4) is proposed
to be underwritten, the Company shall so advise the Anchor Investors and all other
Holders as a part of the written notice given pursuant to Section
3.14(a)(4). In such event, the right of the Anchor Investors and all other
Holders to registration pursuant to this Section 3.14(a) shall be
conditioned upon such persons’ participation in such underwriting and the inclusion
of such persons’ Registrable Securities in the underwriting, and each such person
shall (together with the Company and the other persons distributing their securities
through such underwriting) enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such underwriting by the Company.
If any participating person disapproves of the terms of the underwriting, such
Person may elect to withdraw therefrom by written notice to the Company, the
managing underwriter and the Anchor Investors.
(6) In the event (x) that any of the Additional Investors exercises “piggyback”
registration rights under the Additional Agreements in connection with an Anchor
Investor’s exercise of its demand registration rights pursuant to Section
3.14(a)(2), (y) that the Company grants “piggyback” registration rights to one
or more third parties to include their securities in an underwritten offering under
the Shelf Registration Statement pursuant to Section 3.14(a)(1) or (z) that
a Piggyback Registration under Section 3.14(a)(4) relates to an underwritten
offering, and in any such case the managing underwriters advise the Company that in
their reasonable opinion the number of securities requested to be included in such
offering exceeds the number which can be sold without adversely affecting the
marketability of such offering (including an adverse effect on the per share
offering price), the Company shall include in such registration or prospectus only
such number of securities that in the reasonable opinion of such underwriters can be
sold without adversely affecting the marketability of the offering (including an
adverse effect on the per share offering price), which securities shall be so
included in the following order of priority: (i) first, solely in the case of a
Piggyback Registration under Section 3.14(a)(4) relating to a primary
offering on behalf of the Company, any securities the Company proposes to sell for
its own account, (ii) second, Common Stock and other securities of the Company
issued to the Treasury, (iii) third, Registrable Securities of the Anchor Investors
and all other Holders who have requested registration of Registrable Securities
pursuant to the Additional Agreements, Section 3.14(a)(1) or Section
3.14(a)(4), as applicable, pro rata on the basis of the aggregate number of such
securities or shares owned by each such person and (iv) fourth, any other securities
of the Company that have been requested to be so included, subject to the terms of
the Transaction Documents.
47
(7) In addition to any Shelf Registration Statement, the Company shall
prepare and file with the SEC, and use its reasonable best efforts thereafter to
cause to be effective, registration statements permitting the sale and distribution
in an underwritten offering of up to that number of Registrable Securities equal, in
each case, to 25% of the Registrable Securities outstanding as of the First Closing
Date (as to each such underwritten offering, the “Offering Ceiling”) (i)
first, as soon as practicable after the date twelve months after the First Closing
Date (the “First Secondary Offering Registration”), and (ii) second, as soon
as practicable after the date twelve months after the closing of the First Secondary
Offering Registration (the “Second Secondary Offering Registration” and,
together with the First Secondary Offering Registration, the “Secondary Offering
Registrations”, each a “Secondary Offering Registration”). Each such
offering shall be underwritten by one or more managing underwriters selected by the
holders of a majority of the Registrable Securities to be distributed, and shall be
effected on a “best efforts” basis unless otherwise agreed by the Company, Holders
of a majority of the Registrable Securities to be distributed and the managing
underwriters of such registration. With respect to each Secondary Offering
Registration, the Company shall give prompt written notice to the Anchor Investors
of its intention to effect such Secondary Offering Registration (but, in each case,
no less than ten Business Days prior to the anticipated filing date), and shall
include in such Secondary Offering Registration all Registrable Securities with
respect to which the Company has received a written request for inclusion therein
from an Anchor Investor within five (5) Business Days of the Company’s notice
pursuant to this Section 3.14(a)(7); provided, that CapGen and the Anchor
Investors shall only be permitted to participate in the Second Secondary Offering
Registration. In the event that the amount of Registrable Securities requested to
be included by Holders in either Secondary Offering Registration exceeds the
Offering Ceiling for such registration, the amount of Registrable Securities
requested to be included therein by each Holder shall be reduced proportionally
based on its pro rata ownership of the Registrable Securities as of the First
Closing Date. As to each Secondary Offering Registration, if the managing
underwriters of the underwritten offering to which it relates advise the Company
that in their reasonable opinion the number of Registrable Securities requested to
be included in such offering (after giving effect to any proportional reduction to a
level not in excess of the Offering Ceiling) exceeds the number which can be sold
without adversely affecting the marketability of such offering (including an adverse
effect on the per share offering price), the Company shall include in such
registration or prospectus only such number of securities that in the reasonable
opinion of such underwriters can be sold without adversely affecting the
marketability of the offering (including an adverse effect on the per share offering
price), which securities shall be so included in the following order of priority:
(i) first, Common Stock and other securities of the Company issued to the Treasury,
(ii) second, Registrable Securities of the Anchor Investors and all other Holders,
pro rata on the basis of the aggregate number of such securities or shares owned by
each such Person and (iii) third, any other securities of the Company that have been
requested to be so included, subject to the terms of the Transaction Documents.
(8) In the event that Form S-3 is not available for the registration of the
resale of Registrable Securities under Section 3.14(a)(1), the Company shall
(i) register the resale of the Registrable Securities on another appropriate form,
including, without limitation, Form S-1 and (ii) undertake to register the
Registrable Securities on Form S-3 promptly after such form is available, provided
that the Company shall maintain the effectiveness of the Shelf Registration
Statement then in effect until such time as a Shelf
48
Registration Statement on Form S-3 covering the Registrable Securities has been
declared effective by the SEC.
(b) Expenses of Registration. All Registration Expenses incurred in connection with
any registration, qualification or compliance hereunder shall be borne by the Company. All Selling
Expenses incurred in connection with any registrations hereunder shall be borne by the Holders
selling in such registration pro rata on the basis of the aggregate number of securities or shares
being sold.
(c) Obligations of the Company. The Company shall use its reasonable best efforts for
so long as there are Registrable Securities outstanding, to take such actions as are under its
control to not become an ineligible issuer (as defined in Rule 405 under the Securities Act). In
addition, whenever required to effect the registration of any Registrable Securities or facilitate
the distribution of Registrable Securities pursuant to an effective Shelf Registration Statement,
the Company shall, as expeditiously as reasonably practicable:
(1) By 9:30 a.m. New York City time on the first Business Day after the
Effective Date of a Shelf Registration Statement, file a final prospectus with the
SEC, as required by Rule 424(b) under the Securities Act.
(2) Provide to each Holder a copy of any disclosure regarding the plan of
distribution or the selling Holders, in each case, with respect to such Holder, at
least three (3) Business Days in advance of any filing with the SEC of any
registration statement or any amendment or supplement thereto that includes such
information.
(3) Prepare and file with the SEC a prospectus supplement with respect to a
proposed offering of Registrable Securities pursuant to an effective registration
statement, subject to Section 3.14(c), and keep such registration statement
effective or such prospectus supplement current.
(4) Prepare and file with the SEC such amendments and supplements to the
applicable registration statement and the prospectus or prospectus supplement used
in connection with such registration statement as may be necessary to comply with
the provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement.
(5) Furnish to the Holders and any underwriters such number of copies of the
applicable registration statement and each such amendment and supplement thereto
(including in each case all exhibits) and of a prospectus, including a preliminary
prospectus, in conformity with the requirements of the Securities Act, and such
other documents as they may reasonably request in order to facilitate the
disposition of Registrable Securities owned or to be distributed by them.
(6) Use its reasonable best efforts to register and qualify the securities
covered by such registration statement under such other securities or blue sky laws
of such jurisdictions as shall be reasonably requested by the Holders or any
managing underwriter(s), to keep such registration or qualification in effect for so
long as such registration statement remains in effect, and to take any other action
which may be reasonably necessary to enable such seller to consummate the
disposition in such jurisdictions of the securities owned by such Holder; provided,
that the Company shall not be required in connection therewith or as a condition
thereto to qualify to do business or to file a general consent to service of process
in any such states or jurisdictions.
49
(7) Notify each Holder of Registrable Securities at any time when a prospectus
relating thereto is required to be delivered under the Securities Act of the
happening of any event as a result of which the applicable prospectus, as then in
effect, includes an untrue statement of a material fact or omits to state a material
fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing (which notice shall not
contain any material non-public information).
(8) Within one Business Day after such event, give written notice to the
Holders (which notice shall not contain any material non-public information):
(A) when any registration statement filed pursuant to Section
3.14(a) or any amendment thereto has been filed with the SEC (except for
any amendment effected by the filing of a document with the SEC pursuant to
the Exchange Act) and when such registration statement or any post-effective
amendment thereto has become effective;
(B) of any request by the SEC for amendments or supplements to any
registration statement or the prospectus included therein or for additional
information;
(C) of the issuance by the SEC of any stop order suspending the
effectiveness of any registration statement or the initiation of any
proceedings for that purpose;
(D) of the receipt by the Company or its legal counsel of any
notification with respect to the suspension of the qualification of the
Common Stock for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose;
(E) of the happening of any event that requires the Company to make
changes in any effective registration statement or the prospectus related to
the registration statement in order to make the statements therein not
misleading (which notice shall be accompanied by an instruction to suspend
the use of the prospectus until the requisite changes have been made); and
(F) if at any time the representations and warranties of the Company
contained in any underwriting agreement contemplated by Section
3.14(c)(12) cease to be true and correct.
(9) Use its reasonable best efforts to prevent the issuance or obtain the
withdrawal of any order suspending the effectiveness of any registration statement
referred to in Section 3.14(c)(8)(C) at the earliest practicable time.
(10) Upon the occurrence of any event contemplated by Section
3.14(c)(7) or 3.14(c)(8)(E) and subject to the Company’s rights under
Section 3.14(d), the Company shall promptly prepare a post-effective
amendment to such registration statement or a supplement to the related prospectus
or file any other required document so that, as thereafter delivered to the Holders
and any underwriters, the prospectus shall not contain an untrue statement of a
material fact or omit to state any material fact necessary to make
50
the statements therein, in light of the circumstances under which they were
made, not misleading.
(11) Use reasonable best efforts to procure the cooperation of the Company’s
transfer agent in settling any offering or sale of Registrable Securities, including
with respect to the transfer of physical stock certificates into book-entry form in
accordance with any procedures reasonably requested by the Holders or any managing
underwriter(s).
(12) In the event of an underwritten offering pursuant to Section
3.14(a)(1) or Section 3.14(a)(4) or conducted pursuant to Section
3.14(a)(7), enter into an underwriting agreement in customary form, scope and
substance and take all such other actions reasonably requested by the Holders of a
majority of the Registrable Securities being sold in connection therewith or by the
managing underwriter(s), if any, to expedite or facilitate the underwritten
disposition of such Registrable Securities, and in connection therewith in any
underwritten offering (including making members of management and executives of the
Company available to participate in “road shows,” similar sales events and other
marketing activities), (i) make such representations and warranties to the Holders
that are selling stockholders and the managing underwriter(s), if any, with respect
to the business of the Company and the Company Subsidiaries, and the Shelf
Registration Statement, prospectus and documents, if any, incorporated or deemed to
be incorporated by reference therein, in each case, in customary form, substance and
scope, and, if true, confirm the same if and when requested, (ii) use its reasonable
best efforts to furnish the underwriters with opinions of counsel to the Company,
addressed to the managing underwriter(s), if any, covering the matters customarily
covered in such opinions requested in underwritten offerings, (iii) use its
reasonable best efforts to obtain “cold comfort” letters from the independent
certified public accountants of the Company (and, if necessary, any other
independent certified public accountants of any business acquired by the Company for
which financial statements and financial data are included in the applicable
registration statement) who have certified the financial statements included in such
registration statement, addressed to each of the managing underwriter(s), if any,
such letters to be in customary form and covering matters of the type customarily
covered in “cold comfort” letters, (iv) if an underwriting agreement is entered
into, the same shall contain indemnification provisions and procedures customary in
underwritten offerings, and (v) deliver such documents and certificates as may be
reasonably requested by the Holders of a majority of the Registrable Securities
being sold in connection therewith, their counsel and the managing underwriter(s),
if any, to evidence the continued validity of the representations and warranties
made pursuant to clause (i) above and to evidence compliance with any customary
conditions contained in the underwriting agreement or other agreement entered into
by the Company.
(13) Make available for inspection by a representative of Holders that are
selling stockholders, the managing underwriter(s), if any, and any attorneys or
accountants retained by such Holders or managing underwriter(s), at the offices
where normally kept, during reasonable business hours, financial and other records,
pertinent corporate documents and properties of the Company, and cause the officers,
directors and employees of the Company to supply all information, in each case,
reasonably requested by any such representative, managing underwriter(s), attorney
or accountant in connection with such Shelf Registration Statement.
51
(14) Cause all such Registrable Securities to be listed on each securities
exchange on which the same class of securities issued by the Company are then listed
or, if the same class of securities is not then listed on any securities exchange,
use its reasonable best efforts to cause all such Registrable Securities of such
class to be listed on the NASDAQ Stock Market.
(15) If requested by Holders of a majority of the Registrable Securities being
registered and/or sold in connection therewith, or the managing underwriter(s), if
any, promptly include in a prospectus supplement or amendment such information as
the Holders of a majority of the Registrable Securities being registered and/or sold
in connection therewith or managing underwriter(s), if any, may reasonably request
in order to permit the intended method of distribution of such securities and make
all required filings of such prospectus supplement or such amendment as soon as
practicable after the Company has received such request.
(16) Timely provide to its security holders earning statements satisfying the
provisions of Section 11(a) of the Securities Act and Rule 158 thereunder.
(d) Suspension of Sales. Upon receipt of written notice from the Company that a
registration statement, prospectus or prospectus supplement contains or may contain an untrue
statement of a material fact or omits or may omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading or that circumstances exist that
make inadvisable use of such registration statement, prospectus or prospectus supplement, each
Holder of Registrable Securities shall forthwith discontinue disposition of Registrable Securities
pursuant to such registration statement until such Holder has received copies of a supplemented or
amended prospectus or prospectus supplement, or until such Holder is advised in writing by the
Company that the use of the prospectus and, if applicable, prospectus supplement may be resumed,
and, if so directed by the Company, such Holder shall deliver to the Company (at the Company’s
expense) all copies, other than permanent file copies then in such Holder’s possession, of the
prospectus and, if applicable, prospectus supplement covering such Registrable Securities current
at the time of receipt of such notice (each such suspension, a “Suspension Period”). No
single Suspension Period shall exceed 30 consecutive days, and during any 365 day period, the
aggregate of all Suspension Periods shall not exceed an aggregate of 60 days.
(e) Termination of Registration Rights. A Holder’s registration rights as to any
securities held by such Holder (and its Affiliates, partners, members and former members) shall not
be available unless such securities are Registrable Securities.
(f) Furnishing Information.
(1) Neither the Anchor Investors nor any Holder shall use any free writing
prospectus (as defined in Rule 405) in connection with the sale of Registrable
Securities without the prior written consent of the Company.
(2) It shall be a condition precedent to the obligations of the Company to take
any action pursuant to Section 3.14(c) as to a selling Holder that such
selling Holder, and the underwriters, if any, shall furnish to the Company such
information regarding themselves, the Registrable Securities held by them and the
intended method of disposition of such securities as shall be required to effect the
registered offering of their Registrable Securities.
(g) Indemnification.
52
(1) The Company agrees to indemnify each Holder and, if a Holder is a person
other than an individual, such Holder’s officers, directors, employees, agents,
representatives and Affiliates, and each Person, if any, that controls a Holder
within the meaning of the Securities Act (each, an “Indemnitee”), against
any and all Losses, joint or several, arising out of or based upon any untrue
statement or alleged untrue statement of material fact contained in any registration
statement, including any preliminary prospectus or final prospectus contained
therein or any amendments or supplements thereto or any documents incorporated
therein by reference or contained in any free writing prospectus (as such term is
defined in Rule 405) prepared by the Company or authorized by it in writing for use
by such Holder (or any amendment or supplement thereto); or any omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not
misleading; provided that the Company shall not be liable to such Indemnitee in any
such case to the extent that any such Loss is based solely upon (i) an untrue
statement or omission made in such registration statement, including any such
preliminary prospectus or final prospectus contained therein or any such amendments
or supplements thereto or contained in any free writing prospectus (as such term is
defined in Rule 405) prepared by the Company or authorized by it in writing for use
by such Holder (or any amendment or supplement thereto), in reliance upon and in
conformity with information regarding such Indemnitee or its plan of distribution or
ownership interests which was furnished in writing to the Company by such Indemnitee
expressly for use in connection with such registration statement, including any such
preliminary prospectus or final prospectus contained therein or any such amendments
or supplements thereto, or (ii) offers or sales effected by or on behalf such
Indemnitee “by means of” (as defined in Rule 159A) a “free writing prospectus” (as
defined in Rule 405) that was not authorized in writing by the Company. Such
indemnity shall remain in full force and effect regardless of any investigation made
by or on behalf of an Indemnitee and shall survive the transfer of the Registrable
Securities by the Holders.
(2) If any proceeding shall be brought or asserted against any Indemnitee, such
Indemnitee shall promptly notify the Company in writing, and the Company shall have
the right to assume the defense thereof, including the employment of counsel
reasonably satisfactory to the Indemnitee and the payment of all reasonable fees and
expenses incurred in connection with defense thereof; provided, that the failure of
any Indemnitee to give such notice shall not relieve the Company of its obligations
or liabilities pursuant to this Agreement, except (and only) to the extent that it
shall be finally determined by a court of competent jurisdiction (which
determination is not subject to appeal or further review) that such failure shall
have materially and adversely prejudiced the Company.
An Indemnitee shall have the right to employ separate counsel in any such
proceeding and to participate in the defense thereof, but the fees and expenses of
such counsel shall be at the expense of such Indemnitee or Indemnitees unless: (1)
the Company has agreed in writing to pay such fees and expenses; (2) the Company
shall have failed promptly to assume the defense of such proceeding and to employ
counsel reasonably satisfactory to such Indemnitee in any such proceeding; or (3)
the named parties to any such proceeding (including any impleaded parties) include
both such Indemnitee and the Company, and such Indemnitee shall have been advised by
counsel that a conflict of interest exists if the same counsel were to represent
such Indemnitee and the Company; provided, that the Company shall not be liable for
the fees and expenses of more than one separate firm of attorneys at any time for
all Indemnitees. The Company
53
shall not be liable for any settlement of any such proceeding effected without
its written consent, which consent shall not be unreasonably withheld, delayed or
conditioned. The Company shall not, without the prior written consent of the
Indemnitee, effect any settlement of any pending proceeding in respect of which any
Indemnitee is a party, unless such settlement includes an unconditional release of
such Indemnitee from all liability on claims that are the subject matter of such
proceeding.
Subject to the terms of this Agreement, all fees and expenses of the Indemnitee
(including reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such proceeding in a manner not inconsistent
with this Section 3.14(g)(2)) shall be paid to the Indemnitee, as incurred,
within twenty (20) Business Days of written notice thereof to the Company; provided,
that the Indemnitee shall promptly reimburse the Company for that portion of such
fees and expenses applicable to such actions for which such Indemnitee is finally
judicially determined to not be entitled to indemnification hereunder). The failure
to deliver written notice to the Company within a reasonable time of the
commencement of any such action shall not relieve the Company of any liability to
the Indemnitee under this Section 3.14(g), except to the extent that the
Company is materially and adversely prejudiced in its ability to defend such action.
(3) If the indemnification provided for in Section 3.14(g)(1) is
unavailable to an Indemnitee with respect to any Losses or is insufficient to hold
the Indemnitee harmless as contemplated therein, then the Company, in lieu of
indemnifying such Indemnitee, shall contribute to the amount paid or payable by such
Indemnitee as a result of such Losses in such proportion as is appropriate to
reflect the relative fault of the Indemnitee, on the one hand, and the Company, on
the other hand, in connection with the statements or omissions which resulted in
such Losses as well as any other relevant equitable considerations. The relative
fault of the Company, on the one hand, and of the Indemnitee, on the other hand,
shall be determined by reference to, among other factors, whether the untrue
statement of a material fact or omission to state a material fact relates to
information supplied by the Company or by the Indemnitee and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such
statement or omission; the Company and each Holder agree that it would not be just
and equitable if contribution pursuant to this Section 3.14(g)(3) were
determined by pro rata allocation or by any other method of allocation that does not
take account of the equitable considerations referred to in Section
3.14(g)(1). No Indemnitee guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution
from the Company if the Company was not guilty of such fraudulent misrepresentation.
(4) The indemnity and contribution agreements contained in this Section
3.14(g) are in addition to any liability that the Company may have to the
Indemnitees and are not in diminution or limitation of the indemnification
provisions under Article V of this Agreement.
(h) Assignment of Registration Rights. The rights of each Anchor Investor to
registration of Registrable Securities pursuant to Section 3.14(a) may be assigned by such
Anchor Investor to a transferee or assignee of Registrable Securities to which (i) there is
transferred to such transferee no less than $1,000,000 in Registrable Securities and (ii) such
transfer is permitted under the terms hereof; provided, however, that the transferor shall, within
ten days after such transfer, furnish to
54
the Company written notice of the name and address of such transferee or assignee and the
number and type of Registrable Securities that are being assigned.
(i) Holdback. With respect to any underwritten offering of Registrable Securities by
the Anchor Investors or other Holders pursuant to this Section 3.14, the Company agrees not
to effect (other than pursuant to such registration or pursuant to a Special Registration) any
public sale or distribution, or to file any registration statement (other than such registration or
a Special Registration) covering any of its equity securities, or any securities convertible into
or exchangeable or exercisable for such securities, during the period not to exceed ten days prior
and 90 days following the effective date of such offering or such longer period up to 90 days as
may be requested by the managing underwriter. The Company also agrees to cause each of its
directors and senior executive officers to execute and deliver customary lockup agreements in such
form and for such time period up to 90 days as may be requested by the managing underwriter.
“Special Registration” means the registration of (i) equity securities and/or options or
other rights in respect thereof solely registered on Form S-4 or Form S-8 (or successor form) or
(ii) shares of equity securities and/or options or other rights in respect thereof to be offered to
directors, members of management, employees, consultants, customers, lenders or vendors of the
Company or the Company Subsidiaries or in connection with dividend reinvestment plans.
(j) Rule 144; Rule 144A Reporting. With a view to making available to the Anchor
Investors and Holders the benefits of certain rules and regulations of the SEC which may permit the
sale of the Registrable Securities to the public without registration, the Company agrees to use
its reasonable best efforts to:
(1) make and keep adequate current public information with respect to the
Company available, as those terms are understood and defined in Rule 144(c)(1) or
any similar or analogous rule promulgated under the Securities Act, at all times
after the effective date of this Agreement;
(2) so long as an Anchor Investor or a Holder owns any Registrable Securities,
furnish to such Anchor Investor or such Holder forthwith upon request: (x) a written
statement by the Company as to its compliance with the reporting requirements of
Rule 144 under the Securities Act, and of the Exchange Act; (y) a copy of the most
recent annual or quarterly report of the Company; and (z) such other reports and
documents as the Anchor Investor or Holder may reasonably request in availing itself
of any rule or regulation of the SEC allowing it to sell any such securities without
registration; and
(3) to take such further action as any Holder may reasonably request, all to
the extent required from time to time to enable such Holder to sell Registrable
Securities without registration under the Securities Act.
(k) As used in this Section 3.14, the following terms shall have the following
respective meanings:
(1) “Effective Date” means the date that the Shelf Registration Statement filed
pursuant to Section 3.14(a)(1) is first declared effective by the SEC.
(2) “Effectiveness Deadline” means, with respect to the initial Shelf
Registration Statement required to be filed pursuant to Section 3.14(a)(1),
the earlier of (i) the 90th calendar day following the First Closing Date
and (ii) the 5th Business Day after the date the Company is notified
(orally or in writing, whichever is earlier) by the SEC that such Shelf Registration
Statement will not be “reviewed” or will not be subject
55
to further review; provided, that if the Effectiveness Deadline falls on a
Saturday, Sunday or other day that the SEC is closed for business, the Effectiveness
Deadline shall be extended to the next Business Day on which the SEC is open for
business.
(3) “Holder” means the Investors and any other holder of Registrable Securities
to whom the registration rights conferred by the Transaction Documents have been
transferred in compliance with Section 3.14(h) hereof.
(4) “Holders’ Counsel” means one counsel for the selling Holders chosen by
Holders holding a majority interest in the Registrable Securities being registered.
(5) “Register,” “registered” and “registration” shall refer to a registration
effected by preparing and (a) filing a registration statement in compliance with the
Securities Act and applicable rules and regulations thereunder, and the declaration
or ordering of effectiveness of such registration statement or (b) filing a
prospectus and/or prospectus supplement in respect of an appropriate effective
registration statement.
(6) “Registrable Securities” means (A) all Common Stock held by the Investors
from time to time and the Warrants and (B) any equity securities issued or issuable
directly or indirectly with respect to the securities referred to in clause (A) by
way of conversion, exercise or exchange thereof or stock dividend or stock split or
in connection with a combination of shares, recapitalization, reclassification,
merger, amalgamation, arrangement, consolidation or other reorganization, provided
that, once issued, such securities shall not be Registrable Securities when (i) they
are sold pursuant to an effective registration statement under the Securities Act,
(ii) they may be immediately sold pursuant to Rule 144 without limitation thereunder
on volume or manner of sale and without the requirement for the Company to be in
compliance with the current public information required under Rule 144(c)(1) (or
Rule 144(i)(2), if applicable), (iii) they shall have ceased to be outstanding or
(iv) they have been sold in a private transaction in which the transferor’s rights
under the Transaction Documents are not assigned to the transferee of the
securities. No Registrable Securities may be registered under more than one
registration statement at one time.
(7) “Registration Expenses” means all expenses incurred by the Company in
effecting any registration pursuant to this Agreement (whether or not any
registration or prospectus becomes effective or final) or otherwise complying with
its obligations under this Section 3.14, including, without limitation, all
registration, filing and listing fees, printing expenses, fees and disbursements of
counsel for the Company, blue sky fees and expenses, expenses incurred in connection
with any “road show,” the reasonable fees and disbursements of Holders’ Counsel (not
to exceed $100,000), and expenses of the Company’s independent accountants in
connection with any regular or special reviews or audits incident to or required by
any such registration, but shall not include Selling Expenses and the compensation
of regular employees of the Company, which shall be paid in any event by the
Company.
(8) “Rule 158,” “Rule 159A,” “Rule 405” and “Rule 415” mean, in each case, such
rule promulgated under the Securities Act (or any successor provision), as the same
shall be amended from time to time.
(9) “SEC Guidance” means (i) any publicly-available written or oral guidance,
comments, requirements or requests of the SEC staff and (ii) the Securities Act.
56
(10) “Selling Expenses” means all discounts, selling commissions and stock
transfer taxes applicable to the sale of Registrable Securities and fees and
disbursements of counsel for any Holder (other than the fees and disbursements of
Holders’ Counsel included in Registration Expenses).
(l) At any time, any holder of Registrable Securities (including any Holder) may elect to
forfeit its rights set forth in this Section 3.14 from that date forward; provided, that a
Holder forfeiting such rights shall nonetheless be entitled to participate under Sections
3.14(a)(4)-(7) in any Pending Underwritten Offering to the same extent that such Holder would
have been entitled to if the holder had not withdrawn; and provided, further, that no such
forfeiture shall terminate a Holder’s rights or obligations under Section 3.14(g) with
respect to any prior registration or Pending Underwritten Offering. “Pending Underwritten Offering”
means, with respect to any Holder forfeiting its rights pursuant to this Section 3.14(l),
any underwritten offering of Registrable Securities in which such Holder has advised the Company of
its intent to register its Registrable Securities either pursuant to Section 3.14(a)(1),
3.14(a)(4) or 3.14(a)(7) prior to the date of such Holder’s forfeiture.
(m) The Company and the Holders shall make, no later than the Effectiveness Deadline, any
revisions to the Warrants acceptable to such Holders and necessary in order to permit a public
distribution thereof, including entering into a customary warrant agreement, appointing a warrant
agent and taking such other steps as will be needed to facilitate such a public distribution.
3.15. Certain Other Transactions.
(a) Prior to the Second Closing, notwithstanding anything in the Transaction Documents to the
contrary, the Company shall not directly or indirectly effect or cause to be effected any
transaction with a third party that would reasonably be expected to result in a Change in Control
unless such third party shall have provided prior assurance in writing to the Anchor Investors (in
a form that is reasonably satisfactory to the Anchor Investors) that the terms of the Transaction
Documents shall be fully performed (i) by the Company or (ii) by such third party if it is the
successor of the Company or if the Company is its direct or indirect Subsidiary. For the avoidance
of doubt, it is understood and agreed that, in the event that a Change in Control occurs on or
prior to the Second Closing, the Anchor Investors shall maintain the right under the Transaction
Documents to acquire, pursuant to the terms and conditions of the Transaction Documents, the Common
Stock (or such other securities or property (including cash) into which the Common Stock may have
become exchangeable as a result of such Change in Control), as if both of the Closings (or the
Second Closing, if the First Closing has already occurred) had occurred immediately prior to such
Change in Control, including, for the avoidance of doubt, the Common Stock issuable pursuant to the
Warrants.
(b) In the event that, at or prior to either Closing, (i) the number of shares of Common Stock
or securities convertible or exchangeable into or exercisable for shares of Common Stock issued and
outstanding is changed as a result of any reclassification, stock split (including reverse split),
stock dividend or distribution (including any dividend or distribution of securities convertible or
exchangeable into or exercisable for shares of Common Stock), merger, tender or exchange offer or
other similar transaction, (ii) the Company fixes a record date that is at or prior to the
applicable Closing Date for the payment of any non-stock dividend or distribution on the Common
Stock other than any ordinary cash dividends, then the number of shares of Common Stock to be
issued to the Anchor Investors at the applicable Closing under the Transaction Documents, together
with the applicable implied per share price (and the number of shares and per share price pursuant
to the Rights Offering and the backstop commitment), shall be equitably adjusted and/or the shares
of Common Stock to be issued to the Anchor Investors at the applicable Closing under the
Transaction Documents shall be equitably substituted with shares of other stock or securities or
property (including cash), in each case, to provide the Anchor
57
Investors with substantially the same economic benefit from the Transaction Documents as the
Anchor Investors had prior to the applicable transaction. Notwithstanding anything in the
Transaction Documents to the contrary, in no event shall the Purchase Price or any component
thereof, or the aggregate percentage of shares to be purchased by any Anchor Investor, be changed
by the foregoing.
(c) Notwithstanding anything in the foregoing, the provisions of this Section 3.15
shall not be triggered by (i) the transactions contemplated by the Transaction Documents (other
than the reverse stock split and related matters) or (ii) any issuances of options, restricted
stock units or other equity-based awards granted to newly-appointed directors, employees or
consultants of the Company at or around the same time as the transactions contemplated by the
Transaction Documents to such Persons, including upon exercise of any such options (not to exceed
2.5% of the Capital Stock of the Company on a fully-diluted basis).
(d) The reverse stock split contemplated by this Agreement shall not occur prior to the
issuance of the Warrants.
3.16. Articles of Amendment. In connection with the First Closing, the Company shall
file the Articles of Amendment in the Commonwealth of Virginia, and such Articles of Amendment
shall continue to be in full force and effect as of the First Closing Date and the Second Closing
Date.
3.17. Exchange Offers. As soon as practicable following May 23, 2010, the Company
shall prepare and file with the SEC the Schedule TO covering the Exchange Offers. The Company
shall use reasonable best efforts to have the Schedule TO cleared by the SEC. The Company shall,
as promptly as practicable after receipt thereof, provide each of the Anchor Investors copies of
any written comments and advise the Anchor Investors of any oral comments with respect to the
Schedule TO received from the SEC. The Company shall provide each Anchor Investor with a
reasonable opportunity to review and comment on the Schedule TO, and any amendment thereto, prior
to filing with the SEC, and will provide the Anchor Investors with a copy of all such filings made
with the SEC. Notwithstanding any other provision herein to the contrary, no amendment to the
Schedule TO shall be made without the approval of each Anchor Investor, which approval shall not be
unreasonably withheld or delayed. The Company shall use its reasonable best efforts to take any
action required to be taken under any applicable state securities laws in connection with the
Exchange Offers. The Company shall advise the Anchor Investors, promptly after it receives notice
thereof, of the time when the Exchange Offer has become effective, the issuance of any stop order,
the suspension of the qualification of the Common Stock issuable pursuant to the Exchange Offers
for offering or sale in any jurisdiction, or any request by the SEC for amendment of the Schedule
TO. The Company shall not pay or give, directly or indirectly, any commission or other
remuneration to any Person for soliciting the acquisition of the Series A Preferred Stock and
Series B Preferred Stock or the exchange as contemplated pursuant to the Exchange Offers. The Board
of Directors shall unanimously recommend to the holders of the Series A Preferred Stock and the
Series B Preferred Stock that such stockholders tender their shares of Series A Preferred Stock and
Series B Preferred Stock into the Exchange Offers.
3.18. Rights Offering.
(a) As promptly as practicable following the First Closing, and subject to compliance with all
applicable Law, including the Securities Act, the Company shall distribute to each holder of record
of Common Stock, including any holders who received Common Stock pursuant to the Series A Exchange
and the Series B Exchange as of the close of business on the Business Day immediately preceding the
First Closing Date (each, a “Legacy Stockholder”) non-transferable rights (the
“Rights”) to purchase from the Company an amount of Common Shares calculated pursuant to
Section 3.18(b) at a per share purchase price of $0.40 (“Rights Purchase Price”).
The transactions described in this Section 3.18,
58
including the purchase and sale of Common Shares upon the exercise of Rights and any
commitments to purchase unsubscribed Common Shares in Section 3.18(c), shall be referred to
in this Agreement as the “Rights Offering.” The registration statement relating to the Rights
Offering shall be filed within 15 days after the First Closing.
(b) Each Right shall entitle a Legacy Stockholder to purchase any whole number of Common
Shares, provided that (i) no Legacy Stockholder shall thereby exceed, together with any
other person with whom such Legacy Stockholder may be aggregated under applicable Law, 4.9%
beneficial ownership of the Company’s equity securities and (ii) the aggregate purchase price of
all Common Shares purchased in the Rights Offering shall not exceed Forty-Million Dollars
($40,000,000).
(c) In the event the Rights Offering is over-subscribed, subscriptions by Legacy Stockholders
shall be reduced proportionally based on their pro rata ownership of the Common Stock outstanding
as of the close of business on the trading day immediately preceding the First Closing Date but
assuming that the Exchange Offers shall have occurred on such date.
(d) In the event the Company does not sell at least $20 million in Common Shares pursuant to
the Rights Offering, pursuant to the CapGen Investment Agreement, CapGen shall purchase that number
of Common Shares at the Rights Purchase Price in an aggregate dollar amount equal to $20 million
less the dollar amount of Common Shares sold to the holders of Rights. In addition, to the extent
the Company determines to offer more than $20 million of Common Shares in the Rights Offering, but
in no event in excess of an aggregate of $40 million of Common Shares in the Rights Offering (the
“Additional Rights Shares”), the Anchor Investors hereby agree to purchase, on a Pro Rata
Basis, any Additional Rights Shares that are not purchased by holders of the related Rights
(“Additional Unsubscribed Shares”) at the Rights Purchase Price, subject to and
simultaneously with the other Investors’ purchase, and on a Pro Rata Basis, of the Additional
Unsubscribed Shares. Additionally, the Company agrees that the CapGen Investment Agreement and
each Additional Agreement with the Additional Investors shall include a substantially similar
covenant requiring such Additional Investor to purchase, on a Pro Rata Basis, any Additional
Unsubscribed Shares at the Rights Purchase Price. In no event shall any Anchor Investor, CapGen or
any Additional Investor be required to purchase Additional Unsubscribed Shares in excess of their
respective Pro Rata Basis or such as would cause any Anchor Investor or CapGen to hold more than
24.9% of the Company’s outstanding Common Shares or cause any Additional Investor to hold more than
9.9% of the Company’s outstanding Common Shares. To the extent that the Rights Offering is not
fully sold following the foregoing purchases by holders of Rights, the Anchor Investors, CapGen and
the Additional Investors, then the Company may offer any remaining Additional Unsubscribed Shares
at the Rights Purchase Price.
(e) As used in Section 3.18(d), “Pro Rata Basis” with respect to each Investor
means a commitment by that Investor to purchase that number of Additional Unsubscribed Shares equal
to the total number of Additional Unsubscribed Shares multiplied by a fraction, the numerator of
which is the number of Common Shares purchased by such Investor in connection with the Investment
or the Other Private Placements, as the case may be, and the denominator of which is the total
aggregate number of Common Shares purchased by all Investors in connection with the Investment and
the Other Private Placements, subject to the limitations set forth in the last sentence of
Section 3.18(d) above.
ARTICLE IV
TERMINATION
4.1. Termination. This Agreement may be terminated prior to the First Closing:
59
(a) by mutual written agreement of the Company and each of the Anchor Investors;
(b) by any party, upon written notice to the other parties, in the event that the First
Closing does not occur on or before October 29, 2010; provided, however, that the
right to terminate this Agreement pursuant to this Section 4.1(b) shall not be
available to any party whose failure to fulfill any obligation under this Agreement shall
have been the cause of, or shall have resulted in, the failure of the First Closing to occur
on or prior to such date;
(c) by an Anchor Investor, upon written notice to the Company and the other Anchor
Investor, if (i) there has been a breach of any representation, warranty, covenant or
agreement made by the Company in this Agreement, or any such representation and warranty
shall have become untrue after the date of this Agreement, such that Section
1.2(d)(2)(A) would not be satisfied and (ii) such breach or condition is not curable or,
if curable, is not cured prior to the date that would otherwise be the First Closing Date in
absence of such breach or condition; provided that this Section 4.1(c) shall
only apply if such Anchor Investor is not in material breach of any of the terms of this
Agreement;
(d) by the Company, upon written notice to the Anchor Investors, if (i) there has been
a breach of any representation, warranty, covenant or agreement made by an Anchor Investor
in this Agreement, or any such representation and warranty shall have become untrue after
the date of this Agreement, such that Section 1.2(d)(3)(A) would not be satisfied
and (ii) such breach or condition is not curable or, if curable, is not cured prior to the
date that would otherwise be the First Closing Date in absence of such breach or condition;
provided that this Section 4.1(d) shall only apply if the Company is not in
material breach of any of the terms of this Agreement;
(e) by any party, upon written notice to the other parties, in the event that any
Governmental Entity shall have issued any order, decree or injunction or taken any other
action restraining, enjoining or prohibiting any of the transactions contemplated by this
Agreement, and such order, decree, injunction or other action shall have become final and
nonappealable;
(f) by an Anchor Investor, upon written notice to the Company and the other Anchor
Investor, if such Anchor Investor or any of its Affiliates receives written notice from or
is otherwise advised by, the Federal Reserve that the Federal Reserve will not grant (or
intends to rescind or revoke if previously granted) any of the written confirmations or
determinations referred to in Section 1.2(d)(2)(D); or
(g) by the Company, upon written notice to the Anchor Investors, if the Company
receives written notice from or is otherwise advised by the Federal Reserve that the Federal
Reserve will not grant (or intends to rescind or revoke if previously granted) any of the
written confirmations or determinations referred to in Section 1.2(d)(2)(D).
4.2. Effects of Termination. In the event of any termination of the Transaction
Documents as provided in Section 4.1, this Agreement (other than Section 3.3 and
Article VI of this Agreement, which shall remain in full force and effect) shall forthwith become
wholly void and of no further force and effect; provided that nothing herein shall relieve any
party from liability for fraud or willful breach of this Agreement.
60
ARTICLE V
INDEMNITY
5.1. Indemnification by the Company.
(a) (a) After the First Closing, and subject to Sections 5.1, 5.3 and
5.4, the Company shall indemnify, defend and hold harmless to the fullest extent permitted
by Law the Carlyle Anchor Investor and its Affiliates, and their successors and assigns, officers,
directors, partners, members and employees, as applicable, (the “Carlyle Investor Indemnified
Parties”) and the Anchorage Anchor Investor and its Affiliates, and their successors and assigns,
officers, directors, partners, members and employees, as applicable, (the “Anchorage Investor
Indemnified Parties” and, together with the Carlyle Investor Indemnified Parties, the “Anchor
Investor Indemnified Parties”) against, and reimburse any of the Anchor Investor Indemnified
Parties for:
(1) all Losses that any of the Anchor Investor Indemnified Parties may at any time
suffer or incur, or become subject to as a result of or in connection with the inaccuracy
or breach of any representation or warranty made by the Company in this Agreement or any
certificate delivered pursuant hereto or as a result of or in connection with any breach or
failure by the Company to perform any of their covenants or agreements contained in this
Agreement; and
(2) any action, suit, claim, proceeding or investigation by any stockholder of the
Company or any other Person relating to this Agreement or the other Transaction Documents or
the transactions contemplated hereby or thereby (including the Investment, the Other Private
Placements, the TARP Exchange, the Exchange Offers and the Rights Offering).
(b) Notwithstanding anything to the contrary contained herein, the Company shall not be
required to indemnify, defend or hold harmless any of the Carlyle Investor Indemnified Parties
against, or reimburse any of the Carlyle Investor Indemnified Parties for any any Losses pursuant
to Section 5.1(a)(1)(A) (other than Losses arising out of the inaccuracy or breach of any
Company Specified Representations) (i) with respect to any claim (or series of related claims
arising from the same underlying facts, events or circumstances) unless such claim (or series of
related claims arising from the same underlying facts, events or circumstances) involves Losses in
excess of $100,000 (nor shall any such claim or series of related claims that do not meet the
$100,000 threshold be applied to or considered for purposes of calculating the aggregate amount of
the Losses by any of the Carlyle Investors Indemnified Parties for which the Company has
responsibility under clause (ii) of this Section 5.1(b)); and (ii) until the aggregate
amount of the Carlyle Investor Indemnified Parties’ Losses for which the Carlyle Investor
Indemnified Parties are finally determined to be otherwise entitled to indemnification under
Section 5.1(a)(1)(A)exceeds one percent (1)% of such Carlyle Anchor Investor’s aggregate
purchase price paid to the Company pursuant to Section 1.1 hereof (the “Carlyle
Deductible”), after which the Company shall be obligated for all of the Carlyle Investor
Indemnified Parties’ Losses for which the Carlyle Investor Indemnified Parties are finally
determined to be otherwise entitled to indemnification under Section 5.1(a)(1)(A) that are
in excess of such Carlyle Deductible. Notwithstanding anything to the contrary contained herein,
the Company shall not be required to indemnify, defend or hold harmless the Carlyle Investor
Indemnified Parties against, or reimburse the Carlyle Investor Indemnified Parties for, any Losses
pursuant to Section 5.1(a)(1)(A) in a cumulative aggregate amount exceeding the aggregate
purchase price paid by the relevant Carlyle Anchor Investor to the Company pursuant to Section
1.1 hereof (other than Losses arising out of the inaccuracy or breach of any Company Specified
Representations).
61
(c) Notwithstanding anything to the contrary contained herein, the Company shall not be
required to indemnify, defend or hold harmless any of the Anchorage Investor Indemnified Parties
against, or reimburse any of the Anchorage Investor Indemnified Parties for any Losses
pursuant to Section 5.1(a)(1)(A) (other than Losses arising out of the inaccuracy or breach
of any Company Specified Representations) (i) with respect to any claim (or series of related
claims arising from the same underlying facts, events or circumstances) unless such claim (or
series of related claims arising from the same underlying facts, events or circumstances) involves
Losses in excess of $100,000 (nor shall any such claim or series of related claims that do not meet
the $100,000 threshold be applied to or considered for purposes of calculating the aggregate amount
of the Losses by any of the Anchorage Investor Indemnified Parties for which the Company has
responsibility under clause (ii) of this Section 5.1(c) below); and (ii) until the
aggregate amount of the Anchorage Investor Indemnified Parties’ Losses for which the Anchorage
Investor Indemnified Parties are finally determined to be otherwise entitled to indemnification
under Section 5.1(a)(1)(A) exceeds one percent (1)% of such Anchorage Anchor Investor’s
aggregate purchase price paid to the Company pursuant to Section 1.1 hereof (the
“Anchorage Deductible”), after which the Company shall be obligated for all of the
Anchorage Investor Indemnified Parties’ Losses for which the Anchorage Investor Indemnified Parties
are finally determined to be otherwise entitled to indemnification under Section
5.1(a)(1)(A) that are in excess of such Anchorage Deductible. Notwithstanding anything to the
contrary contained herein, the Company shall not be required to indemnify, defend or hold harmless
the Anchorage Investor Indemnified Parties against, or reimburse the Anchorage Investor Indemnified
Parties for, any Losses pursuant to Section 5.1(a)(1)(A)in a cumulative aggregate amount
exceeding the aggregate purchase price paid by the relevant Anchorage Anchor Investor to the
Company pursuant to Section 1.1 hereof (other than Losses arising out of the inaccuracy or
breach of any Company Specified Representations).
(d) For purposes of Section 5.1(a), in determining whether there has been a breach of
a representation or warranty, the parties hereto shall ignore any “materiality,” “Knowledge”,
“Material Adverse Effect,” or similar qualifications.
5.2. Indemnification by the Anchor Investors.
(a) After the First Closing and subject to Sections 5.2, 5.3 and 5.4,
the Anchor Investors shall indemnify, defend and hold harmless to the fullest extent permitted by
Law the Company against, and reimburse the Company for, all Losses that the Company may at any time
suffer or incur, or become subject to (1) as a result of or in connection with the inaccuracy or
breach of any representation or warranty made by the Anchor Investors in this Agreement or (2) as a
result of or in connection with any breach or failure by the Anchor Investors to perform any of
their covenants or agreements contained in this Agreement.
(b) Notwithstanding anything to the contrary contained herein, no Anchor Investor shall be
required to indemnify, defend or hold harmless the Company against, or reimburse the Company (1)
for Losses for which the Company would be required to indemnify the Anchor Investor Indemnified
Parties pursuant to Section 5.1(a)(1)(B) or (2) for any Losses pursuant to Section
5.2(a)(1) (other than Losses arising out of the inaccuracy or breach of any Anchor Investors
Specified Representations) (i) with respect to any claim (or series of related claims arising from
the same underlying facts, events or circumstances) unless such claim (or series of related claims
arising from the same underlying facts, events or circumstances) involves Losses in excess of
$100,000 of the purchase price paid by such Anchor Investor pursuant to Section 1.1 hereof
(nor shall any such claim or series of related claims that do not meet the $100,000 threshold be
applied to or considered for purposes of calculating the aggregate amount of the Company’s Losses
for which the Anchor Investors has responsibility under clause (ii) of this Section
5.2(b)); and (ii) until the aggregate amount of the Company’s Losses for which the Company are
finally determined to be otherwise entitled to indemnification under Section 5.2(a)(1)
exceeds one
62
percent (1)% of such Anchor Investor’s aggregate purchase price paid to the Company
pursuant to Section 1.1 hereof (the “Company Deductible”), after which the Anchor
Investors shall be obligated for all of the Company’s Losses for which the Company is finally determined to be otherwise
entitled to indemnification under Section 5.2(a)(1) that are in excess of such Company
Deductible. Notwithstanding anything to the contrary contained herein, neither Anchor Investor
shall be required to indemnify, defend or hold harmless the Company against, or reimburse the
Company for, any Losses pursuant to Section 5.2(a)(1) in a cumulative aggregate amount
exceeding the aggregate purchase paid by such Anchor Investor to the Company pursuant to
Section 1.1 hereof (other than Losses arising out of the inaccuracy or breach of any of
such Anchor Investor Specified Representations).
(c) For purposes of Section 5.2(a), in determining whether there has been a breach of
a representation or warranty, the parties hereto shall ignore any “materiality” or similar
qualifications.
5.3. Notification of Claims.
(a) Any Person that may be entitled to be indemnified under this Agreement (the
“Indemnified Party”) shall promptly notify the party or parties liable for such
indemnification (the “Indemnifying Party”) in writing of any claim in respect of which
indemnity may be sought hereunder, including any pending or threatened claim or demand by a third
party that the Indemnified Party has determined has given or could reasonably give rise to a right
of indemnification under this Agreement (including a pending or threatened claim or demand asserted
by a third party against the Indemnified Party) (each, a “Third Party Claim”), describing
in reasonable detail the facts and circumstances with respect to the subject matter of such claim
or demand; provided, however, that the failure to provide such notice shall not
release the Indemnifying Party from any of its obligations under this Agreement except to the
extent that the Indemnifying Party is materially prejudiced by such failure. The parties agree
that notices for claims in respect of a breach of a representation, warranty, covenant or agreement
must be delivered prior to the expiration of any applicable survival period specified in
Section 6.1 for such representation, warranty, covenant or agreement; provided,
that if, prior to such applicable date, a party hereto shall have notified the other parties hereto
in accordance with the requirements of this Section 5.3(a) of a claim for indemnification
under this Agreement (whether or not formal legal action shall have been commenced based upon such
claim), such claim shall continue to be subject to indemnification in accordance with this
Agreement notwithstanding the passing of such applicable date.
(b) Upon receipt of a notice of a claim for indemnity from an Indemnified Party pursuant to
Section 5.3(a) in respect of a Third Party Claim, the Indemnifying Party may, by notice to
the Indemnified Party delivered within twenty (20) Business Days of the receipt of notice of such
Third Party Claim, assume the defense and control of any Third Party Claim, with its own counsel
and at its own expense, but shall allow the Indemnified Party a reasonable opportunity to
participate in the defense of such Third Party Claim with its own counsel and at the Indemnifying
Party’s expense (except that the Indemnifying party shall only be liable for the reasonable fees
and expenses of one law firm for all of the Indemnified Parties). The Indemnified Party may take
any actions reasonably necessary to defend such Third Party Claim prior to the time that it
receives a notice from the Indemnifying Party as contemplated by the immediately preceding
sentence. The Company or the Anchor Investors (as the case may be) shall, and shall cause each of
their Affiliates and representatives to, cooperate fully with the Indemnifying Party in the defense
of any Third Party Claim. The Indemnifying Party shall not, without the prior written consent of
the Indemnified Party (which shall not be unreasonably withheld), consent to a settlement,
compromise or discharge of, or the entry of any judgment arising from, any Third Party Claim,
unless such settlement, compromise, discharge or entry of any judgment does not involve any finding
or admission of any violation of Law or admission of any wrongdoing by the Indemnified Party, and
the Indemnifying Party shall (i) pay or cause to be paid all amounts arising out of such settlement
or judgment concurrently with the effectiveness of such settlement or judgment (unless otherwise
provided
63
in such judgment), (ii) not encumber any of the material assets of any Indemnified Party
or agree to any restriction or condition that would apply to or materially adversely affect any
Indemnified Party or the conduct of any Indemnified Party’s business and (iii) obtain, as a condition of any
settlement, compromise, discharge, entry of judgment (if applicable), or other resolution, a
complete and unconditional release of each Indemnified Party from any and all liabilities in
respect of such Third Party Claim. The Indemnified Party shall not settle, compromise or consent
to the entry of any judgment with respect to any claim or demand for which it is seeking
indemnification from the Indemnifying Party or admit to any liability with respect to such claim or
demand without the prior written consent of the Indemnifying Party (which consent shall not be
unreasonably withheld or delayed).
(c) In the event any Indemnifying Party receives a notice of a claim for indemnity from an
Indemnified Party pursuant to Section 5.3(a) that does not involve a Third Party Claim, the
Indemnifying Party shall notify the Indemnified Party within twenty (20) Business Days following
its receipt of such notice whether the Indemnifying Party disputes its liability to the Indemnified
Party under this agreement. The Indemnified Party shall reasonably cooperate with and assist the
Indemnifying Party in determining the validity of any such claim for indemnity by the Indemnified
Party.
5.4. Indemnification Payment. In the event a claim or any Action for indemnification
hereunder has been finally determined, the amount of such final determination shall be paid (a) if
the Indemnified Party is an Anchor Investor, by the Company to the Indemnified Party and (b) if the
Indemnified Party is the Company, by the Anchor Investors to the Indemnified Party, in each case on
demand in immediately available funds; provided, however, that any reasonable and documented
out-of-pocket expenses incurred by the Indemnified Party as a result of such claim or Action shall
be reimbursed promptly by the Indemnifying Party upon receipt of an invoice describing such costs
incurred by the Indemnified Party. A claim or an Action, and the liability for and amount of
damages therefor, shall be deemed to be “finally determined” for purposes of this Agreement
when the parties hereto have so determined by mutual agreement or, if disputed, when a final
non-appealable governmental order has been entered into with respect to such claim or Action.
5.5. Exclusive Remedies. Except as set forth in this Agreement, the other Transaction
Documents and any other documents delivered in connection with the First Closing of the
transactions contemplated by the Transaction Documents, the Company and its representatives make no
representation or warranty, expressed or implied, at law or in equity, in respect of the Company or
the Company’s business or prospects; and any and all other representations and warranties made by
the Company or its representatives are deemed to have been superseded by this Agreement and do not
survive. The Anchor Investors acknowledge and agree that they are relying solely on their own
investigations and the representations and warranties contained in this Agreement, the other
Transaction Documents, and the other documents delivered in connection with the First Closing in
deciding to enter into this Agreement and consummate the First Closing. Without limiting the
previous two sentences, each party hereto acknowledges and agrees that following the First Closing,
the indemnification provisions hereunder shall be the sole and exclusive remedies of the parties
hereto for any breach of the representations, warranties or covenants contained in the this
Agreement. No investigation of the Company by any Anchor Investor, or by the Company of any Anchor
Investor, whether prior to or after May 23, 2010, shall limit any Indemnified Party’s exercise of
any right hereunder or be deemed to be a waiver of any such right. The parties agree that any
indemnification payment made pursuant to this Agreement shall be treated as an adjustment to the
Purchase Price for Tax purposes, unless otherwise required by Law.
64
ARTICLE VI
MISCELLANEOUS
6.1. Survival. The representations and warranties of the parties hereto contained in
this Agreement shall survive in full force and effect until the date that is eighteen (18) months
after the First Closing Date (or until final resolution of any claim or action arising from the breach
of any such representation and warranty, if notice of such breach was provided prior to the end of
such period), at which time they shall terminate and no claims shall be made for indemnification
under Section 5.1 or Section 5.2, as applicable, for breaches of
representations or warranties thereafter, except the Company Specified Representations (other than
the representations and warranties made in Section 2.2(z), which shall survive until sixty
(60) days following the expiration of the applicable statute of limitations) and the Anchor
Investor Specified Representations shall survive the First Closing indefinitely. The covenants and
agreements set forth in this Agreement shall survive until the earliest of the duration of any
applicable statute of limitations or until performed or no longer operative in accordance with
their respective terms.
6.2. Expenses. At the First Closing, provided the condition set forth in Section
1.2(d)(2)(J) has been satisfied, the Company shall reimburse each Anchor Investor promptly,
upon receipt of invoices from such Anchor Investor, for all reasonable and documented out-of-pocket
expenses incurred by such Anchor Investor and its Affiliates in connection with its due diligence
investigation of the Company and the transactions contemplated by the Transaction Documents, the
preparation, negotiation and enforcement of the Transaction Documents, and the filing or pursuit of
any Governmental Consent required in connection with the foregoing (including, but not limited to,
all fees and expenses of attorneys, consultants, accounting, financial and other advisors) incurred
by or on behalf of the Anchor Investors or their Affiliates in connection with the transactions
contemplated by the Transaction Documents. Except as provided in the foregoing sentence and in the
Carlyle Investor Letter with respect to the Carlyle Anchor Investor and in the Anchorage Investor
Letter with respect to the Anchorage Anchor Investor, each party will pay their own costs and
expenses in connection with this Agreement and the transactions contemplated hereby.
6.3. Other Definitions. Wherever required by the context of this Agreement, the
singular shall include the plural and vice versa, and the masculine gender shall include the
feminine and neuter genders and vice versa, and references to any agreement, document or instrument
shall be deemed to refer to such agreement, document or instrument as amended, supplemented or
modified from time to time.
(a) the term “Agency” means the Federal Housing Administration, the Federal Home Loan Mortgage
Corporation, the Farmers Home Administration (now known as Rural Housing and Community Development
Services), the Federal National Mortgage Association, the Federal National Mortgage Association,
the United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S. Department
of Agriculture or any other federal or state agency with authority to (i) determine any investment,
origination, lending or servicing requirements with regard to mortgage loans originated, purchased
or serviced by the Company or (ii) originate, purchase, or service mortgage loans, or otherwise
promote mortgage lending, including state and local housing finance authorities;
(b) the term “Affiliate” means, with respect to any Person, any Person directly or indirectly
controlling, controlled by or under common control with, such other Person provided that no
security holder of the Company shall be deemed to be an Affiliate of any other security holder or
of the Company or any of its Subsidiaries solely by reason of any investment in the Company. For
purposes of this definition, “control” (including, with correlative meanings, the terms “controlled
by” and “under common control with”) when used with respect to any Person, means the possession,
directly or
65
indirectly, of the power to cause the direction of management or policies of such Person, whether through the ownership of voting securities by contract or otherwise;
(c) the term “Anchorage Anchor Investor” means ACMO-HR, L.L.C.;
(d) the term “Anchorage Designated Director” means, the Person designated by the Anchorage
Anchor Investor to be nominated and elected as a member of the Board of Directors;
(e) the term “Articles of Amendment” means the General Articles of Amendment, the Preferred
Stock Articles of Amendment and any other amendments to the Company’s Articles of Incorporation
that may be required pursuant to the transactions contemplated by the Transaction Documents;
(f) the term “Board of Directors” means the Board of Directors of the Company;
(g) the term “Business Day” means any day except Saturday, Sunday and any day which shall be a
legal holiday or a day on which banking institutions in the State of New York or in the State of
Virginia generally are authorized or required by Law or other governmental actions to close;
(h) the term “CapGen” means CapGen Capital Group VI LP.
(i) the term “CapGen Investment Agreement” means the Amended and Restated Investment
Agreement, dated as of August 11, 2010 by and between the Company and CapGen.
(j) the term “Capital Stock” means capital stock or other type of equity interest in (as
applicable) a Person;
(k) the term “Carlyle Anchor Investor” means Carlyle Global Financial Services Partners, L.P.;
(l) the term “Carlyle Designated Director” means, the Person designated by the Carlyle Anchor
Investor to be nominated and elected as a member of the Board of Directors;
(m) the term “Change in Control” means, with respect to the Company, the occurrence of any one
of the following events:
A. any person is or becomes a beneficial owner (as such term is defined in Rule
13d-3 and Rule 13d-5 under the Exchange Act), other than the Investors and their
Affiliates, directly or indirectly, of 20% of the aggregate voting power of the
voting securities; provided, however, that the event described in this clause (2)
will not be deemed a Change in Control by virtue of any holdings or acquisitions:
(i) by the Company or any of its Subsidiaries, (ii) by any employee benefit plan (or
related trust) sponsored or maintained by the Company or any of its Subsidiaries;
provided that such holdings or acquisitions by any such plan (other than any plan
maintained under Section 401(k) of the Internal Revenue Code of 1986, as amended) do
not exceed 20% of the then outstanding voting securities, (iii) by any underwriter
temporarily holding securities pursuant to an offering of such securities or (iv)
pursuant to a Non-Qualifying Transaction;
B. the consummation of a merger, consolidation, statutory share exchange or
similar transaction that requires adoption by the Company’s stockholders (a
“Business
66
Combination”), unless immediately following such Business Combination: (x)
more than 50% of the total voting power of the corporation resulting from such
Business Combination (the “Surviving Corporation”), or, if applicable, the ultimate
parent corporation that directly or indirectly has beneficial ownership (as such
term is defined in Rule 13d-3 and Rule 13d-5 under the Exchange Act), of 100% of the
voting securities eligible to elect directors of the Surviving Corporation (the “Parent
Corporation”), is represented by voting securities that were outstanding immediately
before such Business Combination (or, if applicable, is represented by shares into
which such voting securities were converted pursuant to such Business Combination),
and (y) at least a majority of the members of the board of directors of the Parent
Corporation (or, if there is no Parent Corporation, the Surviving Corporation)
following the consummation of the Business Combination were Incumbent Directors at
the time the Company’s Board of Directors approved the execution of the initial
agreement providing for such Business Combination (any Business Combination which
satisfies all of the criteria specified in (x) and (y) above will be deemed a
“Non-Qualifying Transaction”);
C. the stockholders of the Company approve a plan of liquidation or dissolution
of the Company or a sale of all or substantially all of the Company’s assets; or
D. a majority of the members of the Board of Directors are not Continuing
Directors; provided that the changes to the membership of the Board of Directors
pursuant to Section 3.5 herein shall not be considered a Change of Control;
(n) the term “Code” means the Internal Revenue Code of 1986, as amended;
(o) the term “Company Specified Representations” means the representations and warranties made
in Section 2.2(a), Section 2.2(c), Section 2.2(d)(1), Section
2.2(z), and Section 2.2(cc);
(p) the term “Continuing Directors” means, as of any date of determination, any member of the
Board of Directors who (i) was a member of the Board of Directors on the date of this Agreement or
(ii) was nominated for election or elected to the Board of Directors with the approval of a
majority of the Continuing Directors who were members of the Board of Directors at the time of such
new director’s nomination or election;
(q) the term “Disclosure Schedule” shall mean a schedule delivered, on or prior to May 23,
2010, by (i) each Anchor Investor to the Company and (ii) the Company to each Anchor Investor
setting forth, among other things, items the disclosure of which is necessary or appropriate either
in response to an express disclosure requirement contained in a provision hereof or as an exception
to one or more representations or warranties contained in Section 2.2 with respect to the
Company, or in Section 2.3 with respect to such Anchor Investor, or to one or more
covenants contained in Article III;
(r) The term “Environmental Laws” means all federal, state or local laws relating to pollution
or protection of human health or the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata), including, without limitation, Laws
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes into the environment;
(s) the term “GAAP” means United States generally accepted accounting principles and practices
as in effect from time to time;
67
(t) the term “General Articles of Amendment” means the amendments to Company’s Articles of
Incorporation required to effect General Stockholder Proposals, pursuant to the Articles of
Amendment attached hereto as Exhibit G;
(u) the term “Governmental Consent” means any notice to, registration, declaration or filing
with, exemption or review by, or authorization, order, consent or approval of, any Governmental
Entity, or the expiration or termination of any statutory waiting periods, including the
expiration or termination of any applicable waiting period under the Xxxx-Xxxxx-Xxxxxx Antitrust
Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the
“HSR Act”);
(v) the term “Governmental Entity” means any court, administrative agency or commission or
other governmental authority or instrumentality, whether federal, state, local or foreign, and any
applicable industry self-regulatory organization;
(w) the term “Insurer” means a Person who insures or guarantees for the benefit of the
mortgagee all or any portion of the risk of loss upon borrower default on any of the mortgage loans
originated, purchased or serviced by the Company, including the Federal Housing Administration, the
United States Department of Veterans’ Affairs, the Rural Housing Service of the U.S. Department of
Agriculture and any private mortgage insurer, and providers of hazard, title or other insurance
with respect to such mortgage loans or the related collateral;
(x) the term “Knowledge” of the Company and words of similar import mean the knowledge of any
directors, executives or other employees of the Company listed on Schedule I hereto;
(y) the term “Anchor Investor Specified Representations” means the representations and
warranties made in Section 2.3(a), Section 2.3(b)A, Section 2.3(d) and
Section 2.3(e);
(z) the term “Loan Investor” means any Person (including an Agency) having a beneficial
interest in any mortgage loan originated, purchased or serviced by the Company or a security backed
by or representing an interest in any such mortgage loan;
(aa) the term “Losses” means any and all losses, damages, reasonable costs, reasonable
expenses (including reasonable attorneys; fees and disbursements), liabilities, settlement
payments, awards, judgments, fines, obligations, claims, and deficiencies of any kind, excluding
exemplary and punitive damages;
(bb) the term “Person” means any individual, firm, corporation, partnership, trust,
incorporated or unincorporated association, joint venture, joint stock company, limited liability
company, Governmental Entity or other entity of any kind, and shall include any successor (by
merger or otherwise) of such entity;
(cc) the term “Proxy Statement” means a proxy statement related to the transactions
contemplated by the Transaction Documents;
(dd) the term “Rule 144” means such rule promulgated under the Securities Act (or any
successor provision), as the same shall be amended from time to time;
(ee) the term “Schedule TO” means a tender offer statement under Section 3(e)(1) of the
Exchange Act on Schedule TO-I and all amendments, with respect to the Exchange Offer, in each case
including the document, all exhibits thereto and any document incorporated by reference therein;
68
(ff) the term “Series A Exchange” means the exchange offer pursuant to which the Series A
Preferred Stock shall be exchanged for Common Stock pursuant to the terms and conditions of such
exchange offer made by the Company to each of the holders of Series A Preferred Stock;
(gg) the term “Series A Stockholder Proposal” means the amendments proposed to be made to the
Series A Preferred Stock as contemplated by the Transaction Documents;
(hh) the term “Series B Exchange” means the exchange offer pursuant to which the Series B
Preferred Stock shall be exchanged for Common Stock pursuant to the terms and conditions of such
exchange offer made by the Company to each of the holders of Series B Preferred Stock;
(ii) the term “Series B Stockholder Proposal” means amendments proposed to be made to the
Series A Preferred Stock as contemplated by the Transaction Documents;
(jj) the term “Stockholder Proposals” means the Series A Stockholder Proposals, the Series B
Stockholder Proposals and the General Stockholder Proposals;
(kk) the term “Subsidiary” means, with respect to any Person, any corporation, partnership,
joint venture, limited liability company or other entity (x) of which such Person or a Subsidiary
of such Person is a general partner or (y) of which a majority of the voting securities or other
voting interests, or a majority of the securities or other interests of which having by their terms
ordinary voting power to elect a majority of the board of directors or persons performing similar
functions with respect to such entity, is directly or indirectly owned by such Person and/or one or
more Subsidiaries thereof;
(ll) the term “Tax” or “Taxes” means all United States federal, state, local or foreign
income, profits, estimated, gross receipts, windfall profits, severance, property, intangible
property, occupation, production, sales, use, license, excise, emergency excise, franchise, capital
gains, capital stock, employment, withholding, transfer, stamp, payroll, goods and services, value
added, alternative or add-on minimum tax, or any other tax, custom, duty or governmental fee, or
other like assessment or charge of any kind whatsoever, together with any interest, penalties,
fines, related liabilities or additions to tax that may become payable in respect thereof imposed
by any Governmental Entity, whether or not disputed;
(mm) the term “Tax Return” shall mean any return, declaration, report or similar statement
required to be filed with respect any Taxes (including any attached schedules), including, without
limitation, any information return, claim or refund, amended return and declaration of estimated
Tax;
(nn) the term “Transaction Documents” means this Agreement, the Equity Commitment Letter, the
Additional Agreements, the Treasury Letter, the Exchange Agreement, the Other Private Placement
documents, the Exchange Offer documents, the Carlyle Investor Letter, the Anchorage Investor
Letter, the Davidson Investor Letter, the Fir Tree Investor Letter and the Rights Offering
documents, as the same may be amended or modified from time to time;
(oo) the word “or” is not exclusive;
(pp) the words “including,” “includes,” “included” and “include” are deemed to be followed by
the words “without limitation”;
69
(qq) the terms “herein,” “hereof” and “hereunder” and other words of similar import refer to
this Agreement as a whole and not to any particular section, paragraph or subdivision; and
(rr) all article, section, paragraph or clause references not attributed to a particular
document shall be references to such parts of this Agreement, and all exhibit and schedule
references not attributed to a particular document shall be references to such exhibits and
schedules to this Agreement.
6.4. Independent Nature of Anchor Investors’ Obligations and Rights. The obligations
of each Anchor Investor under any Transaction Document are several and not joint with the
obligations of any other Investor, and no Anchor Investor shall be responsible in any way for the
performance of the obligations of any other Investor under any Transaction Document. The decision
of each Anchor Investor (other than those Anchor Investors that are Affiliates of each other) to
purchase the Common Shares pursuant to the Transaction Documents has been made by such Anchor
Investor independently of any other non-affiliated Investor and independently of any information,
materials, statements or opinions as to the business, affairs, operations, assets, properties,
liabilities, results of operations, condition (financial or otherwise) or prospects of the Company,
which may have been made or given by any other non-affiliated Investor or by any agent or employee
of any other non-affiliated Investor, and no Anchor Investor and any of its agents or employees
shall have any liability to any other Investor (or any other Person) relating to or arising from
any such information, materials, statement or opinions. Nothing contained in the Transaction
Documents, and no action taken by any Anchor Investor pursuant hereto or thereto, shall be deemed
to constitute the Anchor Investors as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Anchor Investors are in any way acting in concert
or as a group, and the Company will not assert any such claim with respect to such obligations or
the transactions contemplated by the Transaction Documents. Each Anchor Investor (other than those
that are Affiliates of such Anchor Investor) confirms that it has independently participated in the
negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors
and no other non-affiliated Anchor Investor has acted as agent for such Anchor Investor in
connection with making its investment hereunder and that no non-affiliated Investor will be acting
as agent of such Anchor Investor (and its Affiliates) in connection with monitoring its investment
in the Common Shares or enforcing its rights under the Transaction Documents. Each Anchor Investor
shall be entitled to independently protect and enforce its rights, including, without limitation,
the rights arising out of the Transaction Documents, and it shall not be necessary for any other
Anchor Investor to be joined as an additional party in any proceeding for such purpose. It is
expressly understood and agreed that each provision contained in this Agreement is between the
Company and an Anchor Investor, solely, and not between the Company and the Anchor Investors
collectively and not between and among the Anchor Investors.
6.5. Amendment and Waivers. The conditions to each party’s obligation to consummate
each Closing are for the sole benefit of such party and may be waived by such party in whole or in
part to the extent permitted by Law. No amendment or waiver of any provision of this Agreement will
be effective against any party hereto unless it is in a writing signed by a duly authorized officer
of such party that makes express reference to the provision or provisions subject to such amendment
or waiver.
6.6. Amendment and Restatement of Original Investment Agreement. The parties agree
that, effective as of the Modification Date (defined below), (a) the Original Investment Agreement
and the Amended and Restated Investment Agreement shall be amended in their entirety by replacing
such agreements with the provisions of this Agreement and the Original Investment Agreement and the
Amended and Restated Investment Agreement shall be of no further force and effect. Modification
Date shall mean the date on which occurs the execution and delivery by all parties of (i) this
Agreement, (ii) the second amendment and restatement of the Securities Purchase Agreement, dated as
of August 11,
70
2010, by and among the Company and the purchasers signatory thereto (the “Minority Investors Agreement”), (iii) the CapGen Investment Agreement, and (iv) such other
modifications of the other Transaction Agreements as is mutually agreed by the Anchor Investors,
the Company and CapGen.
6.7. Counterparts and Facsimile. For the convenience of the parties hereto, this
Agreement may be executed in any number of separate counterparts, each such counterpart being
deemed to be an original instrument, and all such counterparts will together constitute the same
agreement. Executed signature pages to this Agreement may be delivered by facsimile and such
facsimiles will be deemed as sufficient as if actual signature pages had been delivered.
6.8. Governing Law. This Agreement will be governed by and construed in accordance
with the Laws of the State of New York applicable to contracts made and to be performed entirely
within such State.
6.9. Jurisdiction. The parties hereby agree that any suit, action or proceeding
seeking to enforce any provision of, or based on any matter arising out of or in connection with,
this Agreement or the transactions contemplated hereby shall be brought in the United States
District Court for the Southern District of New York sitting in the borough of Manhattan, New York,
New York, so long as such court shall have subject matter jurisdiction over such suit, action or
proceeding or, if it does not have subject matter jurisdiction, in any New York State court sitting
in the borough of Manhattan, New York, New York, and each of the parties hereby irrevocably
consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in
any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by Law,
any objection that it may now or hereafter have to the laying of the venue of any such suit, action
or proceeding in any such court or that any such suit, action or proceeding which is brought in any
such court has been brought in an inconvenient forum. Process in any such suit, action or
proceeding may be served on any party anywhere in the world, whether within or without the
jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of
process on such party as provided in Section 6.11 shall be deemed effective service of
process on such party. The parties hereby irrevocably and unconditionally consent to submit to the
exclusive jurisdiction of the state and federal courts referred to above for any actions, suits or
proceedings arising out of or relating to this Agreement and the transactions contemplated hereby.
6.10. WAIVER OF JURY TRIAL.
EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY.
6.11. Notices. Any notice, request, instruction or other document to be given
hereunder by any party to the other will be in writing and will be deemed to have been duly given
(a) on the date of delivery if delivered personally or by telecopy or facsimile, upon confirmation
of receipt, (b) on the first Business Day following the date of dispatch if delivered by a
recognized next-day courier service, or (c) on the third Business Day following the date of mailing
if delivered by registered or certified mail, return receipt requested, postage prepaid. All
notices hereunder shall be delivered as set forth below, or pursuant to such other instructions as
may be designated in writing by the party to receive such notice.
(a) If to the Anchor Investors:
71
(i) if to Carlyle Global Financial Services Partners, L.P.:
c/o The Carlyle Group
0000 Xxxxxxxxxxxx Xxxxxx, XX
Xxxxxxxxxx, X.X. 00000-0000
Attn: Xxxxxx X. Xxxxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
0000 Xxxxxxxxxxxx Xxxxxx, XX
Xxxxxxxxxx, X.X. 00000-0000
Attn: Xxxxxx X. Xxxxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
with a copy (which copy alone shall not constitute notice):
Xxxxxxx Xxxxxxx & Xxxxxxxx LLP
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxxxxx Xxxxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxxxxx Xxxxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
(ii) if to ACMO-HR, L.L.C.:
c/o Anchorage Advisors, L.L.C.
000 Xxxxxxxx, 0xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxx Xxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
000 Xxxxxxxx, 0xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxx Xxxxx
Telephone: (000) 000-0000
Fax: (000) 000-0000
with a copy (which copy alone shall not constitute notice):
Milbank, Tweed, Xxxxxx & XxXxxx LLP
0 Xxxxx Xxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxxxx X. Xxxxxx, Esq.
Xxxxxxxx X. Xxxxx, Esq.
Telephone: (000) 000 0000
Fax: (000) 000-0000
0 Xxxxx Xxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attn: Xxxxxx X. Xxxxxx, Esq.
Xxxxxxxx X. Xxxxx, Esq.
Telephone: (000) 000 0000
Fax: (000) 000-0000
(b)
If to the Company:
Hampton Roads Bankshares, Inc.
000 Xxxxxxxxx Xx., Xxxxx 000
Xxxxxxx, Xxxxxxxx 00000
Attn: Xxxxxxx X. Xxxxx, Esq.
Telephone: (000) 000-0000
Fax: (000) 000-0000
000 Xxxxxxxxx Xx., Xxxxx 000
Xxxxxxx, Xxxxxxxx 00000
Attn: Xxxxxxx X. Xxxxx, Esq.
Telephone: (000) 000-0000
Fax: (000) 000-0000
with a copy (which copy alone shall not constitute notice):
Xxxxxxxx Xxxxxx
000 Xxxxxxxxx Xx., Xxxxx 0000
000 Xxxxxxxxx Xx., Xxxxx 0000
Xxxxxxx, Xxxxxxxx 00000
Attn: Xxxxxxx X. Old, Jr.
Telephone: (000) 000-0000
Fax: (000) 000-0000
Attn: Xxxxxxx X. Old, Jr.
Telephone: (000) 000-0000
Fax: (000) 000-0000
72
6.12. Entire Agreement. This Agreement (including the Exhibits and Schedules hereto),
the other Transaction Documents, the Confidentiality Agreements and the letter agreements referred
to in Section 6.2 constitute the entire agreement, and supersede all other prior
agreements, understandings, representations and warranties, inducements or conditions, both written
and oral, among the parties, with respect to the subject matter hereof and thereof.
6.13. Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their respective successors and assigns, including any purchasers of the
Common Shares. The Company shall not assign this Agreement or any rights or obligations hereunder
without the prior written consent of each of the Anchor Investors. An Anchor Investor may assign
some or all of its rights hereunder or thereunder without the consent of the Company (i) to any
third party, if in compliance with the Transaction Documents and Law or (ii) to any Affiliate of
such Anchor Investor, and such assignee shall be deemed to be an Anchor Investor hereunder with
respect to such assigned rights and shall be bound by the terms and conditions of this Agreement
that apply to “Anchor Investors.”
6.14. Captions. The article, section, paragraph and clause captions herein are for
convenience of reference only, do not constitute part of this Agreement and will not be deemed to
limit or otherwise affect any of the provisions hereof.
6.15. Severability. If any provision of this Agreement or the application thereof to
any Person (including the officers and directors of the Anchor Investors and the Company) or
circumstance is determined by a court of competent jurisdiction to be invalid, void or
unenforceable, the remaining provisions hereof, or the application of such provision to persons or
circumstances other than those as to which it has been held invalid or unenforceable, will remain
in full force and effect and shall in no way be affected, impaired or invalidated thereby, so long
as the economic or legal substance of the transactions contemplated hereby is not affected in any
manner materially adverse to any party. Upon such determination, the parties shall negotiate in
good faith in an effort to agree upon a suitable and equitable substitute provision to effect the
original intent of the parties.
6.16. Third Party Beneficiaries. Nothing contained in this Agreement, expressed or
implied, is intended to confer upon any Person or entity (including, but not limited to any
Additional Investors) other than the parties hereto, any benefit right or remedies, except that the
provisions of Sections 3.5, 3.14, 5.1 and 5.2 shall inure to the
benefit of the persons referred to in that Section.
6.17. Public Announcements. Each of the parties hereto will cooperate with each other
in the development and distribution of all news releases and other public information disclosures
with respect to the Transaction Documents and any of the transactions contemplated hereby and
thereby, including any communications to the employees and customers of the Company and its
Affiliates. Without limiting the foregoing, except as otherwise permitted in the next sentence, no
party hereto will make (and each party will use its best efforts to ensure that its Affiliates and
Representatives do not make) any such news release or public disclosure without first consulting
with the other parties hereto and, in each case, also receiving each other party’s consent (which
shall not be unreasonably withheld or delayed). In the event a party hereto is advised by its
outside legal counsel that a particular disclosure is required by Law, such party shall be
permitted to make such disclosure but shall be obligated to use its reasonable best efforts to
consult with the other parties hereto and take their comments into account with respect to the
content of such disclosure before issuing such disclosure.
73
6.18. Specific Performance. The parties agree that irreparable damage would occur in
the event that any of the provisions of this Agreement were not performed in accordance with their
specific terms. It is accordingly agreed that the parties shall be entitled to seek specific
performance of the terms hereof, this being in addition to any other remedies to which they are
entitled at law or equity.
6.19. No Recourse. This Agreement may only be enforced against the named parties
hereto. All claims or causes of action that may be based upon, arise out of or relate to this
Agreement, or the negotiation, execution or performance of this Agreement may be made only against
the entities that are expressly identified as parties hereto or that are subject to the terms
hereof, and no past, present or future director, officer, employee, incorporator, member, manager,
partner, stockholder, Affiliate, agent, attorney or representative of any of the Anchor Investors
or any other party hereto (including any person negotiating or executing this Agreement on behalf
of a party hereto) shall have any liability or obligation with respect to this Agreement or with
respect to any claim or cause of action, whether in tort, contract or otherwise, that may arise out
of or relate to this Agreement, or the negotiation, execution or performance of this Agreement and
the transactions contemplated hereby.
6.20. Consent to Supplemental Waiver. As required pursuant to Section 3 of the
Acknowledgement and Waiver of Directors, attached as Exhibit E to this Agreement and to be
executed by and among the Company, the Anchor Investors and certain directors of the Company, the
Anchor Investors hereby consent to the supplementing of such waivers as specified in Section
1.2(c)(2)(T) of the CapGen Investment Agreement.
[Signature page follows]
74
IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the duly authorized
officers of the parties hereto as of the date first herein above written.
HAMPTON ROADS BANKSHARES, INC. |
||||
By: | /s/ Xxxxxxx X. Xxxxx | |||
Xxxxxxx X. Xxxxx | ||||
Executive Vice President, General Counsel and Chief Operating Officer |
||||
CARLYLE GLOBAL FINANCIAL SERVICES PARTNERS, L.P. |
||||
By: | TCG Financial Services, L.P., its general partner | |||
By: | Carlyle Financial Services, Ltd., its general partner | |||
By: | /s/ Xxxxxx X. Xxxxxxx | |||
Name: | Xxxxxx X. Xxxxxxx | |||
Title: | Managing Director | |||
ACMO-HR, L.L.C. |
||||
By: | Anchorage Capital Master Offshore, Ltd., its sole member | |||
By: | Anchorage Advisors, L.L.C., its investment manager | |||
By: | /s/ Xxxxx Xxxxxx | |||
Name: | Xxxxx Xxxxxx | |||
Title: | Chief Executive Officer |
[Signature Page to Investment Agreement]
[SCHEDULES AND EXHIBITS HAVE BEEN OMITTED]